













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 






Regulation of Calcium Signalling 





(Supervisor: Michael Shipston) 
Presented for the Degree of Doctor of Philosophy 
 
 
The University of Edinburgh 
2019






I declare that, except where explicitly stated otherwise in the text, the word described 
herein is my own, carried out at the Centre for Discovery Brain Sciences, The 
University of Edinburgh. This thesis was composed by myself and has not been 













I would like to extend thanks to so many people who generously helped and supported 
me throughout my PhD study. 
 
Firstly, I would like to express my sincere thanks to my supervisor Prof. Michael 
Shipston for his tremendous support throughout the four years of my PhD. His 
feedback and guidance helped me direct my research all the time as well as the thesis 
write-up. His motivation, experience and knowledge are so valuable that really shapes 
my development as a researcher and formulate my attitude for my career. It’s really 
my pleasure to have this opportunity to work in his lab, which will be the most 
memorable days in my lifetime.  
 
I am hugely appreciative to Dr Nicola Romanò. I am particularly indebted to Nicola 
for his guidance in calcium imaging experiments, complicated data analysis and 
endless patience to my incessant questions. Without your support, I would not be able 
to achieve success in this work.   
 
I would like to give particular thanks to my fellow labmates. Thanks to Dr Peter J. 
Duncan and Heather McClafferty for providing me lab training and assistance with 
biochemical experiments. I have very fond memories of my time in the office with you. 





Thanks to Dr Paul Le Tissier for his advice and encouragement that always inspired 
me when I was in a jam. I am also grateful to all past and present members of the 
Centre for Discovery Brain Sciences who provided technical support. 
 
Finally, but by no means least, I must express my profound gratitude to my parents for 
providing me with incredible support and continuing encouragement throughout my 
studies. I am also grateful to my friends who have all been supportive along the way. 
This work would not have been possible without the support from my family and 
friends. Thank you. 
  






Anterior pituitary corticotrophs, the central components of the hypothalamic-pituitary-
adrenal (HPA) axis, are important for controlling the neuroendocrine response to 
stress. In response to a stressor, corticotrophin-releasing hormone (CRH) and arginine 
vasopressin (AVP) are released from the hypothalamic neuroendocrine neurones and 
act synergistically on corticotrophs to stimulate the release of adrenocorticotrophin 
hormone (ACTH). In turn, ACTH stimulates the secretion of glucocorticoids from 
adrenal glands that exerts negative feedback on the HPA axis. CRH and AVP have been 
shown to stimulate different patterns of electrical excitability in corticotrophs, with 
CRH inducing electrical bursting behaviour that is dependent upon large conductance 
voltage- and calcium-activated potassium (BK) channels whereas AVP-induced 
spiking is BK channel independent. Although CRH and AVP are known to control 
intracellular free calcium ([Ca2+]i) by different signalling pathways, several important 
questions remain. Firstly, most previous studies have examined CRH and/or 
AVP-evoked changes in calcium signalling in response to a single supraphysiological 
concentration of secretagogue whereas in vivo corticotrophs must respond to repeated 
changes in CRH and AVP. Secondly, although CRH and AVP synergise at the level of 
ACTH secretion, whether synergy is also observed at the level of intracellular free 
calcium is essentially unknown. Thirdly, although CRH and AVP regulate different 
patterns of electrical excitability, whether CRH-, or AVP-induced calcium signalling 





is modified by BK channels is not known. Fourthly, BK channels are subject to 
regulation by post-translational modifications, such as S-acylation by zDHHC23, 
however, whether S-acylation controls CRH-induced calcium signalling is not known. 
 
To address these questions and to test the overarching hypothesis that CRH-, but not 
AVP-induced [Ca2+]i signalling is dependent upon functional BK channels, a new 
lentiviral-mediated POMC-GCaMP6s reporter was developed and tested to allow 
specific labelling of live murine corticotrophs in vitro for calcium imaging recordings. 
[Ca2+]i signalling was characterised in wild-type corticotrophs under basal conditions 
and following repeated exposure to pulses of physiological levels of CRH (0.2 nM) 
and/or AVP (2 nM). Murine wild-type corticotrophs showed highly variable 
spontaneous [Ca2+]i signalling. Stimulation with CRH induced a significant sustained 
and repeatable increase of [Ca2+]i that lasted longer than the exposure to CRH. In 
contrast, AVP evoked two phenotypes of [Ca2+]i responses, oscillations and sustained 
increases, that were highly reproducible. No significant differences were observed 
between corticotrophs from male or female mice. Synergistic [Ca2+]i responses 
between CRH and AVP were observed in ~ 30% of female wild-type corticotrophs, 
although this was not significantly different at the population level. However, this was 
never observed in male corticotrophs.  
 





To test the role of BK channels in [Ca2+]i responses, we took both genetic and 
pharmacological approaches. Genetic deletion of BK channels displayed sex 
differences in regulating corticotroph spontaneous [Ca2+]i signalling. Repeated CRH 
stimulation induced significantly reduced [Ca2+]i responses in male, but not female, 
BK-KO corticotrophs compared to wild-type controls. However, CRH-evoked [Ca2+]i 
signalling was unaffected by acute pharmacological inhibition of BK channels with 
paxilline suggesting a compensatory mechanism may underlie the change in 
CRH-evoked [Ca2+]i responses in BK-KO corticotrophs. Genetic deletion of BK 
channels had no impact on [Ca2+]i responses to repeated AVP stimulation in either male 
or female corticotrophs. 
 
Genetic deletion of the S-acyl transferase zDHHC23 had no significant effect on 
spontaneous [Ca2+]i signalling. Both male and female zDHHC23-KO corticotrophs 
showed a progressive attenuation in [Ca2+]i responses to repeated CRH stimulation. 
However, compared to wild-type corticotrophs, [Ca2+]i responses evoked by repeated 
CRH or AVP stimulation were unaffected by knockout of zDHHC23 in either male or 
female corticotrophs. 
 
In conclusion, development of the lentiviral POMC-GCaMP6 calcium reporter 
allowed analysis of spontaneous and secretagogue-evoked [Ca2+]i responses 





specifically in corticotrophs in vitro. CRH evoked sustained elevations of [Ca2+]i 
whereas AVP evoked two patterns of [Ca2+]i response: sustained elevation and 
oscillation. No significant differences were observed between wild-type male and 
female corticotrophs although synergy between CRH and AVP was only observed in 
female corticotrophs. Genetic deletion of BK channels reduced CRH- but not 
AVP-induced [Ca2+]i signalling in male but not female corticotrophs. However, this is 
likely a compensatory mechanism as acute pharmacological inhibition of BK channels 
in wild-type corticotrophs did not show the same effect. zDHHC23 plays a minor role 
in regulating [Ca2+]i signalling in corticotrophs.  
 
Further studies are warranted to investigate the link between changes in electrical 
excitability, calcium signalling and the control of ACTH release in corticotrophs. The 
approach developed here should allow us to probe the mechanism of [Ca2+]i signalling 
and its regulation that is central to understand the physiological role of corticotrophs 
and the control of the stress axis. 
  






In the 21st century, stress is a pervasive feature of fast-paced life. A variety of situations 
and events can cause stress, such as injury, noise, fear, financial difficulty and 
unemployment. Although people can cope with a certain amount of stress in different 
ways, long-term excessive stress can have a negative impact on their mental and 
physical health that may eventually lead to a diverse range of stress-related illnesses, 
including cardiovascular disease, epilepsy, diabetes, hypertension, depression and 
anxiety disorders. Therefore, understanding how the response to stress is controlled is 
important for long-term health and well-being. 
 
In response to stress, two hormones, CRH and AVP, are released from the brain to 
stimulate the secretion of the stress hormone ACTH from cells (corticotrophs) in the 
pituitary gland at the base of the brain. ACTH stimulates the adrenal gland to secrete 
steroid hormones that exert powerful effects on most cells in the body. The two brain 
hormones regulate different patterns of electrical activity of corticotrophs through 
different molecular signalling pathways. Importantly, activation of these signalling 
pathways ultimately controls the levels of an important signalling molecule in 
corticotrophs, calcium ions, that control the release of ACTH. We already know that 
the movement of potassium ions across the cell membrane through ion channel pores, 
called BK channels, is important for controlling CRH-, but not AVP-induced electrical 





excitability in corticotrophs. However, whether BK channels are also important for 
controlling CRH-, or AVP-induced calcium signalling is not known. Furthermore, 
many proteins, including BK channels, are controlled by the addition of fat. It is 
unknown whether the enzymes that control the addition of fat to BK channels is 
important for controlling calcium signalling in corticotrophs. 
 
To address these questions, I first engineered a fluorescent protein that responds to 
calcium by emitting light. This allows specific labelling of live murine corticotrophs 
in vitro to investigate calcium signalling in cells. Most previous studies examined 
corticotroph calcium signalling in response to a single supraphysiological 
concentration of brain hormones whereas in vivo corticotrophs must respond to 
repeated pulses of brain hormone. In this study, I established a repeated stimulation 
protocol that allows robust and repeatable calcium responses to pulses of hormones at 
physiological concentrations. This replicates the typical secretion pulse of two brain 
hormones in vivo, which may provide valuable insight into how corticotrophs 
coordinate adaptive responses to different stress. The experimental results suggested 
that BK channels per se, rather than the key enzyme controls the addition of fat to BK 
channels, play an important role in controlling CRH-, but not AVP-induced calcium 
signalling in corticotrophs. This study also suggested sex differences in controlling 
calcium signalling in corticotrophs as the effect of loss of BK channels was only seen 





in corticotrophs from male mice.  
 
As the regulation of the calcium signalling pathway may be important for controlling 
the secretion of the stress hormone and coordination of appropriate stress responses, it 
is vital to understand the regulation of corticotroph calcium signalling. Further study 
of the link between the changes in electrical excitability, calcium signalling, and stress 
hormone secretion would lead to a greater understanding of their role in regulating 
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Chapter 1: Introduction 
1.1 Stress and health  
In the 21st century, stress is a ubiquitous condition in our daily life. Everyone 
experiences different stressful situations. A recent survey found that 74% of people in 
the UK felt overwhelmed in dealing with stress (Mental Health Foundation, 2018) and 
this has led to an increasing number of stress-related illnesses.  
 
How to define stress? The modern concept of stress recognizes stress as a real or 
sensed threat to disrupt homeostasis, which is a dynamic state of equilibrium in living 
organisms. Any situations or events causing stress are known as a stressor. Stressors 
can be generally divided into two broad categories: physiological stressors including 
pain, injury, noise and temperature extremes; and psychological stressors such as 
anxiety, frustration, interpersonal issues and unemployment. Both types of stressors 
can result in an elevated release of glucocorticoids, which act to increase the level of 
blood glucose as well as regulate multiple physiological functions including fat and 
protein metabolism (Herman et al., 2003; Spiga et al., 2014). Glucocorticoids thus also 
play an important role in human energy balance and dysregulation of glucocorticoid 
secretion may contribute to the development of obesity and metabolic syndrome 
(Nieuwenhuizen & Rutters, 2008).  





Acute stress might be good for humans by providing positive stimuli to emotional and 
intellectual growth and development (Chrousos & Gold, 1992). However, chronic 
stress has a negative impact on both physical and psychological health. Existing 
evidence suggests a consistent association between stress and the risk of 
cardiovascular disease, and chronic stress also predicts the emergence of coronary 
heart disease (CHD) (Krantz & McCeney, 2002; Steptoe & Mika Kivimäki, 2012). 
Exposure to stress may alter brain-gut interactions which leads to a range of 
gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory 
bowel disease (IBD) (Konturek et al., 2011). Long-term stress can also dysregulate the 
human immune system (Morey et al., 2015), which may also be linked to the onset of 
depression (Slavich & Irwin, 2014). Stress is also a major contributing factor to major 
depressive disorders with approximately 80% of community cases of major depression 
being preceded by stressors (Mazure, 1998; Stroud et al., 2008). Moreover, stress has 
been suggested to contribute to the initiation and development of selected cancer types 
(Heffner et al., 2003; Antoni et al., 2006). 
 
Stress evokes adaptive physiological and behavioural responses to reinstate the 
internal environment, which is important in ensuring the survival of organisms. The 
activation of the sympathetic-adrenomedullary (SAM) and hypothalamic-
pituitary-adrenal (HPA) neuroendocrine systems leads to the release of catecholamines 





and glucocorticoids (GCs, specifically cortisol in humans and corticosterone in rodents) 
respectively to regulate many physiological functions.  
 
1.2 The hypothalamic-pituitary-adrenal (HPA) axis 
The hypothalamic-pituitary-adrenal (HPA) axis is the major neuroendocrine system 
activated in response to stress and maintains body homeostasis (Figure 1.1). Physical 
or emotional stressors are perceived and conveyed via numerous neural pathways in 
the brain that eventually activate the paraventricular nucleus (PVN) of the 
hypothalamus (Herman et al., 2003). The excitation of PVN neurons results in the 
release of corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP) 
into the pituitary portal circulation. CRH and AVP act synergistically on anterior 
pituitary corticotrophs to enhance the secretion of adrenocorticotrophin hormone 
(ACTH) (Gillies et al., 1982; Lamberts et al., 1984).  
 
The pituitary gland is located within a protective recess of the sphenoid bone (sella 
turcica) underneath the hypothalamus at the base of the brain. The pituitary gland is 
connected to the hypothalamus by the pituitary stalk and comprised of two functionally 
and morphologically distinct structures: the adenohypophysis (including anterior and 
intermediate lobes) and the neurohypophysis (posterior lobe). In contrast to the 
presence of a clearly defined intermediate lobe in mice and rats, it is largely absent in 






The hypothalamic-pituitary-adrenal (HPA) axis 
 
Figure 1.1 The hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is the 
major neuroendocrine system activated in response to stress. Following stimulation, 
corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) are released 
from hypothalamic neuroendocrine neurones, which stimulate the synthesis and 
secretion of the stress hormone adrenocorticotrophin (ACTH) from corticotrophs in 
the anterior pituitary gland. ACTH then stimulates the synthesis and release of 
glucocorticoids from the adrenal cortex. In turn, glucocorticoids exert a negative 
feedback of the HPA axis at the level of both the pituitary and the hypothalamus. 
  





humans. The anterior and intermediate lobes are derived from oral ectoderm and forms 
Rathke’s pouch, whereas the posterior lobe is neuroectodermal origin (Kelberman et 
al., 2009; Stojilkovic et al., 2010). The posterior lobe secretes antidiuretic hormone 
(ADH, also known as vasopressin) and oxytocin, which are synthesized and released 
from neurones of the supraoptic and paraventricular nuclei of the hypothalamus 
respectively. The intermediate lobe produces and releases melanocyte-stimulating 
hormone (MSH) from melanotrophs. The anterior lobe is composed of five endocrine 
cell types with different relative proportions: somatotrophs (up to 50%), lactotrophs 
(10–25%), gonadotrophs (10–15%), thyrotrophs (< 10%) and corticotrophs (2–15%), 
with each cell type secreting different hormones: growth hormone (GH), prolactin 
(PRL), luteinizing hormone (LH) and follicle-stimulating hormone (FSH), 
thyroid-stimulating hormone (TSH) and ACTH respectively. The anterior lobe also 
contains 5–10% of non-endocrine folliculostellate cells (Ooi et al., 2004; Yeung et al., 
2006; Stojilkovic et al., 2010). 
 
ACTH, a 39 amino acid peptide, is produced as a part of large precursor 
proopiomelanocortin (POMC), a 241 amino acid peptide (Raffin-Sanson et al., 2003). 
Following CRH and/or AVP stimulation, ACTH is released from corticotrophs and 
transported via the systemic circulation to stimulate the synthesis and secretion of 
glucocorticoids from the zona fasciculata of the adrenal by acting on type 2 





melanocortin receptors (MC2-R). Approximately 90–95% of plasma cortisol in 
humans is bound to proteins including corticosteroid binding globulin (CBG) and 
serum albumin, while only 5–10% of the total plasma cortisol circulates in an unbound 
state which is biologically active (Kudielka & Kirschbaum, 2005). Glucocorticoids are 
involved in the physiological adaptations to cope with stress and exert a negative 
feedback of the HPA axis at the level of both the pituitary and the hypothalamus. Two 
types of glucocorticoid receptor are involved in the feedback mechanisms: a high 
affinity mineralocorticoid receptor (MR, type I), which is present in the hypothalamus 
and highly expressed in the hippocampus; and a low-affinity glucocorticoid receptor 
(GR, type II), which is expressed throughout the brain but mainly in hypothalamic 
neurons and corticotrophs (Ratka et al., 1989; Joëls & de Kloet, 1992). Feedback 
inhibition of HPA axis is principally mediated via the GRs, which are activated through 
binding of glucocorticoids and then translocate into the nucleus to regulate relevant 
transcription factors to alter the transcription of glucocorticoid-sensitive genes 
(Papadimitriou & Priftis, 2009).  
 
Glucocorticoid negative feedback can be divided into three time domains: fast (within 
seconds to minutes), intermediate (minutes to 2–3 hours) and slow (over hours to days) 
(Keller-Wood & Dallman, 1984; Shipston, 1995). Previous studies have reported that 
glucocorticoids rapidly regulate ACTH release though a non-genomic signalling 





pathways, including regulation of ion channel activity (Loechner et al., 1999) and 
mediated by one or more membrane-associated glucocorticoid receptors (Tasker et al., 
2006). Compared to controls, injection of corticosterone immediately before CRH 
resulted in a significant reduction in CRH-induced plasma ACTH levels in rats, which 
provides evidence of a rapid and non-genomic effect of glucocorticoids (Hinz & 
Hirschelmann, 2000). Glucocorticoids have been shown to regulate BK channel 
activity in AtT20 cells through a non-genomic mechanism as well (Huang et al., 2006). 
A wide body of evidence reveals that intermediate effects of glucocorticoids involve 
predominantly genomic mechanisms to inhibit secretagogue-evoked ACTH secretion. 
In large part, this appears to be downstream of the protein kinase A (PKA) or protein 
kinase C (PKC) signalling pathways through acting at or beyond intracellular free 
calcium mobilization (Shipston, 1995). Slow glucocorticoid negative feedback 
involves the inhibition of the POMC gene transcription (Autelitano et al., 1989) and 
the reduction of ACTH expression in corticotrophs (Lundblad & Roberts, 1988; Engler 
et al., 1999). In addition, glucocorticoids have been implicated in contributing to the 
downregulation of CRH expression in the PVN as well as CRH receptors in 
corticotrophs (Pozzoli et al., 1996; Herman et al., 2003).  
 
Under basal conditions, glucocorticoids are normally released following a robust 
ultradian and circadian rhythm. The circadian rhythm of the HPA axis is primarily 





regulated by the suprachiasmatic nucleus (SCN) with a daily peak during the active 
time which is daytime in humans and night-time in mice and rats. The rapid ultradian 
oscillations of glucocorticoid levels are thought to originate from the dynamics of 
feedback between the adrenal gland and pituitary corticotrophs (Walker et al., 2010; 
Spiga et al., 2014; Oster et al., 2017).  
 
1.3 Anterior pituitary corticotrophs in the control of 
the HPA axis 
1.3.1 The regulation of corticotrophs 
ACTH-producing corticotrophs, the central components of the HPA axis, are vital for 
mediating the neuroendocrine response to stress. Corticotrophs receive excitatory 
neuropeptide (CRH and AVP) signals from the hypothalamus to stimulate the secretion 
of ACTH. ACTH subsequently stimulates synthesis and release of glucocorticoids 
from the adrenal gland, which in turn exerts negative feedback on corticotrophs to 
inhibit the HPA axis. Therefore, it is important to understand the regulation of 
corticotrophs. 
 
In response to stress, hypothalamic hormones CRH and AVP are released into the 
portal blood circulation from PVN neurones. The portal plasma concentration of CRH 
and AVP is approximately 0.2 nM and 2 nM respectively during stress (Gibbs & Vale, 





1982; Sheward & Fink, 1991). CRH and AVP activate distinct G-protein-coupled 
receptors on anterior pituitary corticotrophs to stimulate ACTH release. CRH is a 
highly conserved peptide hormone composed of 41 amino acids which was first 
discovered and characterized in 1983 (Vale et al., 1983). CRH neurons are situated in 
the parvicellular division of the PVN (pPVN) in the hypothalamus and project axons 
to the median eminence to secret CRH into the portal circulation (Majzoub, 2006). 
Two major subtypes of CRH receptor termed CRH receptor 1 (CRHR1) and CRH 
receptor 2 (CRHR2) belong to the G protein-coupled receptors (GPCRs) family B. 
CRH exerts its physiological effect exclusively via CRHR1 in corticotrophs to regulate 
the HPA axis (Bale & Vale, 2004; Papadimitriou & Priftis, 2009) (Figure 1.2). CRHR1 
couples to the stimulatory Gαs G-protein pathway leading to an activation of adenylate 
cyclase (AC), subsequently inducing the accumulation of cyclic adenosine 
monophosphate (cAMP) and activation of protein kinase A (PKA) (Murat et al., 2012). 
PKA-dependent phosphorylation of L-type Ca2+ channels has been suggested to drive 
an influx of extracellular Ca2+ which is essential for ACTH secretion (Kuryshev et al., 
1995, 1996; Lee & Tse, 1997). However, some studies have also implicated 
calcium-induced calcium release (CICR) resulting in the release of Ca2+ from the 
intracellular stores as a result of activation of ryanodine receptors (RyRs) (Soares et 
al., 2005). The RyR inhibitor ruthenium red induced a significant reduction in 
CRH-induced ACTH release in AtT20 cells suggesting CICR is also involved in the 





regulation of CRH-induced ACTH secretion (Yamamori et al., 2004). 
 
AVP is a 9 amino acid peptide which is synthesized and secreted by magnocellular 
neurons in the paraventricular nucleus (mPVN) and supraoptic nucleus (SON) of the 
hypothalamus as well as CRH-producing parvicellular neurons of the PVN (Antoni, 
1993). AVP produced by pPVN neurons is secreted into the hypophyseal portal 
circulation to regulate the HPA axis. Three specific receptor subtypes, V1a, V1b (or 
V3) and V2 belong to the GPCRs family A and regulate the physiological effects of 
AVP (Papadimitriou & Priftis, 2009; Goncharova, 2013). AVP stimulates the release 
of ACTH through binding to V1b receptors located on corticotrophs (Figure 1.2). V1b 
is coupled to the Gαq pathway which results in an activation of phospholipase C (PLC), 
leading to the cleavage of phosphatidylinositol 4,5-biphosphate (PIP2) to generate 
inositol 1,4,5-triphosphate (IP3), which binds to IP3 receptors (IP3R) on the 
endoplasmic reticulum (ER) to release Ca2+ from intracellular stores, and 
diacylglycerol (DAG), which activates protein kinase C (PKC) (Tse & Lee, 1998; 
Murat et al., 2012). Other studies have demonstrated that AVP, at supraphysiological 
concentrations, evokes transient and plateau phases of ACTH secretion, with the 
transient phase largely resulting from intracellular Ca2+ release while the plateau phase 
primarily involves extracellular Ca2+ entry via voltage-gated Ca2+ channels (VGCC) 
through a PKC-mediated pathway (Tse & Lee, 1998). 






CRH and AVP act synergistically to regulate ACTH secretion 
 
Figure 1.2 CRH and AVP act synergistically to regulate ACTH secretion. CRH and 
AVP activate distinct G-protein coupled receptors to stimulate ACTH secretion. CRH 
acts on CRH receptor 1 (CRHR1) which couples to the Gαs pathway to activate 
adenylate cyclase (AC), increase cyclic adenosine monophosphate (cAMP) and 
activate protein kinase A (PKA). AVP acts on AVP receptor V1b coupled to the Gαq 
pathway leading to cleavage of phosphatidylinositol 4,5-biphosphate (PIP2) to 
generate inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 stimulates 
calcium release from the endoplasmic reticulum (ER) stores whereas DAG activates 
protein kinase C (PKC). PKA and PKC control the activity of ion channels to promote 
an increase of intracellular free calcium which triggers ACTH release. Glucocorticoids 
regulates ACTH secretion through both non-genomic and genomic signalling 
pathways. 





In comparison to AVP, CRH is a more potent secretagogue in most species including 
humans, non-human primates, rats, horses but not sheep. Importantly, CRH and AVP 
have been demonstrated to act synergistically to stimulate the secretion of ACTH 
(Antoni, 1993; Favrod-Coune et al., 1993; Aguilera, 1998). The synergistic effect of 
AVP on CRH-induced cAMP accumulation results in a synergistic release of ACTH. 
Furthermore, it has also been demonstrated that the PKC-dependent reduction of 
TREK channels contributes to the synergy between CRH and AVP (Stojilkovic et al., 
2010; Lee et al., 2015). However, whether CRH and AVP synergy is also observed at 
the level of electrical activity and intracellular free calcium in corticotrophs is very 
poorly understood. 
 
1.3.2 Calcium signalling in corticotrophs 
Many endocrine pituitary cells are able to fire action potentials spontaneously, like 
neurons, which are associated with the rise of intracellular free calcium ([Ca2+]i) 
(Stojilkovic et al., 2010). The pattern of electrical activity varies among pituitary cells 
and two distinct types are observed in corticotrophs: single action potentials (spikes) 
and pseudo-plateau bursting (Liang et al., 2011; Duncan et al., 2015; Fletcher et al., 
2017) (Figure 1.3). However, the link between these distinct patterns of electrical 
activity and associated elevation of [Ca2+]i in corticotrophs remains unclear. In part, 
this has been because of the challenge of unambiguously identifying corticotrophs in 






Two distinct patterns of electrical activity in corticotrophs 
 
Figure 1.3 Two distinct patterns of electrical activity in corticotrophs. Two distinct 
patterns of electrical activity are observed in corticotrophs: (A) single spiking and (B) 
pseudo-plateau bursting evoked by CRH/AVP. Grey shading indicates membrane 
potential between −50 mv to +10 mv. Images are adapted from Duncan et al., 2015. 
  







1.3.2.1 Identification of corticotrophs 
In many previous studies, the AtT20 cell line, which is derived from a 
radiation-induced anterior pituitary tumour, has been widely used to investigate the 
function of corticotrophs (Surprenant, 1982; Ooi et al., 2004). AtT20 cells maintain 
many properties and functions of primary pituitary corticotrophs, however, AtT20 
cells lack AVP receptors and several ionic mechanisms appear to be different from 
native corticotrophs (Woods et al., 1992). Some experiments have also been carried 
out on the cells from human pituitary corticotroph tumours (Mollard et al., 1987; 
Takano et al., 1996). However, the number of studies that have analysed individual 
identified normal corticotrophs has until recently been very limited. 
 
As indicated before, the anterior pituitary gland is made up of five types of hormone 
secreting cells with corticotrophs only comprising ~10% of the population, which 
makes it difficult to identify and distinguish live corticotrophs from the mixed cell 
populations. Several methods have been used in previous studies to identify and label 
corticotrophs from primary cell cultures. Biotinylated CRH peptides has been used to 
identify corticotrophs in vitro (Childs et al., 1987). Treatment with high concentrations 
of CRH results in an increase in corticotroph volume, which allows the purification 





of corticotrophs by centrifugal elutriation (Ritchie et al., 1996; Kuryshev et al., 1997). 
In addition, corticotrophs are identified based on the expression of ACTH that can be 
detected using the reverse haemolytic plaque assay (Lee & Tse, 1997). Post hoc 
staining of fixed cells for ACTH immunoreactivity can also be used for the 
identification of corticotrophs (Brunton et al., 2007). However, all these studies have 
obvious drawbacks: a large majority of experiments are stimulated with CRH and AVP 
that are several orders of magnitude higher than those reported in vivo; prior exposure 
to a high dose of CRH makes it difficult to investigate the spontaneous activity in the 
absence of secretagogues; and all these approaches do not allow analysis of behaviour 
before stimulation/identification in real time in vitro.  
 
1.3.2.2 Measuring intracellular calcium in corticotrophs 
Previous studies have exploited transgenic mice constitutively expressing green 
fluorescent protein (GFP) under control of the Pomc promoter or expressed enhanced 
yellow fluorescent protein (eYFP) with a lentiviral transduction system to label 
corticotrophs in vitro, which allow the identification of corticotrophs without 
compromising normal cell functions (Lee et al., 2011; Liang et al., 2011). A recent 
study used BK-POMC-GFP mice, which expressed green fluorescent protein (GFP) 
under the Pomc promoter to identify corticotrophs in culture (Duncan et al., 2015). 
However, they are not the ideal tools to identify and label corticotrophs when we want 





to investigate [Ca2+]i signalling in corticotrophs at the same time, as they are not able 
to bind Ca2+ and indicate [Ca2+]i dynamic changes by changing their fluorescence 
properties. Importantly, these new labelling approaches provide us a new insight to 
integrate the lentiviral mediated transduction system with genetically encoded calcium 
indicators to identify corticotrophs when investigating [Ca2+]i signalling. 
 
As described above (see 1.3.1), CRH and AVP activate different calcium signalling 
pathways in corticotrophs. CRH primarily evokes calcium influx through L-type 
calcium channels whereas AVP primarily stimulates elevations in [Ca2+]i through a 
combination of both release of calcium from IP3-sensitive intracellular stores and 
influx of calcium via VGCC. In order to measure dynamic changes in [Ca2+]i in 
corticotrophs, a variety of calcium indicators, which are based on fluorescent 
molecules whose fluorescence properties change depending on Ca2+ binding, can be 
used. There are two classes of calcium indicators: synthetic (chemically synthesized) 
calcium indicators and genetically encoded calcium indicators (GECIs) (Horikawa, 
2015; Lock et al., 2015).  
 
Chemical synthetic calcium indicators are small molecules with a fluorescent 
chromophore that are able to chelate Ca2+ with highly selectivity like 
1,2-bis(o-aminophenoxy)ethane-N,N,-N’,N’-tetraacetic acid (BAPTA), including 





fura-2, indo-1, fluo-4 and Oregon Green BAPTA-1 (OGB-1) (Perry et al., 2015). The 
advantages of small molecule dyes include readily available from commercial sources; 
ease for intracellular loading by using their acetoxymethyl esters (AM) instead of gene 
transfer; high sensitivity and fast response kinetics, high spatiotemporal resolution of 
imaging and in several cases allowing ratiometric imaging to avoid artefacts from dye 
accumulation. However, there are also several drawbacks of chemical calcium 
indicators, such as unable to specifically target subpopulations of cells; poor loading 
into some cell types; suffer from deleterious compartmentalization and poor retention; 
photobleaching and leakage of dyes occurring over long-term imaging (Palmer & 
Tsien, 2006; Horikawa, 2015; Suzuki et al., 2016).  
 
GECIs are fluorescent proteins having a specific Ca2+ responsive element which 
modifies the spectral properties of the fluorescent proteins upon Ca2+ binding. GECIs 
can be divided into three categories: (i) bioluminescent sensors, such as aequorin; (ii) 
indicators based on the efficiency change of Förster resonance energy transfer (FRET) 
between two fluorescent proteins; (iii) indicators based on changes in fluorescence 
intensity of a single fluorescent protein (Horikawa, 2015; Perry et al., 2015). 
Compared to synthetic chemical calcium indicators, GECIs provide the following 
advantages: (i) allows selectively targeting to distinct population of cells and 
subcellular compartments using cell specific promoters or expressing specific 





targeting sequences; (ii) incorporated into transgenic or transduced mice/organisms to 
avoid loading exogenous dyes; (iii) enabling a micro-domain or nano-domain of Ca2+ 
dynamic measurement in the immediate vicinity of a given protein and (vi) suitable 
for long-term and non-invasive imaging (Palmer & Tsien, 2006; Lock et al., 2015; 
Suzuki et al., 2016; Garcia et al., 2017). Although some predecessors of GECIs have 
significant limitations ranging from low brightness, low sensitivity and very 
slow kinetics, most recently developed GECIs exhibit improved brightness and speed, 
dynamic range, thermal stability as well as folding efficiency (Mao et al., 2008). 
 
The GCaMP family, single fluorescent protein-based indicators, are one of the most 
widely used GECIs. GCaMPs are composed of a circularly permuted enhanced green 
fluorescent protein (cpEGFP), a calcium binding protein calmodulin (CaM) at the C-
terminus and CaM binding motif M13 peptide, which is derived from skeletal muscle 
myosin light chain kinase, at the N-terminus. Upon Ca2+ binding, the C- and N- 
terminus associate to induce the interaction between the CaM motif and M13 peptide. 
The conformational changes in the CaM/M13 complex cause an increase in 
fluorescence intensity of the cpEGFP-based chromophore (Nakai et al., 2001; 
Akerboom et al., 2009; Chen et al., 2013b). The most recently developed GCaMP 
derivatives in 2013 are GCaMP6s, 6m and 6f (for slow, medium and fast kinetics, 
respectively), which have improved fluorescence intensity and signal-to-noise ratio 





compared to previous versions, with sensitivity comparable to synthetic Ca2+ 
indicators (Chen et al., 2013b; Ding et al., 2014). Of particular interest is GCaMP6s 
that shows the highest Ca2+ sensitivity but slow response kinetics, which may have 
more utility in monitoring cytosolic Ca2+ changes, such as in corticotrophs, where fast 
kinetics are not necessary. In addition, chronic imaging of GCaMP6s-expressing 
neurons has been shown up to 2 months without disturbing their physiological function 
suggesting the superiority of GCaMP6s in non-invasive imaging over extended time 
periods (Chen et al., 2013b; Garcia et al., 2017).  
 
In this Thesis, GCaMP6s was chosen as the calcium indicator of choice to allow real 
time identification and analysis of calcium signals of corticotrophs by exploiting a 
genetic approach to express the calcium indicator under the control of a minimal Pomc 
promoter. A previous study utilized lentiviral mediated transduction of primary murine 
pituitary cells with a fluorescent enhanced yellow fluorescent protein (eYFP) under 
the control of the minimal Pomc promoter as an efficient and specific approach to 
identify and label corticotrophs in vitro (Liang et al., 2011). Importantly, this study 
also revealed that lentiviral mediated transduction of corticotrophs with POMC-eYFP 
reporter does not compromise the viability and function of corticotrophs, which allows 
the systematic analysis of murine corticotroph properties. Furthermore, most previous 
studies of calcium imaging in corticotrophs only recorded for a short period of time in 





response to a single stimulation with secretagogues. However, CRH release is pulsatile 
with a mean ultradian frequency of ~ three pulses per hour (Ixart et al., 1991). To 
imitate a typical CRH exposure at physiologically relevant concentrations, a chronic 
imaging time frame is required to monitor Ca2+ dynamics in response to multiple 
exposures. Thus, a key aim of the Thesis was to develop a lentiviral system to express 
GCaMP6s in corticotrophs under the control of a minimal Pomc promoter to allow 
identification and long-term imaging of corticotrophs in vitro. 
 
1.3.3 Excitability of corticotrophs 
Numerous ion channels are expressed in corticotrophs that are important in regulating 
their electrical activity. Voltage-gated Na+ channels (Nav) generate the fast upstroke of 
the action potential and control the maximum spike amplitude in most nerve, muscle 
and neuroendocrine cells (Stojilkovic et al., 2010). Previous studies have indicated 
that all pituitary cells including corticotrophs express Nav channels that are sensitive 
to tetrodotoxin (TTX), a voltage-gated Na+ channel blocker. However, inhibition of 
Nav channels with TTX has no consistent effect on spontaneous action potentials of 
corticotrophs, whereas removal of extracellular Na+ with the large impermeant organic 
cation N-methyl-D-glucamine (NMDG+) results in cessation of spontaneous action 
potential firing (Liang et al., 2011). Moreover, a background Na+ conductance can be 
recorded at the potassium reversal potential, suggesting a background Na+ 





conductance is crucial in maintaining the resting membrane potential of murine 
corticotrophs (Stojilkovic et al., 2010; Liang et al., 2011). Furthermore, inward-
rectifier K+ channels (Kir) have been shown to contribute to the regulation of resting 
membrane potential in rat but not murine corticotrophs (Kuryshev et al., 1997; Liang 
et al., 2011). TWIK-related K+ channel (TREK)-1have been identified to play a role 
in controlling the resting membrane potential in murine corticotrophs (Lee et al., 2011). 
 
Voltage-gated Ca2+ channels (Cav, also known as VGCC) are composed of five 
subunits: one large α1 subunit and four smaller ancillary subunits, α2, β, γ and δ 
(Stojilkovic, 2008). Electrophysiologically, two major types of Cav channels have been 
identified: high-voltage-activated (HVA) Cav channels require moderate to strong 
depolarisation to open and are distinguished by their single-channel conductance, 
pharmacology and metabolic regulation, including L-, N-, P/Q- and R-type Ca2+ 
channels; low-voltage-activated (LVA) Cav channels, also referred to transient or 
T-type Ca2+ channels, require less membrane depolarisation to activate, which 
followed by a rapid and complete inactivation and a strong membrane 
hyperpolarization is required to release them from inactivation (Stojilkovic, 2008; 
Stojilkovic et al., 2010). The functional expression of VGCC has been well established 
in corticotrophs. CRH-induced [Ca2+]i increase in corticotrophs is due to the firing of 
calcium-dependent action potentials, which are primarily dependent on Ca2+ influx via 





L-type Ca2+ channels (Kuryshev et al., 1996). Activation of T-type Ca2+ channels have 
also been proposed in regulating membrane potential and helping initiate Ca2+ 
dependent action potentials (Guérineau et al., 1991; LeBeau et al., 1997). P/Q-type 
Ca2+ channels have been proposed to drive the depolarization needed to generate action 
potentials and regulate spontaneous electrical activity in corticotrophs (Fiordelisio et 
al., 2007).  
 
Calcium-activated K+ channels (KCa) comprise three families: (i) one family includes 
three small conductance calcium-activated potassium (SK) channels (KCa2.1, 2.2, and 
2.3); (ii) the intermediate conductance calcium-activated potassium (IK) channels 
(KCa3.1) and (iii) large conductance calcium- and voltage-activated potassium (BK) 
channels (Stojilkovic et al., 2010). Pharmacological inhibition of IK channels with an 
IK channel blocker, TRAM-34, results in an increase in corticotroph excitability 
associated with a transition to a pseudo-plateau bursting. In murine corticotrophs, 
genetic deletion of IK channels shows an enhanced level of plasma ACTH and 
corticosterone under restraint stress compared to wild-type controls. Moreover, CRH 
and AVP mRNA expression is significantly elevated in mice lacking IK channels 
(Liang et al., 2011). These data suggested that IK channels play a role in controlling 
the corticotroph excitability and ACTH secretion and may also contribute to regulate 
HPA stress axis function.  





1.3.4 The role of BK channels in corticotroph excitability 
BK channels are composed of four pore-forming α-subunits which assemble as 
tetramers to form functional channels and are encoded by a single gene (KCNMA1) 
in all organisms. The pore-forming α-subunit of BK channel consists of seven 
transmembrane domains (S0-S6), with a pore-gate domain between S5 and S6 
domains and a voltage sensor domain comprised of S1-S4 domains, an extracellular 
amino (NH2 or N-) terminus at the S0 domain and a large intracellular carboxyl 
(COOH or C-) terminus containing two regulators of K+ conductance (RCK1 and 
RCK2). Calcium binding sites called “calcium bowls” are located within the 
C-terminus which is important for Ca2+ sensitivity of the channels (Meera et al., 1997; 
Coetzee et al., 1999). The diversity of BK channel properties and function may be 
achieved by assembly with tissue specific auxiliary β-subunits (β1-β4) (Behrens et al., 
2000; Orio et al., 2002) and γ-subunits (Yan & Aldrich, 2012) as well as various splice 
variants of the α-subunit (Lagrutta et al., 1994; Tseng-Crank et al., 1994; Xie & 
McCobb, 1998; Zarei et al., 2001; Fury et al., 2002; Chen et al., 2005) (Figure 1.4). 
BK channels are widely expressed in virtually all mammalian cells and play important 
roles in a diverse range of physiological processes including smooth muscle 
contraction (Wellman & Nelson, 2003), blood flow (Sausbier et al., 2005), hormone 
secretion (Ghatta et al., 2006), neuronal excitation (Sausbier et al., 2004) and 
neurotransmitter release (Wang et al., 2001). Malfunction of BK channels can lead to 






Schematic illustrating the topology of the BK channel and two 
S-acylated sites in the pore-forming α-subunit 
 
Figure 1.4 Schematic illustrating the topology of the BK channel and two 
S-acylated sites in the pore-forming α-subunit. The pore forming α-subunit of BK 
channels consists of seven transmembrane domains (S0-S6), an extracellular amino 
(NH2) terminus and a large intracellular carboxyl (COOH) terminus containing two 
regulators of K+ conductance RCK1 and RCK2. The regulatory β- and γ-subunits are 
also illustrated. BK channel α-subunits are S-acylated at two distinct sites: the 
intracellular S0-S1 loop and the alternatively spliced stress axis-regulated exon 
(STREX) insert in the linker between the two RCK domains in the C-terminus. 
  





epilepsy (Du et al., 2005), asthma (Seibold et al., 2008), obesity (Jiao et al., 2011), 
hypertension (Brenner et al., 2000) and many other disorders.  
 
Alternative splicing is a regulated process to produce multiple transcripts from a single 
gene through combining exons in different ways. The α-subunits of BK channels, only 
encoded by KCNMA1, undergoes extensive alternative pre-mRNA splicing to 
generate BK channel variants with distinct properties, which is important in 
diversifying channel function. Previous studies have demonstrated that two major 
splice variants are predominantly expressed in the pituitary and adrenal glands. The 
STREX (stress axis-regulated exon) variant containing a cysteine-rich domain of 58 
amino acids insert increases Ca2+ sensitivity, and ZERO channels, which do not 
express STREX splice insert (Saito et al., 1997; Xie & McCobb, 1998). Removal of 
the anterior pituitary gland results in a reduced expression of STREX splice variants 
in the adrenal gland (Xie & McCobb, 1998). Alternative splicing of BK channels 
determines their sensitivity to protein phosphorylation to control channel regulation. 
ZERO variants of BK channels are activated by PKA whereas STREX-containing BK 
channels are inhibited by PKA dependent phosphorylation, which is due to the 
dissociation of STREX domain from the plasma membrane (Tian et al., 2001, 2008). 
In addition, the presence of STREX determines PKC regulation of BK channels. PKC 
phosphorylation inhibits ZERO channels, however, STREX splice variant is entirely 





resistant to PKC phosphorylation unless the channels have been previously inhibited 
by PKA (Zhou et al., 2012). 
 
Previous studies have shown a paradoxical role of BK channels in generating 
spontaneous pseudo-plateau bursting in anterior pituitary somatotrophs and 
gonadotrophs (Van Goor et al., 2001a; Tabak et al., 2011). Anterior pituitary 
corticotrophs, also express BK channels but exhibit primarily spontaneous single 
spikes which can transit to pseudo-plateau bursting when stimulated with CRH 
(Duncan et al., 2015). However, CRH and AVP evoke distinct patterns of electrical 
excitability with AVP promoting an increase in spiking frequency through a 
BK-independent pathway (Duncan et al., 2015). A simplified mathematical model 
used in previous studies (Duncan et al., 2015, 2016) has suggested six major ionic 
currents expressed in corticotrophs including L-type Ca2+ current, inward rectifier K+ 
current, delayed rectifier K+ current, BK-near current, BK-far current and nonselective 
current (Figure 1.5). Two functional populations of BK channels are predicted by the 
model: BK channels in close proximity to VGCC (BK-near) and the other BK channels 
located far from the VGCC (BK-far). The fast activation of BK-near channels caused 
by the high concentration of micro-domain [Ca2+]i close to VGCC has been 
demonstrated to be necessary in promoting pseudo-plateau bursting (Tabak et al., 
2011). In contrast, BK-far channels, responding to the slowly increased bulk cytosolic  






Schematic diagram of the ion channels in corticotroph model 
 
Figure 1.5 Schematic diagram of the ion channels in corticotroph model. Six ionic 
currents are expressed in corticotrophs including L-type Ca2+ current, inward rectifier 
K+ current, delayed rectifier K+ current, BK-near current, BK-far current and 
nonselective current. 
  





[Ca2+]i, predominantly control the termination of bursting (Tsaneva-Atanasova et al., 
2007). However, the molecular biology of these populations has not been established. 
This may represent different splice variants of BK channels or other calcium-activated 
potassium channels, such as IK or SK channels. Importantly, pseudo-plateau bursting 
has been proposed to increase [Ca2+]i to a greater extent than during single spiking, 
and thus proposed to drive a higher level of hormone secretion (Van Goor et al., 2001b; 
Stojilkovic et al., 2005). However, a more recent study, has revealed that spiking may 
be just as effective as bursting at evoking hormone release if the release sites are close 
to Ca2+ channels or at higher spiking frequencies (Tagliavini et al., 2016).  
 
Although loss of BK channels in mice leads to a stress hyporesponsiveness with 
attenuated acute restraint stress induced plasma ACTH and corticosterone levels 
compared to controls, which may involve effects at both the level of the corticotroph 
and the hypothalamus (Brunton et al., 2007). However, whether BK channels also play 
an important role in CRH-, or AVP-induced [Ca2+]i signalling in corticotrophs is 
unknown. 
 
1.4 S-acylation controls BK channel properties and 
function 
1.4.1 S-acylation and its enzymatic regulation  





Most proteins, including ion channels, are regulated by a diverse range of 
post-translational modifications (PTMs), such as lipid modifications and 
phosphorylation. Lipid modifications attach lipids and lipid-like groups onto proteins, 
which increase protein hydrophobicity, affect protein structure and the affinity of 
proteins for membranes (Resh, 2006a; Chamberlain & Shipston, 2015). There are 
three most common lipid modifications: N-myristoylation, prenylation and 
S-acylation. N-myristoylation is the addition of a 14-carbon saturated fatty acid 
myristate to the N-terminal glycine through an amide bond. Prenylation is the addition 
of a 15-carbon (farnesyl) or 20-carbon (geranylgeranyl) isoprenoid to 
the COOH-terminal cysteine residues of the protein though a thioether bond. S-
acylation involves the attachment of a lipid (typically but not exclusively palmitate, a 
16-carbon saturated fatty acid) to intracellular cysteine residues of a target protein via 
a thioester linkage. Importantly, S-acylation, unlike the other two irreversible lipid 
modifications N-myristoylation and prenylation, is the only fully reversible 
post-translational lipid modification of proteins. This ubiquitous PTM provides a 
dynamic mechanism in regulating protein properties and functions across species: 
from yeast to man (Resh, 2006b; Shipston, 2011; Chamberlain & Shipston, 2015). 
S-acylation of most proteins is enzymatically mediated by a large family of 
transmembrane zinc-finger containing protein palmitoyl acyl-transferases (zDHHC 
family). To date, 23/24 zDHHCs genes have been identified in mammals. zDHHCs 





have a highly conserved Asp-His-His-Cys (DHHC) signature sequence within a 
cysteine rich stretch of ∼50 amino acids critical for catalytic activity (Shipston, 2011; 
Chamberlain & Shipston, 2015). In addition, increasing evidence suggests distinct 
zDHHC enzymes display substrate specificity for proteins (Greaves & Chamberlain, 
2011). Subcellular localization and tissue specific distribution of zDHHCs are also 
demonstrated, with the majority of zDHHCs localized to the endoplasmic reticular 
(ER) and/or Golgi membranes and a few localized in the plasma membrane (Ohno et 
al., 2006). Conversely, enzymes that control the de-acylation of proteins have not been 
clearly defined. The cytosolic acyl protein thioesterase 1 (APT1), APT2, the palmitoyl 
protein thioesterase 1 (PPT1) and PPT2 are most likely responsible for the de-acylation 
process (Figure 1.6). PPT1 is primarily expressed in lysosomes that probably involves 
in de-acylation of proteins during degradation (Shipston, 2013, 2014a; Chamberlain 
& Shipston, 2015).  
 
1.4.2 Regulation of BK channels by S-acylation 
S-acylation has been shown to play a diverse role in the regulation of multiple ion 
channels including: the modulation of L-type Ca2+ channels function via the 
β2a subunit (Chien et al., 1996), the regulation of voltage sensing of the voltage-gated 
Kv1.1 channel through protein-membrane interaction (Gubitosi-Klug et al., 2005) and 
the phosphorylat ion-dependent regulation and trafficking of BK channels  






Reversible enzymatic regulation of S-acylation 
 
Figure 1.6 Reversible enzymatic regulation of S-acylation. S-acylation is controlled 
by a large family of transmembrane zinc-finger containing protein palmitoyl 






















(Tian et al., 2001, 2004, 2008; Zhou et al., 2001). Both the BK channel pore-forming 
α-subunit and regulatory β-subunits are S-acylated. In particular, the pore-forming α-
subunit is S-acylated at two distinct sites: cysteine residues within the intracellular 
loop between transmembrane domains S0 and S1 (S0-S1 loop) and the alternatively 
spliced STREX insert in the intracellular linker between the two RCK domains in the 
C-terminus (Shipston, 2013) (Figure 1.4). 
 
Increasing evidence suggests each S-acylation site is regulated by different zDHHCs 
due to their substrate specificity. zDHHCs 3, 5, 7, 9 and 17 have been identified as 
potential enzymes in regulating the S-acylation of the STREX domain, with zDHHC17 
showing greatest selectivity for this site (Tian et al., 2010). The S-acylation of the 
S0-S1 loop of the BK channels is predominately controlled by zDHHC22 and 
zDHHC23, and overexpression of zDHHC23 increases the cell surface expression of 
S0-S1 loop (Jeffries et al., 2010; Tian et al., 2012). APT1 and a splice variant APTL1 
but not APT2 de-acylate BK channels at the S0-S1 loop (Tian et al., 2012). S-acylation 
of the BK channel S0-S1 loop is an important determinant in cell surface expression, 
whereas S-acylation of the STREX domain regulates the BK channel activity mediated 
by AGC family protein kinase dependent phosphorylation. S-acylation of S0-S1 loop 
allows the association of isolated S0-S1 linker with the plasma membrane to control 
surface expression without having an impact on S-acylation of the alternatively spliced 





STREX insert (Jeffries et al., 2010). The S-acylated STREX domain prevents the 
inhibition of STREX containing BK channels through PKC pathway. However, 
de-acylation of STREX insert or PKA-mediated dissociation of STREX variants from 
the plasma membrane inhibits BK channel activity via PKC-dependent 
phosphorylation (Zhou et al., 2010, 2012). Importantly, the zDHHCs controlling the 
S-acylation of S0-S1 loop or STREX domain are also expressed at multiple cellular 
compartments including ER, Golgi and/or plasma membrane suggesting that the 
modulation of BK channel occurs at multiple sites and different stages in the 
trafficking pathways (Shipston, 2014a). Furthermore, S-acylation of β4-subunits 
controls surface delivery of BK channels through masking an α-subunit trafficking 
motif, which provide a dynamic mechanism for specific splice variants surface 
trafficking (Chen et al., 2013a). Although the role of zDHHCs-mediated S-acylation 
in controlling BK channel properties and regulation have been described, the 
functional relevance is largely unknown. As zDHHC23 is highly expressed in murine 
corticotrophs, compared to other pituitary cell types, and zDHHC23 controls surface 
expression of BK channels, we hypothesised that zDHHC23 may control BK channel 
dependent excitability and accompanied calcium signals in corticotrophs. Thus, we 
examined the effect of the deletion of zDHHC23 on intracellular calcium responses in 
corticotrophs. 
 





1.5 Sex differences in HPA axis 
Remarkably, underrepresentation of females in animal models is very common and 
male bias is most obvious in neuroscience studies (Beery & Zucker, 2011). Men or 
male rodents are considered as representatives of the species to generalize findings to 
females and differences from the male are often regarded as abnormal/atypical (Beery 
& Zucker, 2011; Bangasser & Wiersielis, 2018). However, numerous studies have 
revealed sex-specific prevalence rates for many diseases in humans, including several 
stress-related disorders. Women are at two-fold higher risk to develop stress- and 
anxiety-related psychiatric disorders, whereas men are more likely to show antisocial 
behaviour or substance abuse (Weich et al., 2001; Maeng & Milad, 2015). Major 
depressive disorders (MDD) are also sexually dimorphic, where women are 2–3 times 
likely to develop MMD with higher symptom severity, greater functional impairment 
as well as responding differently to treatment compared to men (Labonté et al., 2017). 
Concerning cardiovascular diseases (CVD), while men are prone to occlusive coronary 
artery disease (CAD), women have a higher incidence of ischemic heart disease (IHD) 
(Regitz-Zagrosek & Kararigas, 2017). Rates of chronic pain and autoimmune disease 
are also higher in women than in man (Sorge & Totsch, 2017). Furthermore, women’s 
susceptibility in stress responses may mediate increased risk for Alzheimer's disease 
(AD) (Yan et al., 2018). Interestingly, several studies conclude that women 
subjectively experience more stress than men with higher stress vulnerability and 





longer life expectancy (Kudielka & Kirschbaum, 2005). In this case, sex-specific stress 
responses may contribute to the sex-specific prevalence rates of diseases. 
 
Do males and females differ in their response to stress? Increasing evidence suggests 
sex differences in HPA axis function. Compared to males, females show a higher level 
of glucocorticoid secretion following HPA axis stimulation in animal studies (Haleem 
et al., 1988; Yoshimura et al., 2003). Moreover, sexual dimorphism has been 
demonstrated at the level of ACTH secretion as adult men have higher and more 
frequent ACTH pulses while a higher sensitivity to ACTH is observed in female 
adrenal cortex (Kudielka & Kirschbaum, 2005). CRH neurons show increased CRHR1 
signalling and reduced CRHR1 internalization in female rats (Bourke et al., 2012). 
Bourke and colleagues also suggest that a faster reduction of ACTH and cortisol in 
female rats after CRH stimulation may alter the negative feedback of HPA axis. Acute 
stress results in the longer activation of HPA axis in females (Haleem et al., 1988). The 
activity of HPA axis may vary in female rats upon the different phases of oestrous 
cycles due to the gonadal steroid mediated release of CRH and AVP 
(Panagiotakopoulos & Neigh, 2014). Furthermore, following chronic stress, males 
display a higher level of GABA and increased dopaminergic activity in the frontal 
cortex and amygdala, whereas females exhibit increased levels of serotonin (5-HT) 
and norepinephrine (NE), which suggested that chronic stress affects females and 





males differently (Luine, 2002). 
 
Currently, whether sexual dimorphism of HPA axis function also occurs at the level of 
corticotrophs remains unclear. In large part this is because in most previous rodent 
studies on corticotroph function; in particular in vitro, the sex of animal used in 
corticotroph studies is not reported. Furthermore, in many in vitro studies, data are 
reported from mixed populations of female and male corticotrophs with no 
identification of sex prior to study. This is important as studies have suggested 
differences between male and female pituitary cells. For example, sex steroids are 
implicated in the regulation of ion channel expression, including VGCC, L-type Ca2+ 
currents are higher in female cultured rat melanotrophs, while oestrogen treatment can 
upregulates the expression of L-type Ca2+ channels in male cells (Fiordelisio et al., 
2007). This may affect Ca2+ signalling differentially in male and female cells. Previous 
studies have suggested a probable sexually dimorphic mechanism in [Ca2+]i signalling 
of rat corticotrophs (Guérineau et al., 1991; Romanò et al., 2017). Romanò and 
colleagues observed that only 30% of corticotrophs from male rats showed 
spontaneous [Ca2+]i signalling whereas Guérineau et al. reported that 65% of female 
rat corticotrophs displayed spontaneous [Ca2+]i signalling. However, the [Ca
2+]i 
signalling have not been systematically analysed in mouse corticotrophs between 
males and females. As the regulation of Ca2+ signalling pathway may be vital for 





coordination of appropriate HPA axis stress responses, in this Thesis [Ca2+]i signalling 
has been systematically determined in male and female corticotrophs respectively. 
 
1.6 Hypothesis, aims and objectives 
Anterior pituitary corticotrophs, a key component of the HPA axis, integrate the inputs 
from the hypothalamic secretagogues (CRH and AVP) with the negative feedback from 
the adrenal glucocorticoids to control HPA axis function. Corticotrophs are electrically 
excitable with CRH and AVP stimulating increases in [Ca2+]i via different calcium 
signalling pathways.  
 
BK channels have been shown to be essential for the transition to bursting following 
CRH stimulation and bursting is believed to have higher capacity to drive Ca2+ influx 
than single spiking. Moreover, AVP stimulates an increase in spiking frequency that is 
independent of BK channels function. Therefore, it is hypothesized that genetic 
deletion, or pharmacological blockade, of BK channels will result in the attenuation of 
CRH-induced, but not AVP-induced, [Ca2+]i responses. Furthermore, as BK channel 
surface expression is controlled by zDHHC23, the genetic deletion of zDHHC23 in 
corticotrophs is also predicted to attenuate CRH-induced [Ca2+]i signalling. As 
corticotrophs may display sexual dimorphism, analysis will be performed 
independently in both male and female corticotrophs at physiological levels of CRH 
(0.2 nM) and/or AVP (2 nM) (Gibbs & Vale, 1982; Sheward & Fink, 1991). 





The aim of this Thesis is thus to investigate the hypothesis that: CRH-, but not 
AVP-evoked [Ca2+]i responses in murine corticotrophs are dependent upon the 
function of BK channels.  
 
To address this hypothesis, [Ca2+]i responses to CRH and AVP are investigated in both 
male and female corticotrophs with the following major aims:  
 
In Chapter Three, I first develop and test a new POMC-GCaMP6s reporter using the 
lentivirus transduction system to allow specific labelling of live corticotrophs in vitro 
for calcium imaging recordings. Using this approach, [Ca2+]i responses in wild-type 
corticotrophs are characterised under basal conditions and following CRH and/or AVP 
stimulation including analysis of CRH/AVP synergy at the level of [Ca2+]i. 
 
In Chapter Four, the role of BK channels in controlling spontaneous and 
secretagogue-evoked [Ca2+]i signalling in corticotrophs are investigated when BK 
channels are genetically deleted, or pharmacological blocked by a specific inhibitor, 
paxilline.  
 
In Chapter Five, [Ca2+]i signalling in corticotrophs in which the S-acyl transferase 
zDHHC23, that controls BK channel surface expression, is genetically deleted is 







Importantly, a repeated stimulation protocol is developed throughout the study to 
replicate typical secretion pulse of hypothalamic hormones. Most previous studies 
investigated CRH and/or AVP-evoked [Ca2+]i signalling in response to a single 
supraphysiological concentration of secretagogue whereas in vivo corticotrophs must 
respond to repeated changes in CRH and AVP. Compared to the single stimulus used 
in most previous studies, repeated stimulation of corticotrophs at physiologically 
relevant concentrations may provide new insights into how corticotrophs coordinate 
appropriate and adaptive responses to distinct stressors. 














Materials and Methods 
  





Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 General materials and reagents 
Unless otherwise indicated, general chemical reagents and solvents used in this study 
were from Sigma-Aldrich Company and of analytical grade quality. 
 
2.1.2 Molecular biology reagents 
Abcam Inc., Cambridge, MA, USA 
Chicken Anti-GFP antibody (ab13970) 
Goat Anti-Chicken IgY H&L (Alexa Fluor® 488) (ab150169) 
Rabbit Anti-ACTH antibody (ab74976) 
 
Invitrogen Ltd., Paisley, UK 
Deoxyribonucleotides (dNTPs): 100 mM each of dATP, dTTP, dCTP and dGTP 
(10297018) 
F(ab')2-Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 546 (A11071) 
SYBR® Safe DNA Gel Stain (S33102) 
TO-PRO™-3 Iodide (642/661) - 1 mM Solution in DMSO (T3605) 
UltraPure™ Agarose (16500500) 





Promega, Madison, WI, USA  
GoTaq® G2 DNA Polymerase: includes GoTaq® G2 DNA Polymerase 500 units, 
5X Green GoTaq® Reaction Buffer, 5X Colourless GoTaq® Reaction Buffer (M7845) 
 
Sigma-Aldrich Company Ltd., Gillingham, UK 
Betaine solution (B0300) 
Bovine Serum Albumin: heat shock fraction (A7906) 
Dimethyl sulfoxide (DMSO) (D2650) 
Mowiol® 4-88 (81381) 
PCR primers: made up to 100 μM stocks in TE buffer (10 mM Tris, 1 mM EDTA in 
dH2O).  
 
2.1.3 Cell culture reagents 
Gibco® Life Technologies, Paisley, UK 
Gibco® Dulbecco's Modified Eagle Medium (DMEM + 4.5 g/L high-glucose, 
+L-Glutamine, +25 mM HEPES, −Pyruvate) (42430-025) 
 
Sigma-Aldrich Company Ltd., Gillingham, UK 
Antibiotic Antimycotic Solution (100x), Stabilized: Contains 10000 units penicillin, 
10 mg streptomycin and 25 μg amphotericin B per ml (A5955) 





Aprotinin from bovine lung (10820) 
Bovine Serum Albumin (BSA) solution: 30% in DPBS (A9576) 
Deoxyribonuclease I from bovine pancreas (D5025) 
Fibronectin from bovine plasma (F1141) 
ITS liquid media supplement (100x): Contains 1.0 mg/ml recombinant human insulin, 
0.55 mg/ml human transferrin and 0.5 μg/ml sodium selenite (I3146) 
Trypsin inhibitor from Glycine max (soybean) (T6522) 
 
Thermo Scientific, Paisley, UK 
GeneRuler 1 kb DNA Ladder (SM0311) 
 
Worthington Biochemical Corporation, Lakewood, NJ, USA 
Trypsin (LS003702) 
 
2.1.4 Peptides and channel inhibitors 
Bachem AG, Bubendorf, Switzerland 
Corticotrophin-releasing hormone (CRH); human, rat (H-2435) 
 
Sigma-Aldrich Company Ltd., Gillingham, UK 
[Arg8]-Vasopressin (AVP) acetate salt (V9879) 









Peptide hormones CRH and AVP were used to stimulate corticotrophs at 
physiologically relevant concentrations (0.2 nM CRH and 2 nM AVP) (Gibbs & Vale, 
1982; Sheward & Fink, 1991) which allowed us to investigate the 
secretagogue-induced [Ca2+]i signalling in corticotrophs. Stock solutions were made 
up in 0.01 N HCl and 0.0001 N L-Ascorbic acid and stored at −80 ºC. Ion channel 
blockers nifedipine and paxilline were used to study the role of specific ion channels 
in regulating corticotroph [Ca2+]i signalling. Stock solutions were made in DMSO, 
then aliquoted and stored at -20 ºC (Table 2.1). Everyday a fresh aliquot of each drug 
was used. Stock solutions were diluted to their working concentrations with Ringer’s 
solution containing (in mM) 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 12 NaHCO3, 2 CaCl2, 
1 MgCl2 and 2 glucose with the pH adjusted to 7.3 and osmolarity adjusted with NaCl 
between 300 and 305 mOsmol/l. 
  













AVP 1 mM 2 nM 
10 μl/aliquot 
−80 ºC 
CRH 0.1 mM 0.2 nM 
10 μl/aliquot 
−80 ºC 
Nifedipine 125 mM 2.5 μM 
20 μl/aliquot 
−20 ºC 












Wild-type mice were on a C57/BL6 background. Mice lacking the pore forming exon 
of α-subunit in the BK channel (BK-KO mice) were generated on the same C57/BL6 
background as described (Sausbier et al., 2004). Mice with a genetic deletion of 
zDHHC23 (zDHHC23-KO mice) were generated by Knockout Mouse Project 
(KOMP, www.komp.org, Zdhhc23tm1(KOMP)Vlcg) and backcrossed for at least 10 
generations with mice on a C57/BL6 background. Mice were caged in groups of two 
to four under standard laboratory conditions (lights on at 07.00 h, lights off at 19.00 h, 
21ºC, with tap water and chow available ad libitum). Mice used for anterior pituitary 
cell culture were aged between 2 and 5 months and were matched by age and sex. 
Tissue collection was performed between 09.30h and 11.30h in accordance with 
United Kingdom Home Office requirements. 
 
2.2.2 Mouse PCR genotyping 
2.2.2.1 Preparation of DNA from ear clip samples with Hot Sodium 
Hydroxide and Tris (HotSHOT) 
The Hot Sodium Hydroxide and Tris (HotSHOT) method was used to isolate mouse 
genomic DNA from ear clips (2 mm diameter) for genotyping (Truett et al., 2000). 
Alkaline lysis reagent with 25 mM NaOH, 0.2 mM disodium EDTA, pH 12 was 





prepared by dissolving the salts in water without adjusting the pH. Neutralizing reagent 
with 40 mM Tris-HCl and a pH of 5 was prepared by dissolving Tris-HCl in water 
without adjusting the pH. Both the alkaline lysis and neutralizing reagents were made 
up as 10x stocks and diluted with dH2O on the day of use. 75 μl alkaline lysis reagent 
was added to each ear clip sample and heated to 95℃ for 1 h. After heating, samples 
were then cooled to 4℃ and 75 μl neutralizing reagent were added to each sample. 
The combination of two reagents resulted in a solution composed of 20 mM Tris-HCl 
and 0.1 mM EDTA (pH 8.1) which was similar to a common DNA storage buffer. 
 
2.2.2.2 Amplification of DNA using polymerase chain reaction 
The polymerase chain reaction (PCR) is a technique used to exponentially amplify a 
single copy or a few copies of specific segment of genomic DNA. During this study, 
mice used for anterior pituitary cell culture were selected based on their BK and 
zDHHC23 genotype respectively. GeneAmp® PCR System 2720 thermal cycler 
(Applied Biosciences) was employed for the PCR reactions. 
 
To identify the BK genotype for each mouse, primers (Table 2.2) and cycling 
parameters (Figure 2.1) were used in PCR reactions. Two forward primers were 
designed corresponding to the wild-type and knockout allele (F1 and F2 respectively) 
and a reverse primer (R) common to both alleles. The PCR reaction consisted of 





10-30 ng DNA template, 500 nM of each primer (Eurofins), 2 μl of 10x PCR buffer, 
1.5 mM MgCl2, 2 mM each of dATP, dTTP, dCTP and dGTP, 1-2.5 U of Taq DNA 
polymerase (Invitrogen), made up to a final volume of 20 μl with DEPC-treated 
(0.05% v/v diethyl pyrocarbonate in dH2O) water. The standard protocol started with 
10 minutes at 94 ºC to denature the template, followed by 37 cycles of a denaturing 
step (45 seconds at 94 ºC), an annealing step (30 seconds at 52 ºC) and an elongation 
step (30 seconds at 72 ºC). Annealing temperature was chosen to be 5–6 ºC lower than 
the melting temperatures (Tm) of the primers. After the final cycle, the reaction was 
concluded with 10 minutes at 72 ºC and then held at 4 ºC (Figure 2.1). A negative 
control was always set up in parallel replacing the DNA template with equivalent 
volume of DEPC-treated water to check the contamination. Genotyping was 
performed by a lab member, Dr Peter J. Duncan.  
 
The “Touchdown” PCR method was used to determine the zDHHC23 genotype for 
each mouse with appropriate primers (Table 2.3) and cycling parameters (Figure 2.2). 
Two PCR reactions were performed, where one set of forward and reserve primers 
were designed corresponding to wild-type genotype (Reg-zDHHC23-wtF and 
Reg-zDHHC23-wtR) and the other set of forward and reserve primers were designed 
corresponding to zDHH23-KO genotype (Reg-NeoF and Reg-zDHHC23-R). Each 
PCR reaction consisted of 10-30 ng DNA template, 6.5 μl of 5M betaine, 0.325 μl of  






Primers used for BK-KO genotyping 
Name Target Gene Tm (ºC) Sequence (5’ – 3’) 
BK F1 BK-KO 59.4 TGG TCT TCT TCA TCC TCG GG 
BK F2 BK-KO 57.9 AAG GGC CAT TTT GAA GTC 
BK R BK-KO 59.4 CCA GCC ACA GTG TTT GTT GG 
 
Figure 2.1 
Cycling parameters for BK-KO genotyping  
 
Figure 2.1 Cycling parameters for BK-KO genotyping. BK-KO genotyping started 
with a denaturing stage at 94 ºC for 10 minutes. Next stage was programmed as a 
denaturing step (45 seconds at 94 ºC), an annealing step (30 seconds at 52 ºC) and an 
elongation step (30 seconds at 72 ºC) for 37 cycles. After the final cycle PCR reaction 
was completed with a 10 minute extension at 72 ºC and held at 4 ºC. 
  





DMSO, 200 nM of each primer (Sigma), 0.2 mM each of dATP, dTTP, dCTP and dGTP 
(Invitrogen), 5 μl of 5X GoTaq reaction buffer containing 1.5 mM MgCl2 (Promega), 
1U of Taq DNA polymerase (Promega), made up to a final volume of 25 μl with 
DEPC-treated (0.05% v/v diethyl pyrocarbonate in dH2O) water. 
 
The “Touchdown” PCR protocol started with the initial denaturation for 5 minutes at 
94 ºC to denature the template. In the first 10 cycles, denaturation lasted for 15 seconds 
at 94 ºC; the annealing temperature was decreased 1 ºC every cycle from 65 ºC for 30 
seconds and the extension was at 72 ºC for 40 seconds. In the subsequent 30 cycles, 
the cycling program was set as a denaturing step (15 seconds at 94 ºC), an annealing 
step (30 seconds at 55 ºC) and an elongation step (40 seconds at 72 ºC). The initial 
temperature selected for the annealing step was 65°C so that the annealing temperature 
was progressively decreased to 55°C by the end of this stage (Korbie & Mattick, 2008). 
The gradually reduced annealing temperature increased the specificity and sensitivity 
of the PCR reaction. After the final cycle, a final extension of 5 minutes at 72 ºC was 
performed and then held at 4 ºC (Figure 2.2). 
 
Positive and negative controls were always set up for each genotype. A plasmid 
template from wild-type or heterozygote mice were used to replace the DNA template 
as a positive control. DEPC-treated water was used instead of the DNA template as a 






Primers used for zDHHC23-KO genotyping 
Name Target Gene Tm (ºC) Sequence (5’ – 3’) 
Reg-zDHHC23-wtF Wild-type 71.8 
AGT AAG CAT TTG GAA 
ATG GGC CAC C 
Reg-zDHHC23-wtR Wild-type 66.9 
AGT GAA GGG AGT CTT 
AGC ACT CAG C 
Reg-NeoF zDHHC23-KO 71.0 
GCA GCC TCT GTT CCA 
CAT ACA CTT CA 
Reg-zDHHC23-R zDHHC23-KO 62.9 
AAT TGA AAG GAG GGC 
GAG AAA TGC C 
  






Cycling parameters for zDHHC23-KO genotyping  
 
Figure 2.2 Cycling parameters for zDHHC23-KO genotyping. zDHHC23-KO 
genotyping started with a denaturing stage at 94 ºC for 5 minutes. The second stage 
was programmed as the denaturation (15 seconds at 94 ºC), the annealing step (the 
temperature decreased 1 ºC every cycle from 65 ºC for 30 seconds) and the extension 
(40 seconds at 72 ºC) for 10 cycles. The third stage cycling program was set as a 
denaturing step (15 seconds at 94 ºC), an annealing step (30 seconds at 55 ºC) and an 
elongation step (40 seconds at 72 ºC) for 30 cycles. After the final cycle, PCR reaction 
was completed with a 5 minute extension at 72 ºC and held at 4 ºC. 
  





negative control to confirm the contamination. 
 
2.2.2.3 Agarose gel electrophoresis of DNA 
Gel electrophoresis was used to separate and analyse the PCR amplified DNA 
according to molecular weight on a gel composed of 1% - 1.5% agarose (w/v; 
Invitrogen). 1x TBE buffer (45 mM Tris, 49 mM Boric acid and 1.6 mM EDTA) was 
used to make to gel and 0.01% SYBR® Safe (Invitrogen) DNA gel stain was added 
and mixed well in the gel to allow the visualization of DNA under ultraviolet (UV) 
light. 5 μl of DNA samples were loaded into each lane and with one lane loading 6 μl 
of GeneRuler 1 kb DNA Ladder (Thermo Scientific) to allow molecular weights to be 
determined. Electrophoresis was performed in 1x TBE buffer for 20-30 minutes at a 
constant voltage of 120 V with PowerPac™ Basic Power Supply (Bio-Rad). Gels were 
imaged under UV illumination using the GeneGenius Bio Imaging System 
(SYNGENE) and images were captured using GeneSnap (SYNGENE). 
 
BK-KO genotype was identified with three primers: two forward primers 
corresponding to wild-type and knockout alleles, and one common reverse primer. 
When determining the BK-KO genotype, wild-type mice (+/+) show a single band 
around 480 bp, BK knockout mice (−/−) show a single band around 170 bp, and 
heterozygotes (+/−) show two bands (Figure 2.3). zDHHC23-KO genotype was 





identified with four primers: a set of forward and reverse primers corresponding to 
wild-type genes and the other set of forward and reverse primers corresponding to 
knockout genes. When determining the zDHHC23-KO genotype, wild-type mice (+/+) 
was positive (+) for wild-type primers showing a single band around 300 bp and 
negative (−) showing no bands for knockout primers. zDHHC23 knockout mice (−/−) 
was negative (−) showing no bands for wild-type primers and positive (+) for knockout 
primes showing a single band around 460 bp. Heterozygotes (+/−) showed a single 
band for each set of primers (Figure 2.4). 
 
2.3 Generation of POMC-GCaMP6s lentivirus 
The POMC-GCaMP6s reporter was constructed using a pLenti backbone from 
Addgene plasmid No.20946, whose coding region was replaced with a genetically 
encoded calcium indicator GCaMP6s from Addgene plasmid No.40753 under the 
control of the minimal rat Pomc promoter (Romanò et al., 2017). This ensures specific 
expression in corticotrophs (Hammer et al., 1990). The SURF facility of the University 
of Edinburgh or VectorBuilder Inc. packed the lentivirus for us. Multiple batches of 
virus were generated and used throughout this study, with the titre of virus ranging 
from 6.30 x 108 to 1.81 x 1011 TU/ml. Fresh aliquots of lentivirus were diluted with 
culture medium to transduce each preparation of mouse primary anterior pituitary 
cells (See 2.4.2). The final titre of virus used for transduction ranged from 2.63 x 104   






BK-KO genotyping PCR products separated by agarose gel 
electrophoresis 
 
Figure 2.3 BK-KO genotyping PCR products separated by agarose gel 
electrophoresis. Each numbered lane represented a mouse. When determining the 
BK-KO genotype, wild-type mice (+/+) showed a single band around 480 bp, BK 
knockout mice (−/−) showed a single band around 170bp and heterozygotes (+/−) 
showed two bands. −ve represented a negative control; M represented a 1kb DNA 
ladder. 
  






zDHHC23-KO genotyping PCR products separated by agarose 
gel electrophoresis 
 
Figure 2.4 zDHHC23-KO genotyping PCR products separated by agarose gel 
electrophoresis. Each numbered lane represented a mouse. When determining the 
zDHHC23-KO genotype, wild-type mice (+/+) was positive (+) for wild-type primers 
showing a single band around 300 bp and negative (−) showing no bands for knockout 
primers. zDHHC23 knockout mice (−/−) was negative (−) showing no bands for 
wild-type primers and positive (+) for knockout primes showing a single band around 
460 bp. Heterozygotes (+/−) showed a single band for each set of primers. +ve 
represented a positive control; +/− represented a heterozygote control; −ve represented 
a negative control. M represented a 1kb DNA ladder. 
  





to 2.87 x 106 TU/ml. 
 
2.4 Primary cell culture and lentiviral transduction of 
mouse anterior pituitary cells 
2.4.1 Isolation and culture of mouse anterior pituitary cells 
For each preparation, three genotyped mice (either male or female) were killed by 
cervical dislocation. After removing heads and scalps, the anterior pituitary was gently 
removed from the skull. The anterior lobes were isolated, the posterior lobe was gently 
removed and the intermediate zone was dissected out to avoid contamination from 
POMC-expressing melanotrophs. The isolated anterior pituitary lobes were placed in 
a dish with DMEM (+4.5 g/L high-glucose, +L-Glutamine, +25 mM HEPES, 
−Pyruvate; Gibco) and then chopped with a single edged razor blade in both directions 
(dish rotated by 90º).  
 
The chopped anterior lobes were transferred into a tube with a digestion solution made 
of DMEM containing 0.25% (w/v) Trypsin (Worthington) and 36 Kunitz units/ml 
DNAse I and incubated at 37 ºC for 20–25 minutes in a water bath. The tube was 
shaken every 5 minutes to ensure a complete and equivalent digestion. The tube was 
left for 5 minutes to allow tissue pieces to settle to the bottom after the digestion and 
the supernatant was aspirated. 1 ml of inhibition solution consisted of DMEM 





containing 0.25 mg/ml Soybean Trypsin inhibitor, 100 kallikrein units Aprotinin (200x 
dilution of Sigma stock), 36 Kunitz units/ml DNAse I was added to stop the digestion 
and the tissue pieces were triturated using a 1ml Pipetman tip (Gilson) approximately 
40 times. Another 4 ml of inhibition solution were added into the tube and the cell 
suspension was filtered over a cell strainer with 70 µm nylon mesh (FalconTM, BD 
Biosciences). The cell suspension was then diluted with an equal volume of culture 
medium containing DMEM with ITS (10 μg/ml insulin, 5.5 μg/ml transferrin, 30 nM 
sodium selenite), 0.3% bovine serum albumin (BSA; w/v), 4.2 µg/ml fibronectin and 
antibiotic/antimycotic (100× dilution of Sigma stock) and centrifuged at 100 g for 10 
minutes at room temperature (RT). To disperse single pituitary cells, the supernatant 
was removed without disturbing the pellet which was then triturated with 1 ml culture 
medium for approximately 40 times. Another 1.5 ml of culture medium were added to 
make up the final cell suspension. One 12 mm coverslip was added to each well in a 
12-well plate and 200 µl of the final cell suspension was plated onto the coverslips. 
The 12-well plate was left for 20 minutes to allow the pituitary cells to settle down and 
1 ml of culture medium was then added to each well. Primary pituitary cells were 
incubated at 37 ºC in 95% air/5% CO2. 
 
2.4.2 Lentiviral transduction of mouse anterior pituitary cells 
After incubating for 4–6 h in culture medium, primary pituitary cells were transduced 





with POMC-GCaMP6s lentivirus. The culture medium was then replaced with fresh 
antibiotic/antimycotic free culture medium after 24 h transduction and the medium 
was then changed with a culture medium free of antibiotic/antimycotic every two days. 
Corticotrophs usually displayed fluorescence 48–72 h post-transduction. 
 
2.4.3 Validation and quantification of lentiviral transduction 
2.4.3.1 Immunostaining and imaging  
Mouse anterior pituitary cells cultured on glass coverslips 48–72 h after lentiviral 
transduction were washed with phosphate buffered saline (PBS, containing 137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.8 mM KH2PO4) 3 times and then fixed 
with 4% formaldehyde solution for 30 minutes at room temperature (RT). The 
formaldehyde was aspirated, cells were washed with PBS 3 times, incubated in 
permeabilization buffer (0.3% Triton X-100 in PBS) for 1 hour at RT and then in 
blocking buffer (0.3% Triton X-100, 3% BSA in PBS) for 1 hour at RT. Primary rabbit 
anti-ACTH antibody (1:1000, Abcam) and primary chicken anti-GFP antibody 
(1:2000, Abcam) were diluted in blocking solution and incubated at 4 ºC overnight. 
The next day pituitary cells were washed 3 times with PBS and then incubated with 
secondary antibodies (goat anti-rabbit IgG conjugated with Alexa Fluor 546, 1:1000, 
Invitrogen; goat anti-chicken IgY conjugated with Alexa Fluor® 488, 1:1000, Abcam) 
diluted in blocking buffer for 1 hour at RT. After washing with PBS 3 times, cells were 





incubated for 1–2 min with TO-PRO-3 Iodide for nuclei staining. Subsequently, cells 
were rinsed rapidly in distilled water, drained and then finally mounted on glass slides 
with Mowiol 4-88 mounting medium (Calbiochem) containing 1,4-
diazabizyclo[2.2.2]octane (DABCO, Sigma) as anti-fading agent. Cells were left 
overnight to dry in the dark and stored at 4 ºC before image acquisition.  
 
Z-stack confocal images were obtained using a Nikon A1R confocal laser microscope 
system (Nikon Corp., Tokyo, Japan) equipped with a 20x Plan Apochromat VC 
(NA = 0.75) objective lens. To image GCaMP6s (Alexa Fluor® 488 antibody), 488 nm 
laser was used for excitation and emission was collected using a 525/50 nm bandpass 
filter. For ACTH (Alexa Fluor 546 antibody), excitation was performed by a 561 nm 
laser and fluorescence was detected through a 595/50 nm bandpass filter. TO-PRO was 
excited with a 640 nm laser, emission was recorded at 700/75 nm. The multitracking 
function was used to minimize the cross-talk between different fluorophores. Images 
were acquired with Nikon NIS Elements software and processed with Fiji software 
(Schindelin et al., 2012).  
 
2.4.3.2 Quantification of POMC-GCaMP6s reporter expression  
The expression of GCaMP6s reporter was controlled by the minimal rat Pomc 
promoter using lentivirus-mediated cell transduction in murine primary pituitary cell 





cultures. The efficiency and specificity of lentiviral-mediated transduction of 
corticotrophs with GCaMP6s was quantified: 
 
For efficiency, the percentage of total anterior pituitary cells that were 
immunohistochemically identified as corticotrophs (ACTH positive) that also 
expressed GCaMP6s, was determined. 
 
Efficiency (%) = 
 ACTH and GCaMP6s positive cells
ACTH positive cells
 * 100% 
 
Specificity was determined by calculating the percentage of all anterior pituitary cells 
that expressed GCaMP6s that were also immunohistochemically identified as 
corticotrophs (ACTH positive). 
 
Specificity (%) = 
ACTH and GCaMP6s positive cells
GCaMP6s positive cells
 * 100% 
 
2.5 Calcium imaging  
2.5.1 Calcium imaging recordings   
Calcium imaging recordings were performed on single isolated corticotrophs cultured 
on glass coverslips post-transduction (typically 48h–72h). A coverslip was placed in 
the centre of a circular recording chamber with two parallel silica inserts to keep the 





coverslip stable and allow the linear flow of solution. The chamber was mounted on a 
heated stage (37 ± 1 ℃) that warmed the solution in the chamber to 30 ± 1 ℃. During 
recording, corticotrophs were continuously perfused with oxygenated Ringer’s 
solution at a rate of 1–2 ml/minute with all treatments applied at the same flow rate. 
Isolated cells expressing POMC-CaMP6s lentivirus were imaged with an Olympus 
IX81 epi-fluorescence microscope (Olympus, Tokyo, Japan), equipped with an MT20 
xenon lamp, an EM-CCD digital camera (Hamamatsu Photonics, Hamamatsu City, 
Japan), a VCM-D1 Uniblitz shutter driver (Vincent Associates, NY, USA), which was 
linked to a computer. Hardware control was performed using Cell^R imaging software. 
Images were captured every second using either a 488 nm laser or 492 nm filter for 
excitation and a 547/31 nm bandpass filter for emission.  
 
2.5.2 Calcium imaging protocols  
2.5.2.1 CRH and AVP physiological concentrations and patterns of 
release 
The physiological concentrations of CRH and AVP in the pituitary portal circulation 
of mice is are not well characterized. In anaesthetised rats, during stress CRH 
concentrations are typically reported between 0.11 ± 0.01 nM and 0.19 ± 0.04 nM 
(Gibbs & Vale, 1982; Sheward & Fink, 1991) with AVP at 1.81 ± 0.38 nM (Sheward 
& Fink, 1991). In this PhD study, 0.2 nM CRH and 2 nM AVP were assumed to be 





within the physiological range, albeit of a stressed and anesthetized rat, and hence were 
used. Importantly these concentrations are in accordance with those used in previous 
electrophysiological and calcium imaging studies in both primary rat and mouse 
corticotrophs (Duncan et al., 2015; Romanò et al., 2017). The actual patterns of CRH 
or AVP release in the pituitary portal circulation are also not well characterised. In a 
previous study in rats, the average frequency of CRH pulsatile release was 
approximately every 20 minutes with pulse duration being variable between 2.5 to 10 
minutes based on push pull sampling of every 2.5 minutes or 5 minutes (Ixart et al., 
1991). In this PhD study, a three minute duration square wave pulse of CRH and/or 
AVP was used to replicate a typical release pulse and the stimulus was applied every 
25 minutes to ensure complete washout and recovery to baseline before exposure to 
the next stimulus. 
 
2.5.2.2 Repeated stimulation protocol 
Initial calcium imaging recordings were performed with a repeated stimulation 
protocol (Figure 2.5A, based on that reported in Romanò et al., 2017). Spontaneous 
intracellular free calcium ([Ca2+]i) signalling was recorded for 15–20 minutes. Cells 
were then exposed to a stimulus for three minutes, which was repeated three times at 
25 minutes intervals. Finally, cells were treated with 30 mM potassium chloride for 
one minute to confirm cell viability (Figure 2.5A). During this study, some 





experiments were performed to investigate the synergistic effect of CRH and AVP at 
the level of [Ca2+]i. These recordings also followed a similar repeated stimulation 
protocol, where cells were exposed to either CRH or AVP in a random order, followed 
by the combined stimulus (CRH + AVP).  
 
2.5.2.3 Ion channel blocking protocol 
Based on the repeated stimulation protocol, an ion channel blocking protocol was 
developed to examine the role of specific ion channels (Figure 2.5B). Starting with 
15–20 minutes basal recording to define spontaneous [Ca2+]i signalling, corticotrophs 
were then exposed to a stimulus of interest for three minutes. The second three minute 
stimulation was applied to corticotrophs in the presence of an ion channel blocker, 
which was applied 10 minutes before and after the second stimulus to ensure the 
blockade of specific ion channels. After a 25 minute washout period, cells were 
exposed to the stimulus for the third time to confirm whether the effects of the blocker 
were reversible. Calcium imaging recording was completed with a one minute 30 mM 
potassium chloride stimulus to verify cell viability (Figure 2.5B). 
 
  






Protocols for calcium imaging 
 
Figure 2.5 Protocols for calcium imaging. (A) Repeated stimulation protocol: cells 
were exposed to a stimulus for three minutes that was repeated three times at 25 
minutes intervals. When investigating synergy between CRH and AVP, cells were 
exposed to either CRH or AVP in a random order, followed by the combined stimulus. 
(B) Ion channel blocking protocol: cells were first exposed to a stimulus for three 
minutes. The second three minute stimulation was applied to corticotrophs in the 
presence of an ion channel blocker, applied 10 minutes before and after the second 
stimulus. After a 25 minute washout period, cells were exposed to the stimulus for a 
third time to determine reversibility. 
  





2.6 Data analysis 
2.6.1 Acquisition of data from images 
After collecting the calcium images using Cell^R imaging software, fluorescent 
intensity was calculated with Fiji and background noise was subtracted using a region 
of interest not containing any cell. Extracted calcium imaging traces were then 
analysed using custom scripts written in R by Dr Nicola Romanò (See Appendices I 
and II). 
 
2.6.2 Measurement parameters 
2.6.2.1 Criteria for inclusion of data 
Corticotrophs were exposed to stimuli three times during calcium imaging recordings. 
For inclusion in the data analyses, only the cells that responded to the three consecutive 
stimuli as well as responding to 30 mM potassium chloride, to verify cell viability at 
the end of recording were included (Figure 2.6A). An example of a recording that was 










Criteria of a valid calcium imaging recording 
 
Figure 2.6 Criteria of a valid calcium imaging recording. (A) A valid calcium 
imaging recording includes clear and effective calcium responses to all stimuli and an 
effective response to 30 mM KCl. (B) Cells showing no clear and effective responses 
to all three stimuli or KCl are excluded. 
  





2.6.2.2 Measurement parameters 
In this Thesis, the POMC-GCaMP6s calcium indicator rather than a ratiometric dye 
was used to allow the identification and analysis of intracellular free calcium level in 
corticotrophs. The absolute basal level of calcium signal is dependent on the 
expression level of POMC-GCaMP6s in each cell. Thus, instead of defining the 
absolute basal calcium level, which was the minimum value in the calcium imaging 
experiment, I measured spontaneous and secretagogue-induced [Ca2+]i responses 
relative to the basal calcium level in each cell.  
 
Spontaneous [Ca2+]i signalling was defined by spontaneous active time and maximum 
amplitude (see 3.2.2). The data were presented as a probability density function (p.d.f.) 
histogram with the Y-axis indicating the probability density (of either the percentage 
of active time or of the maximum amplitude). It is important to note that the p.d.f. 
shows the probability per unit value of the observed variable. In other words, to obtain 
the probability that the variable is between two values a and b we should integrate (i.e. 
calculate the area under the curve) the p.d.f. between a and b. This implies that the area 
under the curve of the whole p.d.f. (i.e. its integral between -∞ and +∞) needs to be 1, 
since a probability cannot be greater than 1. However, for an interval [a,b] smaller than 
1, the p.d.f. can take values greater than 1, provided that the area under the curve in 
[a,b] is < 1.  





To quantify the intensity of [Ca2+]i responses to different secretagogues, several 
parameters were used (Figure 2.7), including:  
 AUC (10 min): area under the curve (AUC) for a 10 minute window from the 
time secretagogues arrived in the bath. This is based on previous observations in 
mouse corticotrophs for the typical duration of membrane excitability to a 3 min 
pulse exposure to CRH (0.2 nM) or AVP (2 nM) (Duncan et al., 2015).  
 AUC (peak): AUC measured from the start of secretagogue exposure to first point 
after stimulus [Ca2+]i response returns to baseline.  
 Peak: the highest point after secretagogue arrival in the bath during the 10 minute 
recording window.  
 Time to peak: time from secretagogues arrived in the bath to peak, measuring the 
time needed to reach the maximum [Ca2+]i level change.  
 Response duration: time from secretagogue arrival in the bath to first point after 
stimulus [Ca2+]i response returns to baseline. 
 Peak duration: time from the start of secretagogue exposure to first point after 
stimulus [Ca2+]i response returns to baseline. 
 Time gap: time between secretagogue arrival in the bath and start of the response.  
 
  






Measurement parameters of calcium imaging recordings 
 
Figure 2.7 Measurement parameters of calcium imaging recordings. (A) A 
representative calcium imaging trace following repeated stimulation protocol. (B) 
Area under the curve (AUC) (10min), AUC (peak), peak, time to peak, response 
duration, peak duration, and time gap were measured parameters. Grey shading 
indicates the three minute duration of exposure to stimulus. 
  





2.6.3 Statistical analysis 
The data were expressed as mean ± SEM (standard error of the mean), N = number of 
independent experiments, and n = number of independent cells. All data was presented 
using R (R Development Core Team) and GraphPad Prism v7.00 (GraphPad Software, 
Inc). All statistical analysis was performed using R, with significant differences 
defined by * p < 0.05, ** p < 0.01 and *** p < 0.001.  
 
In this study, all calcium imaging experiments used a repeated stimulation protocol, 
which allowed analysis of repeated [Ca2+]i responses to same/different stimuli in the 
same cell. Thus, all measuring parameters were compared using mixed effects models 
with the nlme R package. In the mixed effects models, genotype of the mouse, sex of 
the mouse and the stimulus were used as fixed factors; the cell, the experiment, and 
experiment date were used as random factors. Estimated marginal means (EMMs) 
were then utilized to compare the [Ca2+]i responses to repeated or different stimuli in 
corticotrophs isolated from mice of different genotypes. To improve model fitting and 
more reliable estimates, the data from different genotypes and sexes were analysed 
together (that is, all data presented in Chapters 3, 4 and 5 were analyzed together), 
which allowed us to use all the data collected to increase the sample size and account 
for the correlations between the data. In this case, we also estimated fewer parameters 
and reduced the likelihood of Type I Errors when making multiple comparisons. 





Since the absolute values of the AUC (10 min), AUC (peak) and peak were variable 
depending on the expression level of the non-ratiometric POMC-GCaMP6s reporter, 
statistical analysis was performed on log-transformed data. When comparing the 
normal mixed effects model and mixed effects logit model, Akaike Information 
Criterion (AIC) and Bayesian Information Criterion (BIC) indicated that the mixed 
effects logit model was better fitted. However, no differences were observed in other 
measuring parameters including time to peak, response duration, peak duration and 
time gap. Therefore, statistical analysis for AUC (10 min), AUC (peak) and peak were 
performed using mixed effects logit models followed by EMMs, while the other 
parameters were analyzed with mixed effects models with EMMs test. 
  




















Calcium signalling in wild-type 
corticotrophs 
  





Chapter 3: Calcium signalling in wild-type 
corticotrophs 
3.1 Introduction 
In this chapter, the first aim was to exploit a lentiviral transduction system that allows 
specific labelling of live murine corticotrophs in vitro. Next, calcium imaging 
experiments were performed on corticotrophs isolated from male and female wild-type 
mice respectively to explore spontaneous intracellular free calcium ([Ca2+]i) of 
corticotrophs and characterise [Ca2+]i signalling following CRH or AVP stimulation in 
terms of their typical pulsatile release and physiological concentrations. Furthermore, 
experiments were also performed in both sexes to investigate whether CRH and AVP 
act in a synergistic manner at the level of intracellular free calcium. 
 
3.1.1 Identification of corticotrophs 
The anterior pituitary gland consists of five types of hormone secreting cells with 
corticotrophs only comprising ~10% of the population, which presents the challenge 
of specific identification of live corticotrophs from the variety of cell populations. 
Methods used in previous studies to identify corticotrophs from primary cell cultures 
have several drawbacks including prior exposure to high dose of CRH and stimulation 
with higher concentrations of CRH up to 100 nM that is far beyond the physiological 





range (Guérineau et al., 1991; Lee & Tse, 1997), which makes it difficult to explore 
the spontaneous [Ca2+]i signalling of corticotrophs and replicate a typical stress 
response in vivo. A lentiviral-mediated POMC-eYFP reporter generated by Liang and 
colleagues allowed the identification and systematic analysis of electrical properties 
of corticotrophs (Liang et al., 2011), however, it’s not suitable for calcium imaging 
study. Integration of the lentivirus transduction system and calcium imaging indicators 
may provide a new tool to specifically label corticotrophs in vitro when investigating 
the [Ca2+]i signalling. 
 
In this chapter, a labelling approach using lentiviral mediated transduction of primary 
murine pituitary cells in vitro with the latest calcium indicator GCaMP6s driven by 
the minimal rat Pomc promoter was examined. 
 
3.1.2 Calcium signalling in corticotrophs 
It has been demonstrated that corticotrophs are electrically excitable and fire action 
potentials which causes transient elevation in [Ca2+]i (Stojilkovic et al., 2010). 
Hypothalamic hormones CRH and AVP stimulate ACTH secretion from corticotrophs 
through different calcium signalling pathways. CRH, the predominant secretagogue, 
acts on corticotrophs via CRHR1 to activate the Gαs pathway resulting in an 
accumulation of cAMP and an activation of PKA, with subsequent influx of 





extracellular Ca2+ via L-type Ca2+ channels (Kuryshev et al., 1995; Murat et al., 2012). 
AVP, on the contrary, acts on corticotrophs via V1b coupled to the Gαq pathway 
leading to the activation of PKC and the generation of IP3 triggering the release of 
Ca2+ from IP3-sensitive intracellular stores (Tse & Lee, 1998). Since CRH and AVP 
regulate corticotrophs through different mechanisms, it is necessary to examine both 
pathways when attempting to examine secretagogue-induced [Ca2+]i signalling in 
corticotrophs.  
 
Two distinct patterns of electrical activity have been observed in secretory cells from 
anterior pituitary lobe: single spikes and pseudo-plateau bursting (Stojilkovic et al., 
2010). Previous studies revealed that pseudo-plateau bursting behaviour has a higher 
capacity to drive Ca2+ influx than large amplitude single-spike action potentials. 
Pseudo-plateau bursting action potentials are believed to generate sufficient calcium 
signals to trigger hormone secretion (Van Goor et al., 2001b; Stojilkovic et al., 2005). 
Other studies indicated that corticotrophs primarily fire spontaneous single spike 
activity that could become pseudo-plateau bursting when stimulated (Kuryshev et al., 
1997; Duncan et al., 2015, 2016). CRH and AVP have been reported to promote 
different patterns of corticotroph electrical activity with CRH driving the transition to 
bursting whereas AVP induces the increase in spiking frequency and increase [Ca2+]i 
in corticotrophs (Leong, 1988; Duncan et al., 2015). The Ca2+ mobilization of 





transforming single spiking into bursting in corticotrophs following CRH stimulation 
may play a vital role in triggering ACTH secretion. However, the mechanism 
underlying the [Ca2+]i signalling remains elusive. In addition, CRH and AVP have been 
demonstrated to act synergistically to regulate ACTH release, however, synergy has 
not been investigated at the level of intracellular free calcium. 
 
In this chapter, calcium imaging experiments were performed to define spontaneous 
[Ca2+]i of corticotrophs and characterise [Ca
2+]i signalling regulated by CRH and AVP. 
The synergy between CRH and AVP was also investigated at the level of [Ca2+]i. 
Considering the possible sex differences in the HPA stress axis, all experiments were 
carried out in male and female wild-type corticotrophs respectively.  
 
3.2 Results 
3.2.1 Identification and labelling of mouse corticotrophs with 
a lentiviral POMC-GCaMP6s reporter 
The anterior pituitary is made up of multiple cell types with corticotrophs representing 
only 5–10% of the cell population. To allow specific targeting of corticotrophs in vitro 
for calcium imaging experiments, genetically encoded calcium indicator GCaMP6s 
was expressed under the control of a minimal rat Pomc promoter using 
lentivirus-mediated cell transduction of isolated mouse anterior pituitary cultures 





(Figure 3.1A). To determine the efficiency and specificity of lentiviral-mediated 
GCaMP6s expression in murine corticotrophs, isolated and dispersed cells were dual 
labelled for ACTH and GCaMP6s using immunohistochemistry. About 53 ± 8.0% of 
anterior pituitary cells that were immunohistochemically identified as corticotrophs 
(ACTH positive, ACTH+) also expressed GCaMP6s, which demonstrated the 
efficiency of lentiviral-mediated expression of GCaMP6s with the specific Pomc 
promoter (Figure 3.1B). Importantly, 83 ± 4.9% of GCaMP6s positive cells were 
immunohistochemically identified as corticotrophs (ACTH+) revealing good 
specificity of the minimal Pomc promoter for driving the expression of GCaMP6s in 
corticotrophs. Thus, POMC-GCaMP6s lentivirus is a useful tool to identify and label 
mouse anterior pituitary corticotrophs in vitro (Figure 3.1C). 
 
3.2.2 Wild-type corticotrophs show variable spontaneous 
[Ca2+]i signalling 
In order to investigate the effects of CRH and/or AVP on [Ca2+]i signalling in 
corticotrophs, it was first essential to determine spontaneous [Ca2+]i signalling of 
corticotrophs under basal conditions. Calcium imaging experiments were performed 
following the protocol in Section 2.5.1 and corticotrophs continuously perfused with 
Ringer’s solution (in mM, 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 12 NaHCO3, 1 MgCl2, 
2 CaCl2, pH 7.3, osmolarity between 300 and 305 mOsmol/l).  






Identification and labelling of murine corticotrophs by 
lentiviral transduction of POMC-GCaMP6s reporter 
 
Figure 3.1 Identification and labelling of murine corticotrophs by lentiviral 
transduction of POMC-GCaMP6s reporter. (A) Representative confocal sections 
of primary anterior pituitary cells following transduction with POMC-GCaMP6s 
lentivirus. The ACTH immunoreactivity (left top panel), GCaMP6s signal (right top 
panel), nuclei stained with TO-PRO (left bottom panel) and merged images (right 
bottom panel) are shown. Arrows show cells positive for ACTH (red), GCaMP6s 
(green) and merged images. Scale bars are 50 µm. (B) Quantification of percentage of 
cells immunoreactive for ACTH (ACTH+) that are also labelled with GCaMP6s 
(GCaMP6s+) reveals efficiency of transduction. (C) Quantification of percentage of 
cells labelled with GCaMP6s (GCaMP6s+) that are also immunoreactive for ACTH 
(ACTH+) reveals specificity. All data are means ± SEM, N > 3 independent 
experiments. 





Previous studies have revealed that a sexually dimorphic mechanism probably exist in 
both calcium signalling and electrical activity of corticotrophs (Guérineau et al., 1991; 
Liang et al., 2011; Romanò et al., 2017). Thus, corticotrophs isolated from male and 
female wild-type mice were investigated respectively. 
 
In calcium imaging experiments using the POMC-GCaMP6s reporter, the absolute 
fluorescent intensity depends on both the intracellular free calcium concentration and 
the expression level of GCaMP6s. To analyse and quantify spontaneous [Ca2+]i 
signalling of corticotrophs, calcium imaging traces were normalized between a value 
of 0 to 1 where 1 is the peak of the response to stimulus in the experiment and 0 is the 
baseline intensity under non-stimulated conditions in the same cell (Figure 3.2). Thus, 
the change of spontaneous [Ca2+]i signalling could be compared between cells. 
 
A “15% threshold” method was used to categorize and analyse spontaneous [Ca2+]i 
signalling over a five minute period of “baseline” before the cells were exposed to any 
treatments. During the 5 min “baseline” period, the time during which the [Ca2+]i 
signalling was above 15% of the peak of the subsequent response to stimulation with 
CRH (or AVP) (normalized to 1), was called active time and expressed as a percentage 
of the total “baseline” period (5 min). When the active time was 0%, the cell was 
defined as no spontaneous [Ca2+]i signalling (Figure 3.2A). Cells displaying 





spontaneous [Ca2+]i signalling could thus be categorized based on the percentage of 
“active time” for each cell (Figure 3.2B).  
 
The active time of spontaneous [Ca2+]i signalling in all wild-type corticotrophs ranged 
from 0% to 100% with a mean of 45.2 ± 2.2% (n = 121 from 56 experiments) and the 
distribution was slightly skewed to the right (Figure 3.3A&B). To examine whether 
there were differences in spontaneous [Ca2+]i signalling between male and female 
wild-type corticotrophs, active time was analysed as a function of sex. The 
spontaneous active time in female wild-type corticotrophs was 39.9 ± 3.0% (n = 72 
from 28 experiments), whereas the mean of male wild-type corticotrophs was 
53.0 ± 3.1% (n = 49 from 28 experiments) (Figure 3.3A), which is significantly 
(p < 0.05) longer compared to females. The distribution of active time in female 
wild-type corticotrophs was negatively skewed while in male wild-type corticotrophs 
was close to normal distribution (Figure 3.3C&D). This indicated that there was a high 
degree of variability as well as sex differences in the active time of spontaneous [Ca2+]i 
signalling in wild-type corticotrophs. 
 
Using the “15% threshold” definition of spontaneous [Ca2+]i signalling, only 3.3% (4 
out of 121 cells) of wild-type corticotrophs were silent (Figure 3.4A) with the rest 
displaying different patterns of spontaneous [Ca2+]i signalling under basal conditions. 





Figure 3.2  
Definition of spontaneous [Ca2+]i signalling 
 
Figure 3.2 Definition of spontaneous [Ca2+]i signalling. Spontaneous [Ca
2+]i 
signalling was defined by “15% threshold” method. During the 5 min “baseline” 
period, the time during which the [Ca2+]i was above 15% of the peak of the response 
to stimulus (normalized as 1) was called active time and expressed as a percentage of 
the total “baseline” period (5 min). (A) The cells whose active time were 0% were 
defined as no spontaneous [Ca2+]i signalling. (B) The cells whose active time were 
more than 0% was defined as displaying spontaneous [Ca2+]i signalling could be 
categorized based on the percentage of “active time” for each cell. 
  






Spontaneous [Ca2+]i active time is significantly higher in male 
than female in wild-type corticotrophs 
 
Figure 3.3 Spontaneous [Ca2+]i active time is significantly higher in male than 
female in wild-type corticotrophs. (A) The mean active time of spontaneous [Ca2+]i 
signalling in all wild-type corticotrophs. (B) The distribution of spontaneous [Ca2+]i 
active time in all wild-type corticotrophs. The distribution of spontaneous [Ca2+]i 
active time in (C) female and (D) male wild-type corticotrophs. Red line indicates the 
fit of distribution density. * p < 0.05 (female n = 72, male n = 49, mixed effects model). 
All data are means ± SEM, N > 3 independent experiments. 
  





The amplitude, duration, frequency and kinetics of spontaneous [Ca2+]i signalling were 
highly variable, the vast majority of cells exhibited two types of calcium behaviour: 
46.3% of wild-type corticotrophs displayed high or low frequency of Ca2+ oscillation 
(Figure 3.4B) and 43.8% of cells showed sustained Ca2+ elevation that lasted for 
several minutes (Figure 3.4C). Besides, a small proportion of cells (6.6%) showed low 
amplitude, complex patterns of [Ca2+]i changes during five minutes of recording 
(Figure 3.4D). Importantly, all patterns of spontaneous [Ca2+]i signalling were found 
both in female (left panel) and male (right panel) wild-type corticotrophs.  
 
The calcium imaging traces were normalized between 0 and 1 (the peak of the response 
to stimulus) which allowed us to compare the relative change in maximum amplitude 
of spontaneous [Ca2+]i signalling in wild-type corticotrophs. The maximum amplitude 
was expressed as a percentage of the peak of the response to stimulus. The spontaneous 
[Ca2+]i signalling in all wild-type corticotrophs had a maximum amplitude of 
69.8 ± 1.7% (n = 121 from 56 experiments) which was positively skewed (Figure 
3.5A&B). The maximum amplitude of spontaneous [Ca2+]i signalling in female 
wild-type corticotrophs was 68.6 ± 2.3% (n = 72 from 28 experiments), which was not 
significantly different from male corticotrophs with a mean of 71.5 ± 1.5% (n = 49 
from 28 experiments) in spontaneous [Ca2+]i maximum amplitude (Figure 3.5A). The 
distribution of spontaneous maximum amplitude was skewed to the right in both male 






Representative examples of spontaneous [Ca2+]i in wild-type 
corticotrophs 
 
Figure 3.4 Representative examples of spontaneous [Ca2+]i signalling in wild-type 
corticotrophs. Corticotrophs exhibited different types of spontaneous [Ca2+]i 
signalling, including (A) silent, (B) Ca2+ oscillation, (C) sustained Ca2+ elevation and 
(D) low amplitude and complex pattern. All patterns of spontaneous [Ca2+]i signalling 
were found in female (left panel) and male (right panel). Traces are shown as 
normalized between 0 and 1, where 0 equals to baseline intensity and 1 is the peak of 
the response to stimulus. 
  





and female wild-type corticotrophs (Figure 3.5C&D) indicating there were no 
significant differences in maximum amplitude of spontaneous [Ca2+]i signalling. 
 
3.2.3 CRH stimulation increases [Ca2+]i signalling in wild-type 
corticotrophs 
CRH is released from hypothalamic neurones to stimulate corticotrophs in response to 
stress in vivo. After determining the spontaneous [Ca2+]i in wild-type corticotrophs 
under basal conditions, it was then important to investigate how [Ca2+]i was regulated 
by CRH stimulation. In order to replicate a typical CRH pulse under stressful 
conditions in terms of its physiologically relevant concentration, pulse duration and 
pulse frequency, wild-type corticotrophs were stimulated with a three minute duration 
of 0.2 nM CRH every 25 minutes for three times with continuous calcium imaging 
recording (Gibbs & Vale, 1982; Ixart et al., 1991). A typical response to 0.2 nM CRH 
observed was a significant and sustained increase of [Ca2+]i that remained elevated 
even after CRH was washed out (Figure 3.6).  
 
To quantify the CRH-induced [Ca2+]i responses, several parameters were measured as 
mentioned in Section Error! Reference source not found., including AUC (10 min), A
UC (peak), peak, time to peak, response duration, peak duration and time gap. 
  






The maximum amplitude of spontaneous [Ca2+]i signalling is 
not different in male and female wild-type corticotrophs 
 
Figure 3.5 The maximum amplitude of spontaneous [Ca2+]i signalling is not 
different in male and female wild-type corticotrophs. (A) The mean maximum 
amplitude of spontaneous [Ca2+]i signalling in all wild-type corticotrophs. (B) The 
distribution of spontaneous [Ca2+]i maximum amplitude in all wild-type corticotrophs. 
The distributions of spontaneous [Ca2+]i maximum amplitude in (C) female and (D) 
male wild-type corticotrophs (female n = 72, male n = 49, mixed effects model). Red 
line indicates the fit of distribution density. All data are means ± SEM, N > 3 
independent experiments. 
  






Stimulation with CRH results in [Ca2+]i increase in wild-type 
corticotrophs 
 
Figure 3.6 Stimulation with CRH results in [Ca2+]i increase in wild-type 
corticotrophs. Representative calcium imaging trace of 0.2 nM CRH-induced [Ca2+]i 
responses in wild-type corticotrophs: sustained elevation of [Ca2+]i. Grey shading 
indicates the three minute duration of exposure to 0.2 nM CRH. 
  





The CRH-induced [Ca2+]i responses were investigated in male and female wild-type 
corticotrophs respectively. Only relevant data from wild-type corticotrophs are 
presented in this chapter. The analysis of these data was done in conjunction with the 
analyses for Chapters Four and Five (see 2.6.3). 
 
3.2.3.1 CRH-induced [Ca2+]i responses are consistent in male wild-type 
corticotrophs 
Calcium imaging recordings were obtained from male wild-type corticotrophs (n = 12 
from 8 experiments) following repeated stimulation protocol: calcium imaging 
experiments were performed starting with 15–20 minutes of basal recording, following 
by a three minute duration of exposure to 0.2 nM CRH and repeated three times at 25 
minutes intervals, then finally treated with a one minute 30 mM potassium chloride 
stimulus to confirm cell viability at the end of recording. 
 
As described before, the vast majority of corticotrophs displayed spontaneous [Ca2+]i 
signalling, whereas only a few of cells were quiescent. With three minutes of 0.2 nM 
CRH stimulation, all corticotrophs responded with a rapid and significant elevation in 
[Ca2+]i, followed by returning to baseline in several different ways. In some cells, the 
[Ca2+]i started to decrease during the CRH stimulus but returned to baseline after the 
end of the stimulus; in some other cells, the response was sustained during the CRH 





exposure, but the [Ca2+]i decreased to baseline rapidly after withdrawal of CRH; the 
response of a few cells ended during the stimulus and the [Ca2+]i returned to baseline 
before the end of the stimulus. At the end, treatment with 30 mM potassium chloride 
for one minute resulted in a rapid rise in the amplitude of [Ca2+]i signal indicating 
corticotrophs were viable at the end of recording (Figure 3.7A). 
 
The superposition of calcium imaging traces of typical experiments in male wild-type 
corticotrophs shown in Figure 3.7B. Following repeated 0.2 nM CRH stimuli, some 
male wild-type corticotrophs showed reduced [Ca2+]i responses (Figure 3.7B, top) 
whereas the others showed robust and similar [Ca2+]i responses (Figure 3.7B, bottom). 
Importantly, this suggests that the repeated stimulus protocol allows reproducible 
[Ca2+]i responses to repeated CRH pulses at physiological concentrations with 
frequency of pulses similar to those reported in vivo. 
 
The effects of repeated 0.2 nM CRH stimulation on [Ca2+]i responses in male wild-type 
corticotrophs were characterized in terms of different parameters mentioned above. 
As the absolute values of AUC and peak are highly variable depending on the 
expression level of POMC-GCaMP6s reporter, the statistical calculations of AUC (10 
min), AUC (peak) and peak were performed on log-transformed data. The statistical 
calculations of other parameters were performed on raw data. Each parameter is shown   






Repeated CRH induces [Ca2+]i responses in male wild-type 
corticotrophs 
 
Figure 3.7 Repeated CRH induces [Ca2+]i responses in male wild-type 
corticotrophs. (A) Representative calcium imaging traces of male wild-type 
corticotrophs exposed to 0.2 nM CRH for three minutes and repeated three times at 25 
minutes intervals. 30 mM potassium chloride was applied at the end for one minute. 
(B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i changes in 
male wild-type corticotrophs with repeated 0.2 nM CRH stimulation. Black line shows 
response to the first stimulus (starting at 15 min), grey line shows response to the 
second stimulus (starting at 40 min), and blue line shows response to the third stimulus 
(starting at 65 min). 
  





in three different ways: (i) raw data in log transformation, (ii) the track between each 
individual cell and (iii) the normalization to Stimulus 1. 
 
Statistical analysis revealed that although AUC (10 min) and AUC (peak) showed a 
declining trend following repeated CRH stimulation, it failed to show any significant 
difference between Stimulus 1 and Stimulus 3 (p = 0.07 and p = 0.05 respectively). 
(Figure 3.8). Repeated CRH stimulation resulted in a significant reduction in peak 
(Figure 3.9A) between Stimulus 1 and Stimulus 3 (p < 0.001), Stimulus 2 and Stimulus 
3 (p < 0.01). Time to peak (Figure 3.9B), response duration (Figure 3.10A), peak 
duration (Figure 3.10B) and time gap (Figure 3.11) were not significantly different 
between repeated CRH stimulation. 
 
Although peak showed significant reduction following repeated CRH stimulation, 
AUC (10 min) and AUC (peak) [Ca2+]i responses were stable. These results suggest 
that [Ca2+]i responses to repeated CRH stimulation were relatively consistent in male 
corticotrophs. 
 
3.2.3.2 CRH-induced [Ca2+]i responses are consistent in female wild-type 
corticotrophs 
Calcium imaging recordings were obtained from female wild-type corticotrophs  






Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
male wild-type corticotrophs to repeated CRH 
 
Figure 3.8 Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in male wild-
type corticotrophs to repeated CRH. Quantification of effects of repeated exposure 
to 0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak) (n = 12 from 8 experiments, 
mixed effects models). All data are means ± SEM. 
  






Attenuation of peak but not time to peak of [Ca2+]i responses 
in male wild-type corticotrophs to repeated CRH 
 
Figure 3.9 Attenuation of peak but not time to peak of [Ca2+]i responses in male 
wild-type corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) peak and (B) time to peak. ** p < 0.01 and *** p < 
0.001 (n = 12 from 8 experiments, mixed effects model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
male wild-type corticotrophs to repeated CRH 
 
Figure 3.10 Response duration and peak duration of [Ca2+]i responses in male 
wild-type corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) response duration and (B) peak duration (n = 12 from 
8 experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in male wild-type corticotrophs 
to repeated CRH 
 
Figure 3.11 Time gap of [Ca2+]i responses in male wild-type corticotrophs to 
repeated CRH. Quantification of effects of repeated exposure to 0.2 nM CRH in time 
gap (n = 12 from 8 experiments, mixed effects model). All data are means ± SEM. 
  





(n = 14 from 7 experiments) following the same protocol used in male wild-type 
corticotrophs. Following stimulation with 0.2 nM CRH for three minutes, all female 
corticotrophs showed a rapid and significant increase in [Ca2+]i response compared to 
basal [Ca2+]i level. The [Ca
2+]i signalling remained elevated even after withdrawal of 
CRH before returning to baseline (Figure 3.12A). The superposition of calcium 
imaging traces revealed that repeated 0.2 nM CRH stimulation resulted in repeatable 
[Ca2+]i responses in female wild-type corticotrophs (Figure 3.12B). 
 
To quantify the repeated 0.2 nM CRH induced [Ca2+]i responses in female wild-type 
corticotrophs, the same parameters were measured as in male wild-type corticotrophs. 
Log transformation was performed in AUC (10 min), AUC (peak) and peak whereas 
the raw data was used in other parameters when performing statistical analysis. 
Repeated CRH stimulation significantly (p < 0.05) reduced AUC (peak) of Stimulus 3 
compared to Stimulus 1 (Figure 3.13B). Peak was also significantly decreased between 
Stimulus 1 and Stimulus 3 (p < 0.001), Stimulus 2 and Stimulus 3 (p < 0.05) (Figure 
3.14A). AUC (10 min) (Figure 3.13A), time to peak (Figure 3.14B), response duration, 
peak duration (Figure 3.15) and time gap (Figure 3.16) showed no statistically 
significant differences following repeated CRH stimulation. 
 
In contrast to the consistency of AUC (10 min), the significant reduction observed in  






Repeated CRH induces [Ca2+]i responses in female wild-type 
corticotrophs 
 
Figure 3.12 Repeated CRH induces [Ca2+]i responses in female wild-type 
corticotrophs. (A) Representative calcium imaging traces of female wild-type 
corticotrophs exposed to 0.2 nM CRH for three minutes and repeated three times at 25 
minutes intervals. 30 mM potassium chloride was applied at the end for one minute. 
(B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i changes in 
female wild-type corticotrophs with repeated 0.2 nM CRH stimulation. Black line 
shows response to the first stimulus (starting at 15 min), grey line shows response to 
the second stimulus (starting at 40 min), and blue line shows response to the third 
stimulus (starting at 65 min). 
  






AUC (10 min) but not AUC (peak) of [Ca2+]i responses is stable 
in female wild-type corticotrophs to repeated CRH 
 
Figure 3.13 AUC (10 min) but not AUC (peak) of [Ca2+]i responses is stable in 
female wild-type corticotrophs to repeated CRH. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak). 
* p < 0.05 (n = 14 from 7 experiments, mixed effects model). All data are 
means ± SEM. 






Attenuation of peak but not time to peak of [Ca2+]i responses 
in female wild-type corticotrophs to repeated CRH 
 
Figure 3.14 Attenuation of peak but not time to peak of [Ca2+]i responses in female 
wild-type corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) peak and (B) time to peak. ** p < 0.01 and *** 
p < 0.001 (n = 14 from 7 experiments, mixed effects model). All data are 
means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
female wild-type corticotrophs to repeated CRH 
 
Figure 3.15 Response duration and peak duration of [Ca2+]i responses in female 
wild-type corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) peak and (B) time to peak (n = 14 from 7 experiments, 
mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in female wild-type 
corticotrophs to repeated CRH 
 
Figure 3.16 Time gap of [Ca2+]i responses in female wild-type corticotrophs to 
repeated CRH. Quantification of effects of repeated exposure to 0.2 nM CRH in time 
gap (n = 14 from 7 experiments, mixed effects model). All data are means ± SEM. 
  





AUC (peak) might be due to the decline of peak. These results suggest that [Ca2+]i 
response to repeated 0.2 nM CRH is consistent in female wild-type corticotrophs. 
 
3.2.3.3 CRH-induced [Ca2+]i responses are not significantly different 
between male and female wild-type corticotrophs 
Although both male and female wild-type corticotrophs displayed a reduction in 
CRH-induced AUC (peak) and peak of [Ca2+]i responses, we investigated whether 
there were differences between male and female wild-type corticotrophs in 
CRH-induced [Ca2+]i responses. 
 
Statistical analysis revealed that although female wild-type corticotrophs tended to 
have higher [Ca2+]i responses in AUC (10 min), AUC (peak) (Figure 3.17) and peak  
(Figure 3.18A), they were not significantly different between male and female 
wild-type corticotrophs. There were no significant differences between male and 
female wild-type corticotrophs in time to peak (Figure 3.18B), response duration 
(Figure 3.18C), peak duration and time gap (Figure 3.19) either. 
 
In summary, there were no significant differences between male and female wild-type 
corticotrophs in CRH-induced [Ca2+]i responses. 
 






No significant sex difference in CRH-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses in wild-type corticotrophs 
 
Figure 3.17 No significant sex difference in CRH-induced AUC (10 min) or AUC 
(peak) of [Ca2+]i responses in wild-type corticotrophs. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak) (male 
n = 12 from 8 experiments, female n = 14 from 7 experiments, mixed effects model). 
All data are means ± SEM. 
  






No significant sex difference in CRH-induced peak, time to 
peak or response duration of [Ca2+]i responses in wild-type 
corticotrophs 
 
Figure 3.18 No significant sex difference in CRH-induced peak, time to peak or 
response duration of [Ca2+]i responses in wild-type corticotrophs. Quantification 
of effects of repeated exposure to 0.2 nM CRH in (A) peak, (B) time to peak and (C) 
response duration (male n = 12 from 8 experiments, female n = 14 from 7 experiments, 
mixed effects model). All data are means ± SEM. 
  






No significant sex difference in CRH-induced peak duration or 
time gap of [Ca2+]i responses in wild-type corticotrophs 
 
Figure 3.19 No significant sex difference in CRH-induced peak duration or time 
gap of [Ca2+]i responses in wild-type corticotrophs. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) peak duration and (B) time gap (male n = 12 
from 8 experiments, female n = 14 from 7 experiments, mixed effects model). All data 
are means ± SEM. 
  





3.2.3.4 CRH-induced [Ca2+]i responses are nifedipine-sensitive 
To examine whether CRH-induced [Ca2+]i responses are regulated by an influx of 
extracellular Ca2+ through L-type voltage gated calcium channels, calcium imaging 
experiments were performed on male wild-type corticotrophs (n = 9 from 2 
experiments) treated with 0.2 nM CRH in the presence of the L-type calcium channel 
blocker nifedipine (2.5 μM). 
 
Following the ion channel blocking protocol (see 2.5.2.3), male wild-type 
corticotrophs were stimulated with 0.2 nM CRH for three minutes and repeated three 
times after 15–20 minutes basal recording. The second CRH stimulation was applied
in the presence of 2.5 μM nifedipine and nifedipine was applied 10 minutes before and 
after the stimulation to ensure the blockade of calcium channels. Following a 25 
minute washout period, corticotrophs were treated with CRH for the third time and 
finally a one minute 30 mM potassium chloride to verify cell viability (Figure 3.20A). 
Stimulation with CRH alone induced significant elevation of [Ca2+]i in corticotrophs. 
Spontaneous [Ca2+]i signalling and CRH-induced [Ca
2+]i responses were both 
inhibited in the presence of nifedipine (Figure 3.20B). Following nifedipine washout, 
the spontaneous [Ca2+]i signalling did not restore completely and the [Ca
2+]i response 
to CRH was not fully recovered either, 7 out of 9 cells showed partial recover and the 
remaining 2 cells did not recover at all. 






Nifedipine inhibits CRH-induced [Ca2+]i response in male 
wild-type corticotrophs 
 
Figure 3.20 Nifedipine inhibits CRH-induced [Ca2+]i response in male wild-type 
corticotrophs. (A) Representative calcium imaging traces of the effects of nifedipine 
on CRH-induced [Ca2+]i response in male wild-type corticotrophs. (B) Superposition 
of extracts of the trace shown in A, showing [Ca2+]i changes in male wild-type 
corticotrophs. Black line shows [Ca2+]i response to the 0.2 nM CRH alone, grey line 
shows [Ca2+]i response to 0.2 nM CRH in the presence of 2.5 μM nifedipine.  
  





The effects of nifedipine on CRH-induced [Ca2+]i signalling were evaluated by AUC 
(10 min), AUC (peak) and peak. Treatment with 2.5 μM nifedipine resulted in a 
significant (p < 0.001) reduction in AUC (10 min) and AUC (peak). After washout 
nifedipine, the [Ca2+]i response to the third CRH stimulation was significantly 
(p < 0.001) smaller in AUC (10 min) and AUC (peak) compared to the first CRH 
stimulation (Figure 3.21). Peak was also significantly (p < 0.001) reduced when treated 
with nifedipine and showed significant (p < 0.001) smaller [Ca2+]i response to the third 
CRH stimulation  (Figure 3.22). These results revealed that the elevation of [Ca2+]i 
was largely abolished by L-type calcium channel blocker nifedipine and the effects of 
nifedipine were not fully reversible upon washout. 
 
In summary, CRH-evoked [Ca2+]i responses were nifedipine-sensitive and elevated 
[Ca2+]i responses were largely driven by an influx of extracellular calcium. 
 
3.2.4 AVP-induced [Ca2+]i responses are consistent in 
wild-type corticotrophs 
After characterizing both spontaneous and CRH-evoked [Ca2+]i signalling in wild-type 
corticotrophs, experiments were designed to investigate the [Ca2+]i signalling in 
corticotrophs exposed to 2 nM AVP, which is physiological relevant concentration in 
portal circulation (Sheward & Fink, 1991).  






Nifedipine significantly reduced CRH-induced AUC (10 min) 
and AUC (peak) of [Ca2+]i responses in male wild-type 
corticotrophs  
 
Figure 3.21 Nifedipine significantly reduced CRH-induced AUC (10 min) and 
AUC (peak) of [Ca2+]i response in male wild-type corticotrophs. Quantification of 
effects of repeated exposure to 0.2 nM CRH in the presence of nifedipine in (A) AUC 
(10 min) and (B) AUC (peak). *** p < 0.001 (n = 9 from 2 experiments, mixed effects 
model). All data are means ± SEM. 






Nifedipine significantly reduced CRH-induced peak of [Ca2+]i 
responses in male wild-type corticotrophs 
 
Figure 3.22 Nifedipine significantly reduced CRH-induced peak of [Ca2+]i 
response in male wild-type corticotrophs. Quantification of effects of repeated 
exposure to 0.2 nM CRH in the presence of nifedipine in peak. *** p < 0.001 (n = 9 
from 2 experiments, mixed effects model). All data are means ± SEM. 
  





Wild-type corticotrophs were stimulated with a 2 nM AVP pulse for three minutes 
every 25 minutes with continuous calcium imaging recording. Two typical [Ca2+]i 
responses to AVP were observed in corticotrophs: 60% (24/40) of cells displayed 
similar responses to 0.2 nM CRH, with a sustained elevation of [Ca2+]i for several 
minutes (Figure 3.23A); the other 40% (16/40) of corticotrophs exhibited a rhythmic 




The parameters used to quantify AVP-induced [Ca2+]i responses are the same as used 
in CRH-induced [Ca2+]i responses, which are AUC (10 min), AUC (peak), peak, time 
to peak, response duration, peak duration and time gap. It was more difficult to clearly 
define the start and the end of the [Ca2+]i response in corticotrophs showing oscillatory 
[Ca2+]i behaviour, which might lead to measurement error in AUC (peak) and peak 
duration. The statistical analysis of AUC (10 min), AUC (peak) and peak were 
performed on log-transformed data due to the variability of absolute values and the 
statistical calculation of other parameters used raw data. To examine whether there 
were sex differences in AVP-induced [Ca2+]i responses, calcium imaging experiments 
were performed on corticotrophs isolated from male and female wild-type 
corticotrophs respectively. 
  






Stimulation with AVP results in two phenotypes of [Ca2+]i 
responses in wild-type corticotrophs 
 
Figure 3.23 Stimulation with AVP results in two phenotypes of [Ca2+]i responses 
in wild-type corticotrophs. Representative calcium imaging traces of two phenotype 
of 2 nM AVP-induced [Ca2+]i responses in wild-type corticotrophs: (A) a sustained 
elevation of [Ca2+]i and (B) a rhythmic and oscillatory [Ca
2+]i behaviour, accompanied 
with an increased peak of [Ca2+]i. Grey shading indicates the three minute duration of 
exposure to 2 nM AVP. 
  





3.2.4.1 AVP-induced [Ca2+]i responses are consistent in male wild-type 
corticotrophs 
Calcium imaging recordings were obtained from male wild-type corticotrophs (n = 16 
from 9 experiments). Following 15–20 minutes recording under basal condition, 
corticotrophs were stimulated for three minutes with 2 nM AVP and repeated every 25 
minutes for three times with continuous calcium imaging recording, then treated with 
30 mM potassium chloride stimulus for one minute to validate cell viability at the end 
of recording. 
 
Prior to AVP stimulation, all corticotrophs displayed some spontaneous [Ca2+]i 
signalling. Although none of them was absolutely silent, but a small minority (< 10%) 
with active time lower than 5%. When stimulated with 2 nM AVP, two phenotypes of 
[Ca2+]i responses were observed in male wild-type corticotrophs. In 12 out of 16 cells, 
the [Ca2+]i was raised and sustained for several minutes and returned to baseline later 
(Figure 3.24A, top). The other 4 cells showed increased amplitude of [Ca2+]i together 
with an oscillatory behaviour (Figure 3.24A, bottom). For any given cell, the [Ca2+]i 
responses to repeated AVP stimulation were highly reproducible and consistent (Figure 
3.24B). 
 
Since there were two phenotypes of [Ca2+]i responses when stimulated with 2 nM AVP,  






Repeated AVP induces consistent [Ca2+]i responses in male 
wild-type corticotrophs 
 
Figure 3.24 Repeated AVP induces consistent [Ca2+]i responses in male wild-type 
corticotrophs. (A) Representative calcium imaging traces of male wild-type 
corticotrophs exposed to 2 nM AVP for three minutes and repeated three times at 25 
minutes intervals. 30 mM potassium chloride was applied at the end for one minute. 
(B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i changes in 
male wild-type corticotrophs with repeated 2 nM AVP stimulation. Black line shows 
response to the first stimulus (starting at 15 min), grey line shows response to the 
second stimulus (starting at 40 min), and blue line shows response to the third stimulus 
(starting at 65 min). 
  





all corticotrophs were first separated into two groups based on their responding 
phenotypes, sustained increase of [Ca2+]i and oscillatory [Ca
2+]i behaviour, to examine 
whether there was any significant difference between them in all parameters. None of 
these parameters showed significant differences between the two phenotypes of [Ca2+]i 
responses (data not shown), thus statistical analysis was performed on all male 
wild-type corticotrophs together.  
 
Statistical analysis revealed that there were no significant differences between 
repeated AVP stimulation for AUC (10 min), AUC (peak) (Figure 3.25), peak, time to 
peak (Figure 3.26), response duration, peak duration (Figure 3.27) or time gap (Figure 
3.28). These results suggest that [Ca2+]i responses evoked by repeated 2 nM AVP 
stimulation were highly reproducible and consistent in male wild-type corticotrophs.  
 
3.2.4.2 Attenuated peak of [Ca2+]i responses to repeated AVP stimulation 
in female wild-type corticotrophs 
The calcium imaging experiments were repeated in corticotrophs isolated from female 
wild-type mice (n = 24 from 8 experiments) following the same protocol used in male 
wild-type corticotrophs.  
 
Upon stimulation of 2 nM AVP, all female wild-type corticotrophs showed an increase  






Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
male wild-type corticotrophs to repeated AVP 
 
Figure 3.25 Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in male 
wild-type corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (n = 16 from 9 
experiments, mixed effects model). All data are means ± SEM. 
  






Peak and time to peak of [Ca2+]i responses in male wild-type 
corticotrophs to repeated AVP 
 
Figure 3.26 Peak and time to peak of [Ca2+]i responses in male wild-type 
corticotrophs to repeated AVP. Quantification of effects of repeated exposure to 
2 nM AVP in (A) peak and (B) time to peak (n = 16 from 9 experiments, mixed effects 
model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
male wild-type corticotrophs to repeated AVP 
 
Figure 3.27 Response duration and peak duration of [Ca2+]i responses in male 
wild-type corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) response duration and (B) peak duration (n = 16 from 9 
experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in male wild-type corticotrophs 
to repeated AVP 
 
Figure 3.28 Time gap of [Ca2+]i responses in male wild-type corticotrophs to 
repeated AVP. Quantification of effects of repeated exposure to 2 nM AVP in time gap 
(n = 16 from 9 experiments, mixed effects model). All data are means ± SEM. 
  





in [Ca2+]i responses and both phenotypes of AVP-induced [Ca
2+]i responses were 
observed as in male wild-type corticotrophs. In 12 out of 24 cells, a sustained [Ca2+]i 
elevation was observed (Figure 3.29A, top). In remaining 12 cells, [Ca2+]i had high 
frequency oscillations, accompanied with an increase in [Ca2+]i amplitude (Figure 
3.29A, bottom). Superposition of calcium imaging traces revealed that [Ca2+]i 
responses to repeated 2 nM AVP stimulation were highly repeatable and consistent in 
female wild-type corticotrophs in both phenotypes of [Ca2+]i response (Figure 3.29B). 
 
All calcium imaging recordings were then classified into two groups according to their 
[Ca2+]i responding phenotypes to examine all measurement parameters as in wild-type 
male corticotrophs. Statistical analysis revealed that there were no significant 
differences between AVP-induced sustained [Ca2+]i elevation and oscillatory [Ca
2+]i 
behaviour in any parameter in female wild-type corticotrophs (data not shown). Thus, 
the statistical analysis of the effects of AVP on [Ca2+]i responses was performed on all 
female wild-type corticotrophs together. 
 
Statistical analysis revealed that there were no significant differences in AUC (10 min) 
or AUC (peak) following AVP stimulation in female wild-type corticotrophs (Figure 
3.30). Repeated AVP stimulation significantly (p < 0.05) reduced peak in Stimulus 3 
compared to Stimulus 1 (Figure 3.31A). Time to peak (Figure 3.31B), response  






Repeated AVP induces consistent [Ca2+]i responses in female 
wild-type corticotrophs 
 
Figure 3.29 Repeated AVP induces consistent [Ca2+]i responses in female 
wild-type corticotrophs. (A) Representative calcium imaging traces of female 
wild-type corticotrophs exposed to 2 nM AVP for three minutes and repeated three 
times at 25 minutes intervals. 30 mM potassium chloride was applied at the end for 
one minute. (B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i 
changes in female wild-type corticotrophs with repeated 2 nM AVP stimulation. Black 
line shows response to the first stimulus (starting at 15 min), grey line shows response 
to the second stimulus (starting at 40 min), and blue line shows response to the third 
stimulus (starting at 65 min). 
  





duration, peak duration (Figure 3.32) and time gap showed no statistically significant 
differences between repeated AVP stimulation (Figure 3.33). These results suggested 
that AVP-induced [Ca2+]i responses were highly repeatable and stable in female 
wild-type corticotrophs.  
 
3.2.4.3 Female wild-type corticotrophs have longer response duration to 
repeated AVP stimulation compared to males  
Although both male and female wild-type corticotrophs displayed stable [Ca2+]i 
responses to repeated AVP stimulation, we examined whether there were differences 
between male and female corticotrophs. 
 
AVP evoked two phenotypes of [Ca2+]i responses that were both found in male and 
female wild-type corticotrophs. As shown before, there were no significant differences 
between two phenotypes of [Ca2+]i responses in both sexes. Thus, the effects of 2 nM 
AVP on [Ca2+]i responses were compared on all calcium imaging recordings without 
classification between male and female wild-type corticotrophs. 
 
There were no statistically significant differences between male and female wild-type 
corticotrophs in AVP-evoked [Ca2+]i responses for AUC (10 min), AUC (peak) (Figure 
3.34), peak or time to peak (Figure 3.35A&B). However, female corticotrophs showed  






Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
female wild-type corticotrophs to repeated AVP 
 
Figure 3.30 Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in female 
wild-type corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (n = 24 from 8 
experiments, mixed effects model). All data are means ± SEM. 
  






Attenuation of peak but not time to peak of [Ca2+]i responses 
in female wild-type corticotrophs to repeated AVP 
 
Figure 3.31 Attenuation of peak but not time to peak of [Ca2+]i responses in female 
wild-type corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) peak and (B) time to peak. * p < 0.05 (n = 24 from 8 
experiments, mixed effects model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
female wild-type corticotrophs to repeated AVP 
 
Figure 3.32 Response duration and peak duration of [Ca2+]i responses in female 
wild-type corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) response duration and (B) peak duration (n = 24 from 8 
experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in female wild-type corticotrophs 
to repeated AVP 
 
Figure 3.33 Time gap of [Ca2+]i responses in female wild-type corticotrophs to 
repeated AVP. Quantification of effects of repeated exposure to 2 nM AVP in time gap 
(n = 24 from 8 experiments, mixed effects model). All data are means ± SEM. 
  





a significant (p < 0.05) longer response duration compared to males in Stimulus 2 
(Figure 3.35C). Peak duration and time gap (Figure 3.36) were not significantly 
different between male and female wild-type corticotrophs either.  
 
In summary, there were no major sex differences in wild-type corticotrophs in [Ca2+]i 
response to repeated 2nM AVP stimulation. 
 
3.2.5 Do wild-type corticotrophs display synergy between 
CRH and AVP at the level of intracellular free calcium? 
Previous studies have reported that CRH and AVP stimulate corticotrophs in a 
synergistic way to increase the secretion of ACTH, in part through synergy at the level 
of cAMP accumulation (Gillies et al., 1982; Lamberts et al., 1984). Stimulation of 
corticotrophs with CRH and AVP individually both increased [Ca2+]i. After the 
characterisation of CRH- or AVP-induced [Ca2+]i in wild-type corticotrophs, the 
following experiments were designed to investigate whether there was synergy 
between CRH and AVP at the level of [Ca2+]i. 
 
  






No significant sex difference in AVP-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses in wild-type corticotrophs 
 
Figure 3.34 No significant sex differences in AVP-induced AUC (10 min) or AUC 
(peak) of [Ca2+]i responses in wild-type corticotrophs. Quantifications of effects of 
repeated exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (male n = 16 
from 9 experiments, female n = 24 from 8 experiments, mixed effects model). All data 
are means ± SEM. 
 
  






Female wild-type corticotrophs have longer response duration 
but not peak or time to peak of [Ca2+]i responses to repeated 
AVP compared to males 
 
Figure 3.35 Female wild-type corticotrophs have longer response duration but 
not peak or time to peak of [Ca2+]i responses to repeated AVP compared to males. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) peak, (B) time to 
peak and (C) response duration. * p < 0.05 (male n = 16 from 9 experiments, female 
n = 24 from 8 experiments, mixed effects model). All data are means ± SEM. 
  






No significant sex difference in AVP-induced peak duration or 
time gap of [Ca2+]i responses in wild-type corticotrophs 
 
Figure 3.36 No significant sex difference in AVP-induced peak duration or time 
gap of [Ca2+]i responses in wild-type corticotrophs. Quantification of effects of 
repeated exposure to 2 nM AVP in (A) peak duration and (B) time gap (male n = 16 
from 9 experiments, female n = 24 from 8 experiments, mixed effects model). All data 
are means ± SEM. 
  





3.2.5.1 No synergistic [Ca2+]i response between CRH and AVP in male 
wild-type corticotrophs 
Calcium imaging experiments were performed on male wild-type corticotrophs 
following the repeated stimulation protocol (see 2.5.2.1): spontaneous [Ca2+]i 
signalling was recorded for 15 minutes, then corticotrophs were stimulated with 0.2 
nM CRH and 2 nM AVP separately followed by the combination of two single stimuli. 
Each stimulation lasted for three minutes with a 25 minute interval. Finally, 
corticotrophs were exposed to 30 mM potassium chloride for one minute to confirm 
cell viability at the end of recording. To counteract the possible influence caused by 
the sequence of exposure to CRH and AVP, the order of two single stimuli was 
randomized (CRH, AVP, combination, n = 8 or AVP, CRH, combination, n = 3 from 6 
experiments).  
 
All male wild-type corticotrophs responded to 0.2 nM CRH with a significant and 
sustained elevation of [Ca2+]i regardless of the exposure order, which was the same as 
the responses to repeated CRH stimulation. When stimulated with 2 nM AVP, two 
phenotypes of [Ca2+]i responses observed before were both found in corticotrophs no 
matter what the exposure sequence was. In 6 out of 11 cells, the sustained [Ca2+]i 
increase was observed and the other 5 cells showed an oscillatory [Ca2+]i behaviour 
when stimulated with AVP. Stimulation with the combination of 0.2 nM CRH and 





2 nM AVP, male wild-type corticotrophs always displayed a rapid and significant 
elevation of [Ca2+]i and sustained for a few minutes (Figure 3.37A & Figure 3.38A). 
Extracts of calcium imaging traces suggested the [Ca2+]i responses to two single 
stimuli and combined stimulus were highly coincident, no matter what the exposure 
sequence was and what the phenotypes of AVP-induced calcium responses were 
(Figure 3.37B & Figure 3.38B). 
 
To determine whether CRH and AVP act in a synergistic manner at the level of [Ca2+]i 
in male wild-type corticotrophs, the AUC of the combined stimulus was compared to 
the sum of the AUC of the two single stimuli. If the AUC of the combined stimulus is 
larger than the sum of the AUC of the two single stimuli indicating the corticotroph 
shows synergistic [Ca2+]i response. As AVP-induced oscillatory [Ca
2+]i responses 
always showed smaller AUC compared to sustained elevation of [Ca2+]i during peak 
duration, sustained increase of [Ca2+]i (n = 8) and oscillatory [Ca
2+]i behaviour (n = 3) 
were compared to examine whether there were significant differences between the two 
phenotypes of [Ca2+]i responses in AUC (10 min) and AUC (peak). Neither AUC 
(10 min) nor AUC (peak) showed statistically significant differences between the two 
phenotypes of [Ca2+]i responses (data not shown), thus statistical analysis of AUC 
(10 min) and AUC (peak) was performed on all male wild-type corticotrophs together. 
The effects of two single stimuli and combined stimulus on [Ca2+]i responses were also   






CRH, AVP and CRH/AVP induce [Ca2+]i responses in male 
wild-type corticotrophs 
 
Figure 3.37 CRH, AVP and CRH/AVP induce [Ca2+]i responses in male wild-type 
corticotrophs. (A) Representative calcium imaging traces of male wild-type 
corticotrophs exposed to 0.2 nM CRH, 2 nM AVP and 0.2 nM CRH together with 2 nM 
AVP at 25 minutes intervals. 30 mM potassium chloride was applied at the end for one 
minute. (B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i 
changes in male wild-type corticotrophs with stimuli. Black line shows response to 0.2 
nM CRH (starting at 15 min), grey line shows response to 2 nM AVP (starting at 40 
min), and blue line shows response to the combined stimulus (starting at 65 min). 
  






AVP, CRH and CRH/AVP induce [Ca2+]i responses in male 
wild-type corticotrophs 
 
Figure 3.38 AVP, CRH and CRH/AVP induce [Ca2+]i responses in male wild-type 
corticotrophs. (A) Representative calcium imaging traces of male wild-type 
corticotrophs exposed to 2 nM AVP, 0.2 nM CRH, and 0.2 nM CRH together with 2 
nM AVP at 25 minutes intervals. 30 mM potassium chloride was applied at the end for 
one minute. (B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i 
changes in male wild-type corticotrophs with stimuli. Black line shows response to 
2 nM AVP (starting at 15 min), grey line shows response to 0.2 nM CRH (starting at 
40 min), and blue line shows response to the combined stimulus (starting at 65 min). 
  





characterized in peak, time to peak, response duration, peak duration and time gap. 
The statistical analysis of AUC (10 min), AUC (peak) and peak were performed on 
log-transformed data and other parameters were analysed on raw data. 
 
There were no statistically significant differences among the [Ca2+]i responses induced 
by CRH, AVP and the combined stimulus in AUC (10 min) or AUC (peak). However, 
the combined stimulus was significantly (p < 0.001) smaller than the sum of the two 
single stimuli in both AUC (10 min) and AUC (peak), indicating none of these 
corticotrophs showed synergy between CRH and AVP at the level of [Ca2+]i (Figure 
3.39). Peak and time to peak were not significantly different following the three stimuli 
(Figure 3.40A&B). Stimulation with CRH and AVP together resulted in a significantly 
(p < 0.001) longer response duration (Figure 3.40C) and peak duration (Figure 3.41A) 
compared to CRH but not AVP stimulus. No significant differences were observed in 
time peak (Figure 3.41B) between CRH-, AVP- and CRH/AVP-induced [Ca2+]i 
responses. 
 
These results suggested that there was no synergistic [Ca2+]i response to CRH/ AVP in 
male wild-type corticotrophs. CRH/AVP induced longer response duration and peak 
duration compared to CRH stimulus alone. 
 






No synergistic [Ca2+]i response between CRH and AVP in male 
wild-type corticotrophs 
 
Figure 3.39 No synergistic [Ca2+]i response between CRH and AVP in male 
wild-type corticotrophs. Quantification of effects of exposure to 0.2 nM CRH, 2 nM 
AVP and the combination of the two in (A) AUC (10 min) and (B) AUC (peak). The 
comparison of the AUC of the combined stimulus and the sum of the two single stimuli 
was used as a measurement of synergy. *** p < 0.001 (n = 11 from 6 experiments, 
mixed effects model). All data are means ± SEM. 






CRH/AVP induces longer response duration but not peak or 
time to peak of [Ca2+]i responses in male wild-type 
corticotrophs 
 
Figure 3.40 CRH/AVP induces longer response duration but not peak or time to 
peak of [Ca2+]i responses in male wild-type corticotrophs. Quantification of effects 
of exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak, 
(B) time to peak and (C) response duration. *** p < 0.001 (n = 11 from 6 experiments, 
mixed effects model). All data are means ± SEM. 
  






CRH/AVP induces longer peak duration but not time gap of 
[Ca2+]i responses in male wild-type corticotrophs 
 
Figure 3.41 CRH/AVP induces longer peak duration but not time gap of [Ca2+]i 
responses in male wild-type corticotrophs. Quantification of effects of exposure to 
0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak duration and (B) 
time gap. *** p < 0.001 (n = 11 from 6 experiments, mixed effects model). All data 
are means ± SEM. 
  





3.2.5.2 No synergistic [Ca2+]i response between CRH and AVP in female 
wild-type corticotrophs at the population level 
Calcium imaging experiments were performed on female wild-type corticotrophs 
isolated following the same protocol used in male wild-type corticotrophs. The order 
of CRH and AVP was random to minimize the possible impact resulted from the 
sequence of exposure to two single stimuli (CRH, AVP, combination, n = 8 or AVP, 
CRH, combination, n = 7 from 5 experiments). 
 
When stimulated with 0.2 nM CRH, 2 nM AVP and the combined stimulus 
sequentially (n = 8), all 8 corticotrophs showed sustained increase of [Ca2+]i to CRH  
stimulus, 5 out of 8 cells had sustained elevation of [Ca2+]i to AVP stimulus and the 
other 3 cells displayed oscillatory [Ca2+]i behaviour. All 8 cells showed a significant 
and rapid increase of [Ca2+]i following combination stimulus (Figure 3.42A). When 
the order of stimulus was 2 nM AVP, 0.2 nM CRH and the combination of the two 
(n = 7), 1 out of 7 corticotrophs responding to all three stimuli with oscillatory [Ca2+]i 
behaviour, which was not observed in wild-type corticotrophs exposed to repeated 
CRH stimulation. In the remaining 6 cells, all cells responded to CRH and the 
combination of the two single stimuli with sustained [Ca2+]i increase, with 3 of them 
showing [Ca2+]i oscillation and the rest 3 cells showing sustained [Ca
2+]i responses to 
AVP stimulus (Figure 3.43B). Although two phenotypes of [Ca2+]i responses were 





observed in all stimuli, extracts of calcium imaging traces suggested that [Ca2+]i 
responses to two single stimuli and combined stimulus were highly coincident 
regardless of the order of stimulus (Figure 3.42B & Figure 3.43B). 
 
The synergistic [Ca2+]i responses and the effects of two single stimuli and combined 
stimulus on [Ca2+]i responses were assessed with the same parameters used in male 
wild-type corticotrophs. Statistical analysis revealed that female wild-type 
corticotrophs showed no significant differences between AVP-induced sustained 
elevation of [Ca2+]i (n = 8) and oscillatory [Ca
2+]i behaviour (n = 7) in either AUC 
(10 min) or AUC (peak) (data not shown). Thus, statistical analysis was performed on 
all female wild-type corticotrophs together. 
 
AVP-induced AUC (10 min) [Ca2+]i responses was significantly lower than [Ca
2+]i 
responses induced by CRH (p < 0.01) and the combined stimulus (p < 0.01). 
AVP-induced AUC (peak) was also significantly lower than CRH (p < 0.05) and the 
combined stimulus (p < 0.001). Importantly, the combined stimulus was significantly 
smaller than the sum of the two single stimuli in both AUC (10 min) (p < 0.001) and 
AUC (peak) (p < 0.01), which suggests that there was no synergistic [Ca2+]i responses 
CRH and AVP in female wild-type corticotrophs (Figure 3.44). Although the synergy 
was not observed when considering the population, in 4 out of 15 cells (26.7%) the  






CRH, AVP and CRH/AVP induce [Ca2+]i responses in female 
wild-type corticotrophs 
 
Figure 3.42 CRH, AVP and CRH/AVP induce [Ca2+]i responses in female 
wild-type corticotrophs. (A) Representative calcium imaging traces of female 
wild-type corticotrophs exposed to 0.2 nM CRH, 2 nM AVP and 0.2 nM CRH together 
with 2 nM AVP at 25 minutes intervals. 30 mM potassium chloride was applied at the 
end for one minute. (B) Superposition of extracts of the two traces shown in A, 
showing [Ca2+]i changes in female wild-type corticotrophs with stimuli. Black line 
shows response to 0.2 nM CRH (starting at 15 min), grey line shows response to 2 nM 
AVP (starting at 40 min), and blue line shows response to the combined stimulus 
(starting at 65 min). 
  






AVP, CRH and CRH/AVP induce [Ca2+]i responses in female 
wild-type corticotrophs 
 
Figure 3.43 AVP, CRH and CRH/AVP induce [Ca2+]i responses in female 
wild-type corticotrophs. (A) Representative calcium imaging traces of female 
wild-type corticotrophs exposed to 2 nM AVP, 0.2 nM CRH and 0.2 nM CRH together 
with 2 nM AVP at 25 minutes intervals. 30 mM potassium chloride was applied at the 
end for one minute. (B) Superposition of extracts of the two traces shown in A, 
showing [Ca2+]i changes in female wild-type corticotrophs with stimuli. Black line 
shows response to 2 nM AVP (starting at 15 min), grey line shows response to 0.2 nM 
CRH (starting at 40 min), and blue line shows response to the combined stimulus 
(starting at 65 min). 
 





AUC (peak) but not AUC (10 min) of the combined stimulus was larger than the sum 
of the two single stimuli. Peak, time to peak, response duration (Figure 3.45) and peak 
duration (Figure 3.46A) were not significantly different among CRH-, AVP- and 
CRH/AVP-induced [Ca2+]i responses. Stimulation with AVP showed a significantly 
longer time gap compared to CRH stimulus (p < 0.01) and the combined stimulus 
(p < 0.001) (Figure 3.46A). 
 
These results suggested that there was no synergistic [Ca2+]i response between CRH 
and AVP in female wild-type corticotrophs at the level of population, however, a 
proportion of corticotrophs (26.7%) showed synergistic [Ca2+]i response at the level of 
single cell. AVP-induced significantly smaller AUC (10 min) and AUC (peak) but 
longer time gap compared to CRH stimulus and the combined stimulus. 
 
3.2.5.3 CRH/AVP-induced [Ca2+]i responses are not significantly different 
between male and female wild-type corticotrophs 
Although no synergistic [Ca2+]i responses between CRH and AVP were observed in 
either male or female wild-type corticotrophs at the population level, we investigated 
whether there were differences between male and female wild-type corticotrophs. 
 
 






No synergistic [Ca2+]i response between CRH and AVP in 
female wild-type corticotrophs 
 
 
Figure 3.44 No synergistic [Ca2+]i response between CRH and AVP in female 
wild-type corticotrophs. Quantification of effects of exposure to 0.2 nM CRH, 2 nM 
AVP and the combination of the two in (A) AUC (10 min) and (B) AUC (peak). The 
comparison of the AUC of the combined stimulus and the sum of the two single stimuli 
was used as a measurement of synergy. * p < 0.05, ** p < 0.01 and *** p < 0.001 
(n = 15 from 5 experiments, mixed effects model). All data are means ± SEM. 






Peak, time to peak and response duration of [Ca2+]i responses 
to CRH, AVP and CRH/AVP in female wild-type corticotrophs 
 
Figure 3.45 Peak, time to peak and response duration of [Ca2+]i responses to CRH, 
AVP and CRH/AVP in female wild-type corticotrophs. Quantification of effects of 
exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak, (B) 
time to peak and (C) response duration (n = 15 from 5 experiments, mixed effects 
model). All data are means ± SEM. 
  






AVP induces longer time gap but not peak duration of [Ca2+]i 
response in female wild-type corticotrophs 
 
Figure 3.46 AVP induces longer time gap but not peak duration of [Ca2+]i 
responses in female wild-type corticotrophs. Quantification of effects of exposure 
to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak duration and 
(B) time gap. ** p < 0.01 and *** p < 0.001 (n = 15 from 5 experiments, mixed effects 
model). All data are means ± SEM. 
  





Statistical analysis revealed that there were no significant differences between male 
and female wild-type corticotrophs in AUC (10 min) and AUC (peak), although female 
corticotrophs tended to have higher variability (Figure 3.47). Peak, time to peak, 
response duration and peak duration failed to show any significant sex difference either 
(Figure 3.48). Male corticotrophs displayed longer mean time gap following two single 
stimuli and the combined stimulus compared to females with statistical analysis 
approaching significance (p = 0.08) (Figure 3.49). 
 
In summary, there were no statistically significant differences between male and 
female wild-type corticotrophs in [Ca2+]i responses induced by CRH, AVP and the 
combination of the two. 
  






No significant sex difference in AUC (10 min) or AUC (peak) of 
[Ca2+]i responses to CRH, AVP and CRH/AVP in wild-type 
corticotrophs 
 
Figure 3.47 No significant sex difference in AUC (10 min) or AUC (peak) of [Ca2+]i 
responses to CRH, AVP and CRH/AVP in wild-type corticotrophs. Quantification 
of effects of exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in 
(A) AUC (10 min) and (B) AUC (peak) (male n = 11 from 6 experiments, female 
n = 15 from 5 experiments, mixed effects model). All data are means ± SEM. 
  






No significant sex difference in peak, time to peak, response 
duration or peak duration of [Ca2+]i responses to CRH, AVP and 
CRH/AVP in wild-type corticotrophs 
 
Figure 3.48 No significant sex difference in peak, time to peak, response duration 
or peak duration of [Ca2+]i responses to CRH, AVP and CRH/AVP in wild-type 
corticotrophs. Quantification of effects of exposure to 0.2 nM CRH, 2 nM AVP and 
the combination of the two in (A) peak, (B) time to peak, (C) response duration and 
(D) peak duration (male n = 11 from 6 experiments, female n = 15 from 5 experiments, 
mixed effects model). All data are means ± SEM. 
  






No significant sex difference in time gap of [Ca2+]i responses 
to CRH, AVP and CRH/AVP in wild-type corticotrophs 
 
Figure 3.49 No significant sex difference in time gap of [Ca2+]i responses to CRH, 
AVP and CRH/AVP in wild-type corticotrophs. Quantification of effects of exposure 
to 0.2 nM CRH, 2 nM AVP and the combination of the two in time gap (male n = 11 
from 6 experiments, female n = 15 from 5 experiments, mixed effects model). All data 
are means ± SEM. 
  






In this chapter, I exploited a genetic approach for expression of the GCaMP6s calcium 
sensor specifically in murine anterior pituitary corticotrophs by using lentiviral driven 
expression under the control of a minimal rat Pomc promoter. This allowed robust 
real-time identification of murine corticotrophs and examination of spontaneous, 
CRH- and AVP-induced [Ca2+]i responses in murine corticotrophs. Importantly, these 
studies allowed robust and repeatable [Ca2+]i responses to pulses of secretagogues at 
physiological concentrations with frequency of pulses similar to those reported in vivo. 
Wild-type corticotrophs displayed robust and sustained [Ca2+]i responses to CRH, 
whereas AVP evoked two patterns of [Ca2+]i responses, sustained elevation and 
oscillatory behaviour. The [Ca2+]i responses to CRH and AVP were similar in male and 
female wild-type corticotrophs whereas spontaneous [Ca2+]i signalling was 
significantly higher in male corticotrophs. Although synergistic [Ca2+]i responses was 
observed in a small proportion of corticotrophs from female wild-type mice, synergy 
was not observed in males. This characterisation provides a platform to further 
interrogate the regulation of [Ca2+]i signalling in murine corticotrophs as addressed in 
Chapter Four and Chapter Five. 
  





3.3.1 Specific labelling of murine corticotrophs and 
spontaneous [Ca2+]i in wild-type murine corticotrophs 
By using lentiviral-mediated transduction of isolated mouse anterior pituitary cultures, 
the genetically encoded calcium indicator GCaMP6s was expressed under the control 
of a minimal rat Pomc promoter. This allowed labelling of live corticotrophs with 83% 
specificity and 53% efficiency as determined by co-localisation with ACTH. 
Importantly, in all analysed corticotrophs a priori identification of corticotrophs using 
POMC-GCaMP6s responded to CRH and/or AVP suggesting that the specificity of 
labelling likely represent an underestimate in the immunohistochemical analysis. 
Indeed, previous studies from the Shipston laboratory, expressing eYFP under the 
control of the same minimal promoter revealed a specificity greater than 99.5%. 
Importantly, lentiviral expression has no significant effect on basal or 
secretaogue-evoked ACTH secretion or electrical properties (Liang et al., 2011) 
supporting that lentiviral mediated-transduction has no significant effect on 
corticotroph viability or physiology. Thus, this approach could be used to target 
corticotrophs in vitro for calcium imaging experiments.  
 
To determine spontaneous [Ca2+]i signalling, a “15% threshold” method was used to 
define whether the corticotrophs were active or silent over the five minute period of 
“baseline” recording before exposure to any secretagogue. This is important as the vast 





majority of previous studies on corticotrophs have used high concentrations of 
secretagogues to isolate and/or identify cells prior to analysis. Calcium imaging 
experiments performed in this PhD revealed that the vast majority (> 95%) of mouse 
corticotrophs displayed spontaneous [Ca2+]i signalling while only a small proportion 
of them was absolutely silent. This was different from previous studies on male rat 
pituitary corticotrophs where only 30% of cells showed spontaneous [Ca2+]i transients 
(Romanò et al., 2017). Spontaneous [Ca2+]i signalling in murine corticotrophs were 
highly variable between cells and all spontaneously active corticotrophs could be 
classified into three categories: high or low frequency of [Ca2+]i oscillation, sustained 
elevation of [Ca2+]i
 as well as low amplitude and complex patterns of [Ca2+]i changes 
that was only seen in a small proportion of cells (< 5%). Importantly, all patterns of 
spontaneous [Ca2+]i signalling were found in both female and male wild-type 
corticotrophs. However, the distribution and mean of spontaneous active time in male 
wild-type corticotrophs were significantly (p < 0.01) higher compared to females, 
although the maximum amplitude of spontaneous [Ca2+]i signalling was not 
significantly different between male and female corticotrophs. Whether the variety of 
spontaneous [Ca2+]i signalling that could be categorized into subtypes suggest 
potential distinct subpopulation of corticotrophs or reflect stochastic variability in 
corticotrophs behaviour is not known. To address this, an approach would be to analyse 
corticotroph [Ca2+]i responses in pituitary slices instead of pituitary cultures to 





compare [Ca2+]i signalling of corticotrophs from different regions of the anterior 
pituitary gland to determine whether there is heterogeneity of corticotroph behaviour 
when in a network of cells. 
 
3.3.2 CRH induces sustained [Ca2+]i increase in wild-type 
corticotrophs 
Following three minutes of 0.2 nM CRH stimulation, wild-type corticotrophs 
responded with a significant and rapid sustained elevation of global [Ca2+]i signalling 
that continued for several minutes even after the removal of secretagogue. Importantly, 
the majority of analysed parameters were stable with repeated exposure to CRH in 
both male and female corticotrophs although there was a significant decrease in peak 
of [Ca2+]i responses in corticotrophs from both sexes by the third pulse. In addition, 
there were no significant differences in CRH-induced [Ca2+]i responses between male 
and female wild-type corticotrophs. L-type calcium channel blocker nifedipine largely 
abolished both spontaneous [Ca2+]i and CRH-evoked [Ca
2+]i responses in male 
wild-type corticotrophs suggesting that these [Ca2+]i responses were driven 
predominantly by an influx of extracellular calcium as previously reported (Guérineau 
et al., 1991; Kuryshev et al., 1996; Romanò et al., 2017). 
  





3.3.3 AVP induces two patterns of [Ca2+]i responses 
Wild-type corticotrophs stimulated with a 2 nM AVP pulse for three minutes exhibited 
two phenotypes of [Ca2+]i responses: sustained elevation of [Ca
2+]i for several minutes, 
similar to that observed with CRH stimulation, and oscillatory [Ca2+]i behaviour 
accompanied with increased amplitude of [Ca2+]i “oscillations”. Importantly, these 
distinct patterns were deterministic — in the same corticotroph repeated exposure to 
AVP always produced the same [Ca2+]i response phenotype. 
 
AVP-induced increases in [Ca2+]i is dependent on two mechanisms: calcium released 
from IP3-regulated internal stores and influx through L-type calcium channels. In 
pituitary corticotrophs, AVP activates V1b G-protein-coupled membrane receptor that 
activates PLC, leading to the increase of IP3 and the formation of DAG with 
subsequent activation of PKC (Antoni, 1993; Corcuff et al., 1993; Stojilkovic et al., 
2010). Most previous studies have used AVP at supraphysiological (10–100 nM) and 
reported a biphasic pattern of [Ca2+]i response (transient and plateau phase) in 
corticotrophs with IP3-mediated [Ca
2+]i release controlling the transient phase and Ca
2+ 
entry though voltage-gated calcium channel (VGCC) required for the plateau phase of 
AVP-induced Ca2+ signal (Tse & Lee, 1998). The AVP-induced oscillatory [Ca2+]i 
response reported in this Thesis is reminiscent of GnRH-evoked [Ca2+]i responses in 
pituitary gonadotrophs dependent upon release of Ca2+ from IP3-sensitive calcium 





stores (Tse & Hille, 1992; Stojilkovic, 2012). Further studies to interrogate the relative 
contribution of Ca2+ influx via VGCC versus IP3-mediated [Ca
2+]i release are required, 
for example using pharmacological inhibitors to address this issue. Furthermore, 
whether these distinct phenotypes reflect different subpopulations of corticotrophs or 
reflect variations in the size of the intracellular IP3-sensetive calcium store between 
corticotrophs remains to be determined. 
 
3.3.4 Lack of synergistic [Ca2+]i responses to CRH and AVP 
In corticotrophs, CRH acts in synergy with AVP to increase the secretion of ACTH. 
This synergy has been considered to occur at multiple levels of the CRH- and 
AVP-signalling pathways. For example, at the level of second messenger, cAMP 
accumulation induced by CRH via CRHR1 receptor is potentiated by AVP likely 
though the regulation of a Ca2+ dependent adenylate cyclase and control of 
phosphodiesterase activity (Abou-Samra et al., 1987; Stojilkovic et al., 2010; Antoni, 
2012). In addition, the synergy between CRH and AVP may involve the molecular 
interaction (heterodimerization) between CRHR1 and V1b receptors (Murat et al., 
2012). However, whether synergy occurs at the level of [Ca2+]i is largely unexplored. 
The ability to expose corticotrophs to repeated pulses of secretagogue allowed me to 
directly test if synergy also occurs at the level of [Ca2+]i. Calcium imaging data showed 
that a three minute exposure of CRH/AVP resulted in a rapid and significant sustained 





increase of [Ca2+]i for several minutes. No significant synergistic [Ca
2+]i response was 
observed between CRH and AVP in any male wild-type corticotroph. Although there 
was no significant synergistic [Ca2+]i response in female wild-type corticotrophs at the 
population level, 26.7% (4 out of 15 cells) of single corticotrophs displayed synergistic 
[Ca2+]i responses to CRH and AVP stimulation. A recent study reported similar results 
that no synergistic [Ca2+]i response was seen at the population level, however, ~ 30% 
of male rat corticotrophs examined showed synergy to CRH and AVP at the level of 
single cells (Romanò et al., 2017). There were no significant differences between male 
and female wild-type corticotrophs in [Ca2+]i responses induced by CRH, AVP and the 
combination of the two either. 
 
These results showed that there was no significant synergistic [Ca2+]i response to CRH 
and AVP at the population level in either male or female wild-type corticotrophs, but 
26.7% of female corticotrophs elicited synergistic [Ca2+]i responses. Again, whether 
this proportion of corticotrophs that display synergy represents a distinct population 
or reflects variation in signalling pathways remains to be addressed. 
 
3.4 Chapter summary 
A lentiviral-mediated POMC-GCaMP6s transduction was developed to identify and 
label mouse anterior pituitary corticotrophs in vitro. Wild-type corticotrophs showed 





highly variable spontaneous [Ca2+]i signalling that probably suggest the existence of 
potential subpopulation of corticotrophs. CRH induced sustained and significant 
elevation of [Ca2+]i that is nifedipine-sensitive and depends on an influx of 
extracellular Ca2+. In particular, repeated CRH stimulation evoked robust and 
repeatable [Ca2+]i responses which had a reduction in peak of [Ca
2+]i responses and no 
significant sex differences were observed. Stimulation with AVP resulted in two 
phenotypes of [Ca2+]i response: sustained elevation of [Ca
2+]i and oscillatory [Ca
2+]i 
behaviour. Repeated AVP stimulation evoked highly reproducible and deterministic 
[Ca2+]i responses in both male and female wild-type corticotrophs, although male wild-
type corticotrophs had longer response duration compared to females. There were no 
significant synergistic [Ca2+]i responses to CRH and AVP in either male or female 
wild-type corticotrophs. 
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Chapter 4: Calcium signalling in BK-KO 
corticotrophs 
4.1 Introduction 
In this chapter, the aim was to investigate the role of large conductance calcium- and 
voltage-activated potassium (BK) channels in regulating intracellular free calcium 
([Ca2+]i) responses in corticotrophs. Calcium imaging recordings were first obtained 
from male and female BK channel knockout (BK-KO) corticotrophs respectively to 
determine the role of BK channels in spontaneous [Ca2+]i signalling, CRH- or 
AVP-induced elevation of [Ca2+]i as well as the synergy between CRH and AVP in 
corticotrophs. Secondly, the experiments were designed to examine whether 
pharmacological blockade of BK channels with the specific BK channel blocker 
paxilline had similar effect as genetic deletion of BK channels in corticotrophs. 
 
4.1.1 BK channels regulate corticotroph activity 
Previous investigation of the role of BK channels in the regulation of the HPA axis 
indicated that, compared to wild-type mice, plasma ACTH and corticosterone are 
significantly decreased in female BK channel knockout mice following acute restraint 
stress (Brunton et al., 2007). These studies, using mice with a global deletion of BK 
channels revealed that this stress hyporespensiveness is likely a result of changes in 





properties at multiple levels of the HPA axis. Importantly, recent in vitro studies in 
male murine corticotrophs revealed that the CRH-dependent transition from action 
potential spiking to bursting is dependent on functional BK channels, whereas AVP 
promotes an increase in spiking frequency alone via a BK-independent pathway 
(Duncan et al., 2015; Fletcher et al., 2017).  
 
Interestingly, a shift of firing patterns from spiking to plateau-bursting in gonadotrophs 
has been implicated in triggering luteinizing hormone secretion (Van Goor et al., 
2001b). Bursting behaviour is suggested to be more capable of driving the influx of 
extracellular Ca2+ than spiking, which is believed to result in a higher level of [Ca2+]i 
to drive hormone secretion (Van Goor et al., 2001b; Stojilkovic et al., 2005). However, 
recent modelling studies revealed that the pattern of spiking activity can also result in 
highly efficient global calcium signalling (Tagliavini et al., 2016). The patterns of Ca2+ 
entry driven by action potentials and their relationships are likely to be important for 
ACTH secretion.  
 
In this chapter, calcium imaging experiments were performed to determine the role of 
BK channels in regulating spontaneous [Ca2+]i and CRH- or AVP-evoked [Ca
2+]i 
signalling in corticotrophs with both genetic and pharmacological approaches. We 
hypothesised that corticotrophs isolated from BK-KO mice would show an attenuated 





[Ca2+]i responses to CRH but not AVP, and this would be mimicked in wild-type 
corticotrophs treated with the specific BK channel blocker paxilline. As CRH and AVP 
did not display significant synergistic [Ca2+]i responses in wild-type corticotrophs at 
the level of the population, we predicted that synergy would also be absent in BK-KO 
corticotrophs. All experiments were performed on corticotrophs isolated from BK-KO 
mice of both sexes according to the potential sexual dimorphism in response to stress. 
 
4.2 Results 
4.2.1 Genetic deletion of BK channels differentially controls 
spontaneous [Ca2+]i signalling in male and female 
corticotrophs 
To investigate the role of BK channels in regulating spontaneous [Ca2+]i signalling, the 
basal [Ca2+]i of corticotrophs isolated form BK-KO mice were continuously recorded 
for five minutes before exposure to secretagogues. The active time and maximum 
amplitude of spontaneous [Ca2+]i signalling were analysed between sexes. Only data 
from BK-KO corticotrophs and the comparison between wild-type and BK-KO 
corticotrophs are presented in this chapter. The analysis of these data was done in 
conjunction with the analyses for Chapters Three and Five (see 2.6.3).The active time 
of spontaneous [Ca2+]i signalling was 49.8 ± 3.6% when comparing all male and 
female corticotrophs with a skewed distribution to lower values (n = 71 cells from 29 





experiments). Importantly, the active time was 32.1 ± 6.1% in male BK-KO 
corticotrophs (n = 18 from 12 experiments), which was significantly lower (p < 0.01) 
than female BK-KO corticotrophs with an active time of 55.8 ± 4.1% (n = 53 from 17 
experiments) (Figure 4.1A&B). The distribution of spontaneous active time in male 
corticotrophs was significantly skewed to the left compared to female corticotrophs 
(Figure 4.1C&D). 
 
Using the “15% threshold” definition revealed that 5.6% (4 out of 71 cells) of all 
BK-KO corticotrophs were silent during the basal recoding period, 47.9% of cells 
displayed oscillatory [Ca2+]i behaviour, 32.4% of cells had sustained [Ca
2+]i elevation 
and the rest 10 out of 71 cells (14.1%) showed a low amplitude and complex pattern 
of calcium behaviour (Figure 4.3A). In female BK-KO corticotrophs, oscillatory 
[Ca2+]i behaviour and sustained [Ca
2+]i elevation were 35.9% and 39.6% respectively. 
However, 72.2% of male BK-KO corticotrophs displayed oscillatory [Ca2+]i behaviour 
and only 22.2% of cells showed sustained [Ca2+]i elevation. In addition, no silent cells 
were found in male BK-KO corticotrophs. The differences between male and female 
BK-KO corticotrophs in spontaneous [Ca2+]i signalling patterns might due to the 
relatively low number of male BK-KO corticotrophs analysed (n = 18).Next, the 
maximum amplitude of spontaneous [Ca2+]i signalling between BK-KO corticotrophs 
was compared using normalized calcium imaging traces as before. The maximum  






Spontaneous [Ca2+]i active time is significantly higher in 
female than male in BK-KO corticotrophs 
 
Figure 4.1 Spontaneous [Ca2+]i active time is significantly higher in female than 
male in BK-KO corticotrophs. (A) The mean active time of spontaneous [Ca2+]i 
signalling in all BK-KO corticotrophs. (B) The distribution of spontaneous [Ca2+]i 
active time in all BK-KO corticotrophs. The distribution of spontaneous [Ca2+]i active 
time in (C) female and (D) male BK-KO corticotrophs. ** p < 0.01 (female n = 53, 
male n = 18, mixed effects model). Red line indicates the fit of distribution density. 
All data are means ± SEM, N > 3 independent experiments. 
  





amplitude of spontaneous [Ca2+]i signalling in all BK-KO corticotrophs was 64.1 ± 3.0% 
(n = 71 from 29 experiments) showing a positive skewed distribution (Figure 4.2A&B). 
The spontaneous [Ca2+]i signalling in female BK-KO corticotrophs had a maximum 
amplitude of 63.7 ± 3.6% (n = 53 from 17 experiments), which was not significantly 
different from male BK-KO corticotrophs with a maximum amplitude of 65.2 ± 5.2% 
(n = 18 from 12 experiments) (Figure 4.2A). The maximum amplitude displayed a 
highly positive skewed distribution in both male and female BK-KO corticotrophs 
(Figure 4.2C&D). These results demonstrated that there were no significant sex 
differences in maximum amplitude of spontaneous [Ca2+]i signalling in BK-KO 
corticotrophs. 
 
To determine the role of BK channels in spontaneous [Ca2+]i signalling, statistical 
analysis was performed between wild-type and BK-KO corticotrophs for active time 
and maximum amplitude. When combining data from both male and female 
corticotrophs, the active time in wild-type corticotrophs was 45.2 ± 2.2% (n = 121 
from 56 experiments) revealing no significant differences compared to BK-KO 
corticotrophs with the active time of 49.8 ± 3.6% (n = 71 from 29 experiments) (Figure 
4.3B). There were no significant differences in maximum amplitude either (mean of 
69.8 ± 1.5% in wild-type and 64.1 ± 3.0% in BK-KO corticotrophs respectively) 
(Figure 4.3C). However, compared to female wild-type corticotrophs, the spontaneous  






The maximum amplitude of spontaneous [Ca2+]i signalling is 
not different between male and female BK-KO corticotrophs 
 
Figure 4.2 The maximum amplitude of spontaneous [Ca2+]i signalling is not 
different between male and female BK-KO corticotrophs. (A) The mean maximum 
amplitude of spontaneous [Ca2+]i signalling in all BK-KO corticotrophs. (B) The 
distribution of spontaneous [Ca2+]i maximum amplitude in all BK-KO corticotrophs. 
The distributions of spontaneous [Ca2+]i maximum amplitude in (C) female and (D) 
male BK-KO corticotrophs (female n = 53, male n = 31, mixed effects model). Red 
line indicates the fit of distribution density. All data are means ± SEM, N > 3 
independent experiments. 
  






Genetic deletion of BK channels results in an increase in 
spontaneous [Ca2+]i active time in female corticotrophs 
 
Figure 4.3 Genetic deletion of BK channels results in an increase in spontaneous 
[Ca2+]i active time in female corticotrophs. (A) All patterns of spontaneous [Ca
2+]i 
signalling were seen in BK-KO corticotrophs. (B) The distribution and mean of 
spontaneous [Ca2+]i active time in male and female wild-type and BK-KO 
corticotrophs. (C) The distribution and mean of spontaneous [Ca2+]i maximum 
amplitude in male and female wild-type and BK-KO corticotrophs. * p < 0.05 
(wild-type n = 121, BK-KO n = 71, mixed effects model). Green line and red line 
indicate the fit of distribution density of wild-type and BK-KO corticotrophs 
respectively. All data are means ± SEM, N > 3 independent experiments. 
  





active time was significantly longer (p < 0.05) and distribution skewed to the right in 
female BK-KO corticotrophs, although there were no statistical differences in 
maximum amplitude. In contrast, male BK-KO corticotrophs showed a shorter active 
time that approach to significance (p = 0.07) with a distribution skewed to the left 
compared to wild-type. No significant difference were observed between them in 
maximum amplitude. 
 
In conclusion, these results indicated sex differences in spontaneous [Ca2+]i signalling 
in male and female BK-KO corticotrophs. Deletion of BK channels led to a significant 
increase in the active time of spontaneous [Ca2+]i signalling in female corticotrophs, 
with the maximum amplitude of spontaneous [Ca2+]i signalling independent of BK 
channels in both sexes. 
 
4.2.2 CRH-induced [Ca2+]i responses are suppressed in male 
but not female BK-KO corticotrophs 
To address whether BK channels also play a role in CRH-evoked [Ca2+]i responses, we 
characterised [Ca
2+]i responses to repeated CRH stimulation in male and female 
corticotrophs in which BK channels were genetically deleted. 
 





4.2.2.1 CRH-induced [Ca2+]i responses are consistent in male BK-KO 
corticotrophs 
Calcium imaging experiments were performed on male BK-KO corticotrophs (n = 12 
from 8 experiments) using the same repeated stimulation protocol as for wild-type 
corticotrophs (see 3.2.3.1). 
 
Upon repeated exposure to 0.2 nM CRH for three minutes, all corticotrophs displayed 
a rapid and significant [Ca2+]i elevation that returned to the basal level a few minutes 
later. It’s interesting to note that in 1 out of 12 cells (8.3%), CRH-induced oscillatory 
[Ca2+]i behaviour, something that was never observed in male wild-type corticotrophs 
(Figure 4.4A). However, whether this reflects a potential effect of loss of BK channels 
cannot be determined due to the low numbers observed. Superposition of calcium 
imaging traces indicated consistent and robust changes in [Ca2+]i in response to the 
three CRH exposures in male BK-KO corticotrophs (Figure 4.4B). 
 
The effects of 0.2 nM CRH on [Ca2+]i in male BK-KO corticotrophs were evaluated 
using the same parameters as for wild-type corticotrophs including AUC (10min), 
AUC (peak), peak, time to peak, response duration, peak duration and time gap. Log 
transformation was performed on AUC (10min), AUC (peak) and peak as before. 
Overall, there were no significant differences between three stimuli for AUC (10 min),   






Repeated CRH induces [Ca2+]i responses in male BK-KO 
corticotrophs 
 
Figure 4.4 Repeated CRH induces [Ca2+]i responses in male BK-KO 
corticotrophs. (A) Representative calcium imaging traces of male BK-KO 
corticotrophs exposed to 0.2 nM CRH for three minutes and repeated three times at 25 
minutes intervals. 30 mM potassium chloride was applied at the end for one minute. 
(B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i changes in 
male BK-KO corticotrophs with repeated 0.2 nM CRH stimulation. Black line shows 
response to the first stimulus (starting at 15 min), grey line shows response to the 
second stimulus (starting at 40 min), and blue line shows response to the third stimulus 
(starting at 65 min). 
  





AUC (peak) (Figure 4.5), peak, time to peak (Figure 4.6), response duration or peak 
duration (Figure 4.7). However, a significantly (p < 0.05) shorter time gap between 
Stimulus 2 and Stimulus 3 was observed (Figure 4.8). 
 
These results suggest that the [Ca2+]i responses are largely consistent upon repeated 
0.2 nM CRH stimulation in male BK-KO corticotrophs. 
 
4.2.2.2 Attenuated AUC (peak) of [Ca2+]i responses to repeated CRH 
stimulation in female BK-KO corticotrophs 
Calcium imaging recordings were obtained from female BK-KO corticotrophs (n = 20 
from 6 experiments) following the same experimental protocol used in male 
corticotrophs.  
 
Similar to male BK-KO corticotrophs, two phenotypes of [Ca2+]i responses were 
observed: 18 out of 20 cells (90.0%) showed sustained elevation of [Ca2+]i (Figure 
4.9A, top) and the other 2 cells (10.0%) exhibited oscillatory [Ca2+]i behaviour (Figure 
4.9A, bottom). As for male wild-type corticotrophs this oscillatory [Ca2+]i  response 
was never observed in female wild-type corticotrophs again suggesting BK channels 
may play a role in modulating the pattern of [Ca2+]i dynamics. Two phenotypes of 
[Ca2+]i responses were both repetitive upon repeated CRH stimulation in female   






Stable AUC (10 min) and AUC (peak) [Ca2+]i responses in male 
BK-KO corticotrophs to repeated CRH 
 
Figure 4.5 Stable AUC (10 min) and AUC (peak) [Ca2+]i responses in male BK-KO 
corticotrophs to repeated CRH. Quantification of effects of repeated exposure to 
0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak) (n = 12 from 8 experiments, 
mixed effects model). All data are means ± SEM. 
 
  






Peak and time to peak of [Ca2+]i responses in male BK-KO 
corticotrophs to repeated CRH 
 
Figure 4.6 Peak and time to peak of [Ca2+]i responses in male BK-KO 
corticotrophs to repeated CRH. Quantification of effects of repeated exposure to 
0.2 nM CRH in (A) peak and (B) time to peak (n = 12 from 8 experiments, mixed 
effects model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
male BK-KO corticotrophs to repeated CRH 
 
Figure 4.7 Response duration and peak duration of [Ca2+]i responses in male 
BK-KO corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) response duration and (B) peak duration (n = 12 from 
8 experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in male BK-KO corticotrophs to 
repeated CRH 
 
Figure 4.8 Time gap of [Ca2+]i responses in male BK-KO corticotrophs to 
repeated CRH. Quantification of effects of repeated exposure to 0.2 nM CRH in time 
gap. * p < 0.05 (n = 12 from 8 experiments, mixed effects model). All data are 
means ± SEM. 
  





BK-KO corticotrophs (Figure 4.9B). 
 
In contrast to the stable [Ca2+]i responses to repeated CRH stimulation observed in 
male BK-KO corticotrophs, [Ca2+]i responses in female BK-KO corticotrophs were 
significantly attenuated in AUC (peak) (p < 0.05) but not AUC (10 min) (Figure 4.10) 
by Stimulus 3 compared to Stimulus 1. However, there were no significant differences 
between [Ca2+]i responses for peak, time to peak (Figure 4.11), response duration, peak 
duration (Figure 4.12) or time gap (Figure 4.13) between Stimulus 1 and Stimulus 3 
in female BK-KO corticotrophs. 
 
Although AUC (peak) showed significant reduction following repeated CRH 
stimulation, AUC (10 min) and peak of [Ca2+]i responses were stable. These data 
suggest that stimulation with repeated 0.2 nM CRH could largely induce robust [Ca2+]i 
responses in female BK-KO corticotrophs.  
 
4.2.2.3 Female BK-KO corticotrophs have higher AUC (10 min), AUC 
(peak) and peak of [Ca2+]i responses to repeated CRH stimulation 
compared to males 
Attenuation of AUC (peak) of [Ca2+]i responses to repeated CRH stimulation was 
observed in female but not male BK-KO corticotrophs suggesting that there were sex  






Repeated CRH induces [Ca2+]i responses in female BK-KO 
corticotrophs 
 
Figure 4.9 Repeated CRH induces [Ca2+]i responses in female BK-KO 
corticotrophs. (A) Representative calcium imaging traces of female BK-KO 
corticotrophs exposed to 0.2 nM CRH for three minutes and repeated three times at 25 
minutes intervals. 30 mM potassium chloride was applied at the end for one minute. 
(B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i changes in 
female BK-KO corticotrophs with repeated 0.2 nM CRH stimulation. Black line shows 
response to the first stimulus (starting at 15 min), grey line shows response to the 
second stimulus (starting at 40 min), and blue line shows response to the third stimulus 
(starting at 65 min). 
  






Attenuated AUC (peak) but not AUC (10 min) of [Ca2+]i 
responses in female BK-KO corticotrophs to repeated CRH 
 
Figure 4.10 Attenuated AUC (peak) but not AUC (10 min) of [Ca2+]i responses in 
female BK-KO corticotrophs to repeated CRH. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak). 
* p < 0.05 (n = 20 from 6 experiments, mixed effects model). All data are 
means ± SEM. 
  






Peak and time to peak of [Ca2+]i responses in female BK-KO 
corticotrophs to repeated CRH 
 
Figure 4.11 Peak and time to peak of [Ca2+]i responses in female BK-KO 
corticotrophs to repeated CRH. Quantification of effects of repeated exposure to 
0.2 nM CRH in (A) peak and (B) time to peak (n = 20 from 6 experiments, mixed 
effects model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
female BK-KO corticotrophs to repeated CRH 
 
Figure 4.12 Response duration and peak duration of [Ca2+]i responses in female 
BK-KO corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) response duration and (B) peak duration (n = 20 from 
6 experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in female BK-KO corticotrophs 
to repeated CRH 
 
Figure 4.13 Time gap of [Ca2+]i responses in female BK-KO corticotrophs to 
repeated CRH. Quantification of effects of repeated exposure to 0.2 nM CRH in time 
gap (n = 20 from 6 experiments, mixed effects model). All data are means ± SEM. 
  





differences in BK-KO corticotrophs. Statistical analysis of each parameter was then 
performed between male and female BK-KO corticotrophs to determine the sex 
differences at the level of CRH-evoked [Ca2+]i responses. 
 
Female BK-KO corticotrophs displayed significantly (p < 0.01) larger AUC (10 min) 
and AUC (peak) in all three CRH stimuli compared to males (Figure 4.14). Female 
BK-KO corticotrophs also showed significantly (p < 0.001) higher peak than male in 
each stimulus responding to repeated CRH stimulation (Figure 4.15A). However, there 
were no statistically significant differences between male and female BK-KO 
corticotrophs in time to peak, response duration (Figure 4.15B&C), peak duration or 
time gap (Figure 4.16). 
 
The sex differences observed in AUC (10 min), AUC (peak) and peak may suggest 
that deletion of BK channels affect male and female corticotrophs in different ways in 
responses to CRH stimulation. 
 
4.2.2.4 CRH-induced [Ca2+]i responses are suppressed in male BK-KO 
corticotrophs compared to male wild-type corticotrophs 
Although consistent [Ca2+]i responses induced by repeated CRH stimulation were 
observed in both male wild-type and BK-KO corticotrophs, statistical analysis of each  






Female BK-KO corticotrophs have higher AUC (10 min) and 
AUC (peak) of [Ca2+]i responses to repeated CRH compared to 
males 
 
Figure 4.14 Female BK-KO corticotrophs have higher AUC (10 min) and AUC 
(peak) of [Ca2+]i responses to repeated CRH compared to males. Quantification of 
effects of repeated exposure to 0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak). 
** p < 0.01 (male n = 12 from 8 experiments, female n = 20 from 6 experiments, mixed 
effects model). All data are means ± SEM. 
  






Female BK-KO corticotrophs have higher peak but not time to 
peak or response duration of [Ca2+]i responses to repeated 
CRH compared to males 
 
Figure 4.15 Female BK-KO corticotrophs have higher peak but not time to peak 
or response duration of [Ca2+]i responses to repeated CRH compared to males. 
Quantification of effects of repeated exposure to 0.2 nM CRH in (A) peak, (B) time to 
peak and (C) response duration. *** p < 0.001 (male n = 12 from 8 experiments, 
female n = 20 from 6 experiments, mixed effects model). All data are means ± SEM. 
  






No significant sex difference in CRH-induced peak duration or 
time gap of [Ca2+]i responses in BK-KO corticotrophs 
 
Figure 4.16 No significant sex difference in CRH-induced peak duration or time 
gap of [Ca2+]i responses in BK-KO corticotrophs. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) peak duration and (B) time gap (male n = 12 
from 6 experiments, female n = 20 from 6 experiments, mixed effects model). All data 
are means ± SEM. 
  





parameter was performed between male wild-type and BK-KO corticotrophs to 
examine whether genetic deletion of BK channels have effect on the [Ca2+]i responses 
induced by repeated 0.2 nM CRH stimulation in male corticotrophs. Compared to male 
wild-type corticotrophs, AUC (10 min) and AUC (peak) were significantly (p < 0.01) 
suppressed in all three stimuli following repeated CRH stimulation in male BK-KO 
corticotrophs (Figure 4.17). CRH-induced peak was also significantly suppressed in 
Stimulus 1 (p < 0.001), Stimulus 2 (p < 0.001) and Stimulus 3 (p < 0.01) in male 
BK-KO corticotrophs (Figure 4.18A). There were no significant differences between 
male wild-type and BK-KO corticotrophs in time to peak (Figure 4.18B), response 
duration (Figure 4.18C), peak duration or time gap (Figure 4.19). 
 
Overall, these results suggest that genetic deletion of BK channels suppressed the 
[Ca2+]i responses to repeated CRH stimulation in male corticotrophs. 
 
4.2.2.5 CRH-induced [Ca2+]i responses are not affected by 
pharmacological inhibition of BK channels in male corticotrophs 
Previous experiments suggest that genetic deletion of BK channels significantly 
suppressed [Ca2+]i responses to repeated CRH stimulation in male corticotrophs. To 
examine whether pharmacological inhibition of BK channels have similar effects on 
male corticotrophs, calcium imaging experiments were performed on male wild-type  






Suppressed AUC (10 min) and AUC (peak) of [Ca2+]i responses 
in male BK-KO corticotrophs to repeated CRH compared to 
male wild-type corticotrophs 
 
Figure 4.17 Suppressed AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
male BK-KO corticotrophs to repeated CRH compared to male wild-type 
corticotrophs. Quantification of effects of repeated exposure to 0.2 nM CRH in (A) 
AUC (10 min) and (B) AUC (peak). ** p < 0.01 (wild-type n = 12 from 8 experiments, 
BK-KO n = 12 from 8 experiments, mixed effects model). All data are means ± SEM. 
  






Suppressed peak but not time to peak or response duration of 
[Ca2+]i responses in male BK-KO corticotrophs to repeated 
CRH compared to male wild-type corticotrophs 
 
Figure 4.18 Suppressed peak but not time to peak or response duration of [Ca2+]i 
responses in male BK-KO corticotrophs to repeated CRH compared to male 
wild-type corticotrophs. Quantification of effects of repeated exposure to 0.2 nM 
CRH in (A) peak, (B) time to peak and (C) response duration. ** p < 0.01, *** 
p < 0.001 (wild-type n = 12 from 8 experiments, BK-KO n = 12 from 8 experiments, 
mixed effects model). All data are means ± SEM. 






No significant differences in CRH-induced peak duration and 
time gap [Ca2+]i responses between male wild-type and BK-KO 
corticotrophs 
 
Figure 4.19 No significant differences in CRH-induced peak duration and time 
gap [Ca2+]i responses between male wild-type and BK-KO corticotrophs. 
Quantification of effects of repeated exposure to 0.2 nM CRH in (A) peak duration 
and (B) time gap (wild-type n = 12 from 8 experiments, BK-KO n = 12 from 8 
experiments, mixed effects model). All data are means ± SEM. 
  





corticotrophs (n = 10 from 5 experiments) treated with 0.2 nM CRH in the presence 
of specific BK channel blocker paxilline (1 μM). 
 
Following the ion channel blocking protocol (see 2.5.2.3), male wild-type 
corticotrophs were stimulated with 0.2 nM CRH for three minutes and repeated three 
times after 15–20 minutes spontaneous [Ca2+]i signalling recording. The second CRH 
stimulation was applied in the presence of 1 μM paxilline and paxilline was applied 
10 minutes before and after the stimulation to ensure the blockade of BK channels. 
Following by a 25 minute washout period, corticotrophs were treated with CRH for 
the third time and finally a one minute 30 mM potassium chloride to verify cell 
viability (Figure 4.20A). Stimulation with CRH alone induced significant increase of 
[Ca2+]i in male wild-type corticotrophs. However, CRH-induced [Ca
2+]i response was 
not affected when BK channels were pharmacologically blocked by paxilline (Figure 
4.20B). Following paxilline washout, the [Ca2+]i response to CRH was similar to the 
first stimulus. 
 
Analysis of 5 min “baseline” period before the second CRH stimulus suggested that 
paxilline had no significant effect on either spontaneous [Ca2+]i active time or 
maximum amplitude compared to the spontaneous [Ca2+]i signalling before the first 
CRH stimulus in male wild-type corticotrophs (data not shown). The effects of  






Paxilline has no significant inhibition on CRH-induced 
[Ca2+]i response in male BK-KO corticotrophs 
 
Figure 4.20 Paxilline has no significant inhibition on CRH-induced [Ca2+]i 
response in male BK-KO corticotrophs. (A) Representative calcium imaging traces 
of the effects of paxilline on [Ca2+]i responses to 0.2 nM CRH in male BK-KO 
corticotrophs. (B) Superposition of extracts of the trace shown in A, showing [Ca2+]i 
changes in male BK-KO corticotrophs. Black line shows the response to 0.2 nM CRH 
alone, grey line shows the response to 0.2 nM CRH in the presence of 1 μM paxilline.  
  





paxilline on CRH induced [Ca2+]i responses were evaluated by AUC (10 min), AUC 
(peak) and peak. Statistical analysis revealed that paxilline had no significant 
inhibition effect on CRH-induced AUC (10 min), AUC (peak) (Figure 4.21) or peak 
(Figure 4.22) in male wild-type corticotrophs, which is different from genetic deletion 
of BK channels in male corticotrophs. Interestingly, in comparison to stimulation with 
CRH alone, 5 out of 10 (50%) cells showed larger AUC (peak) and 4 of them also 
showed larger AUC (10 min) in the presence of paxilline. In addition, higher peak was 
observed in 70% (7 out of 10) of cells when treated with paxilline. 
 
These results suggest that spontaneous and CRH-induced [Ca2+]i responses in male 
wild-type corticotrophs was not affected by pharmacological inhibition of BK 
channels with paxilline. 
 
4.2.2.6 CRH-induced [Ca2+]i responses are not significantly different 
between female wild-type and BK-KO corticotrophs 
The same statistical analysis was then performed between female wild-type and 
BK-KO corticotrophs to examine whether genetic deletion of BK channels had effects 
on CRH-induced [Ca2+]i responses in female corticotrophs.  
 
Unlike the suppressed [Ca2+]i responses in AUC (10 min), AUC (peak) and peak   






Pharmacological inhibition of BK channels has no significant 
effect on CRH-induced AUC (10 min) and AUC (peak) of [Ca2+]i 
responses in male corticotrophs 
 
Figure 4.21 Pharmacological inhibition of BK channels has no significant effect 
on CRH-induced AUC (10 min) and AUC (peak) of [Ca2+]i responses in male 
corticotrophs. Quantification of effects of repeated exposure to 0.2 nM CRH in (A) 
AUC (10 min) and (B) AUC (peak) (n = 10 from 5 experiments, mixed effects model). 
All data are means ± SEM. 






Pharmacological inhibition of BK channels has no significant 
effect on CRH-induced peak of [Ca2+]i responses in male 
corticotrophs 
 
Figure 4.22 Pharmacological inhibition of BK channels has no significant effect 
on CRH-induced peak of [Ca2+]i responses in male corticotrophs. Quantification 
of effects of repeated exposure to 0.2 nM CRH in peak (n = 10 from 5 experiments, 
mixed effects model). All data are means ± SEM. 
  





observed in male BK-KO corticotrophs, there were no significant differences in these 
parameters at each CRH stimulus between female wild-type and BK-KO corticotrophs 
(Figure 4.23 and Figure 4.24A). Female wild-type and BK-KO corticotrophs also had 
no significant differences in time to peak, response duration (Figure 4.24B&C), peak 
duration or time gap (Figure 4.25) following repeated CRH stimulation, although 
female wild-type corticotrophs tended to have higher variability. 
 
In summary, these results suggest that genetic deletion of BK channels had no 
significant effect on [Ca2+]i responses to repeated CRH stimulation in female 
corticotrophs, which is different from male corticotrophs. 
 
4.2.2.7 CRH-induced [Ca2+]i responses are not affected by 
pharmacological inhibition of BK channels in female corticotrophs 
Although pharmacological inhibition of BK channels had no significant effect on 
CRH-induced [Ca2+]i responses in male wild-type corticotrophs, we investigated 
whether pharmacological inhibition of BK channels would affect CRH-induced [Ca2+]i 
responses in female wild-type corticotrophs. 
 
Calcium imaging recordings were obtained from female wild-type corticotrophs 
(n = 19 from 8 experiments) following the same ion channel blocking protocol used  






No significant differences in CRH-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses between female wild-type and 
BK-KO corticotrophs 
 
Figure 4.23 No significant differences in CRH-induced AUC (10 min) or AUC 
(peak) of [Ca2+]i responses between female wild-type and BK-KO corticotrophs. 
Quantification of effects of repeated exposure to 0.2 nM CRH in (A) AUC (10 min) 
and (B) AUC (peak). * p < 0.05 (wild-type n = 14 from 7 experiments, BK-KO n = 20 
from 6 experiments, mixed effects model). All data are means ± SEM. 
  






No significant differences in CRH-induced peak, time to peak 
or response duration of [Ca2+]i responses between female 
wild-type and BK-KO corticotrophs 
 
Figure 4.24 No significant differences in CRH-induced peak, time to peak or 
response duration of [Ca2+]i responses between female wild-type and BK-KO 
corticotrophs. Quantification of effects of repeated exposure to 0.2 nM CRH in (A) 
peak, (B) time to peak and (C) response duration. *** p < 0.001 (wild-type n = 14 
from 7 experiments, BK-KO n = 20 from 6 experiments, mixed effects model). All 
data are means ± SEM. 






No significant differences in CRH-induced peak duration or 
time gap of [Ca2+]i responses between female wild-type and 
BK-KO corticotrophs 
 
Figure 4.25 No significant differences in CRH-induced peak duration or time gap 
of [Ca2+]i responses between female wild-type and BK-KO corticotrophs. 
Quantification of effects of repeated exposure to 0.2 nM CRH in (A) peak duration 
and (B) time gap (wild-type n = 14 from 7 experiments, BK-KO n = 20 from 6 
experiments, mixed effects model). All data are means ± SEM. 
  





in male wild-type corticotrophs. Stimulation with CRH alone, female wild-type 
corticotrophs displayed significant and sustained elevation of [Ca2+]i (Figure 4.26A). 
However, stimulation with CRH did not show significant effect on [Ca2+]i responses 
in female wild-type corticotrophs when BK channels were pharmacological blocked 
by paxilline (Figure 4.26B). After washing out paxilline, all corticotrophs responded 
to CRH with similar [Ca2+]i responses as seen in the first stimulus. 
 
Compared to the spontaneous [Ca2+]i signalling under 5 min “baseline” period before 
the first CRH stimulus, neither spontaneous [Ca2+]i active time nor maximum 
amplitude before the second CRH stimulus was affected by treatment with paxilline in 
female wild-type corticotrophs (data not shown). Statistical analysis revealed that 
blockade of BK channels with paxilline had no significant inhibition effect on 
CRH-induced AUC (10 min), AUC (peak) (Figure 4.27) or peak (Figure 4.28) in 
female wild-type corticotrophs. It is worth noting that, compared to stimulation with 
CRH alone, larger AUC (10 min) was observed in 47.4% of (9 out of 19) cells when 
treated with paxilline, with 8 of them also showing larger AUC (10 min). 52.6% (10 
out of 19) of cells exhibited higher peak in the presence of paxilline.  
 
These data suggest that pharmacological inhibition of BK channels with paxilline had 
no significant inhibition effect on CRH-induced [Ca2+]i responses in female wild-type  






Paxilline has no significant inhibition on CRH-induced 
[Ca2+]i response in female BK-KO corticotrophs  
 
Figure 4.26 Paxilline has no significant inhibition on CRH-induced [Ca2+]i 
response in female BK-KO corticotrophs. (A) Representative calcium imaging 
traces of the effects of paxilline on [Ca2+]i responses to 0.2 nM CRH in female BK-KO 
corticotrophs. (B) Superposition of extracts of the trace shown in A, showing [Ca2+]i 
changes in female BK-KO corticotrophs. Black line shows the response to 0.2 nM 
CRH alone, grey line shows the response to 0.2 nM CRH in the presence of 1 μM 
paxilline.  






Pharmacological inhibition of BK channels has no significant 
effect on CRH-induced AUC (10 min) and AUC (peak) of [Ca2+]i 
responses in female corticotrophs 
 
Figure 4.27 Pharmacological inhibition of BK channels has no significant effect 
on CRH-induced AUC (10 min) and AUC (peak) of [Ca2+]i responses in female 
corticotrophs. Quantification of effects of paxilline on exposure to 0.2 nM CRH in 
(A) AUC (10 min) and (B) AUC (peak) (n = 19 from 8 experiments, mixed effects 
model). All data are means ± SEM. 






Pharmacological inhibition of BK channels has no significant 
effect on CRH-induced peak of [Ca2+]i responses in female 
corticotrophs 
 
Figure 4.28 Pharmacological inhibition of BK channels has no significant effect 
on CRH-induced peak of [Ca2+]i responses in female corticotrophs. Quantification 
of effects of paxilline on exposure to 0.2 nM CRH in peak (n = 19 from 8 experiments, 
mixed effects model). All data are means ± SEM. 





corticotrophs, which is similar to female BK-KO corticotrophs.  
 
In summary, global genetic deletion of BK channels resulted in statistically significant 
reduction of AUC (10 min), AUC (peak) and peak in male but not female 
corticotrophs. This suggest that functional BK channels are essential in regulating 
CRH-induced [Ca2+]i responses in murine corticotrophs with sex differences. 
However, CRH-induced [Ca2+]i responses were unaffected by pharmacological 
inhibition of BK channels with paxilline suggesting a compensatory mechanism may 
underlie the changes in CRH-evoked [Ca2+]i responses in BK-KO corticotrophs. 
 
4.2.3 Genetic deletion of BK channels has no significant effect 
on AVP-induced [Ca2+]i responses in male and female 
corticotrophs 
BK channels have been suggested to play an important role in regulating spontaneous 
and CRH-evoked [Ca2+]i signalling in murine corticotrophs, experiments were then 
carried out to examine whether genetic deletion of BK channels would affect 
AVP-induced [Ca2+]i responses in corticotrophs. 
 
Two phenotypes of [Ca2+]i responses observed in wild-type corticotrophs were also 
found in BK-KO corticotrophs. Following repeated 2 nM AVP stimulation, 66.7% 





(12/18) of cells displayed sustained elevation of [Ca2+]i and 22.2% (4/18) of cells 
showed oscillatory[Ca2+]i behaviour in all three stimuli. The remaining 2 cells (11.1%) 
exhibited sustained [Ca2+]i increase as well as oscillated [Ca
2+]i behaviour in one single 
cell among three times [Ca2+]i responses to repeated AVP stimulation. Interestingly, 
the mixture of two phenotypes of [Ca2+]i responses to AVP was never observed in one 
single cell isolated from wild-type mice. More importantly, the oscillatory [Ca2+]i 
behaviour was less likely to appear in all BK-KO corticotrophs (22.2%) compared to 
wild-type (40.0%). These results suggest that BK channels may contribute to regulate 
the patterns of [Ca2+]i responses in corticotrophs. Next, the quantification of 
AVP-evoked [Ca2+]i responses was performed on male and female BK-KO 
corticotrophs respectively and the effects of 2 nM AVP on [Ca2+]i responses in BK-KO 
corticotrophs were quantified with the same parameters as used in wild-type 
corticotrophs. 
 
4.2.3.1 Repeated AVP evokes robust [Ca2+]i responses in male BK-KO 
corticotrophs 
Calcium imaging experiments were performed on male BK-KO corticotrophs (n = 6 
from 3 experiments) following the same repeated stimulation protocol used previously 
for wild-type corticotrophs (see 3.2.4.1). 
 





Stimulation with repeated 2 nM AVP, 2 out of 6 cells showed sustained elevation of 
[Ca2+]i (Figure 4.29A, top) and 3 cells had repetitive oscillatory [Ca
2+]i responses 
(Figure 4.29A, bottom). The remaining 1 cell displayed both sustained [Ca2+]i increase 
and oscillatory [Ca2+]i behaviour following repeated AVP stimulation (data not shown). 
The mixture of two phenotypes of [Ca2+]i responses was not observed in the same 
corticotroph from male wild-type mice. Superposition of extracts of representative 
calcium imaging traces shown in Figure 4.29B suggested that no matter what types of 
[Ca2+]i responses male BK-KO corticotrophs exhibited, either of them was highly 
reproducible and consistent. 
 
To examine whether the two phenotypes of [Ca2+]i responses and the mixture of them 
have significant differences in response to AVP, all parameters were analysed among 
them. Statistical analysis revealed that none of them had significant differences in any 
parameters (data not shown). Therefore, statistical analysis was performed on all male 
BK-KO corticotrophs together. AUC (10 min), AUC (peak) (Figure 4.30), peak, time 
to peak (Figure 4.31), response duration, peak duration (Figure 4.32) and time gap 
(Figure 4.33) showed no statistically significant differences following repeated AVP 
stimulation. 
 
These results revealed that male BK-KO corticotrophs were able to induce consistent   






Repeated AVP induces repeatable [Ca2+]i responses in male 
BK-KO corticotrophs 
 
Figure 4.29 Repeated AVP induces repeatable [Ca2+]i responses in male BK-KO 
corticotrophs. (A) Representative calcium imaging traces of male BK-KO 
corticotrophs exposed to 2 nM AVP for three minutes and repeated three times at 25 
minutes intervals. 30 mM potassium chloride was applied at the end for one minute. 
(B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i changes in 
male BK-KO corticotrophs with repeated 2 nM AVP stimulation. Black line shows 
response to the first stimulus (starting at 15 min), grey line shows response to the 
second stimulus (starting at 40 min), and blue line shows response to the third stimulus 
(starting at 65 min). 
  






Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
male BK-KO corticotrophs to repeated AVP 
 
Figure 4.30 Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in male 
BK-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (n = 6 from 3 
experiments, mixed effects model). All data are means ± SEM. 
  






Peak and time to peak of [Ca2+]i responses in male BK-KO 
corticotrophs to repeated AVP 
 
Figure 4.31 Peak and time to peak of [Ca2+]i responses in male BK-KO 
corticotrophs to repeated AVP. Quantification of effects of repeated exposure to 
2 nM AVP in (A) peak and (B) time to peak (n = 6 from 3 experiments, mixed effects 
model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
male BK-KO corticotrophs to repeated AVP 
 
Figure 4.32 Response duration and peak duration of [Ca2+]i responses in male 
BK-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) response duration and (B) peak duration (n = 6 from 3 
experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in male BK-KO corticotrophs to 
repeated AVP 
 
Figure 4.33 Time gap of [Ca2+]i responses in male BK-KO corticotrophs to 
repeated AVP. Quantification of effects of repeated exposure to 2 nM AVP in time gap 
(n = 6 from 3 experiments, mixed effects model). All data are means ± SEM. 
  





and repetitive [Ca2+]i responses when stimulated with repeated 2 nM AVP. 
 
4.2.3.2 Repeated AVP evokes robust [Ca2+]i responses in female BK-KO 
corticotrophs 
Calcium imaging experiments were performed on female BK-KO corticotrophs 
(n = 12 from 5 experiments) following the same protocol used in male BK-KO 
corticotrophs. 
 
Similar to male BK-KO corticotrophs, two phenotypes of [Ca2+]i responses and the 
mixture of the two phenotypes were observed in female BK-KO corticotrophs when 
stimulated with 2 nM AVP. 10 out of 12 cells (83.3%) displayed sustained elevation 
of [Ca2+]i, whereas oscillatory [Ca
2+]i behaviour and the mixture was only found in 1 
single cell (Figure 4.34A). However, 50% of cells responded with a sustained increase 
[Ca2+]i and the other 50% showed oscillatory [Ca
2+]i responses in female wild-type 
corticotrophs. Only 8.3% of female corticotrophs (1/12) showed oscillatory [Ca2+]i 
behaviour with genetic deletion of BK channels. In addition, the mixture of the two 
response patterns was not observed in single female wild-type corticotrophs. The 
differences between both male and female wild-type and BK-KO corticotrophs 
suggest that BK channels may be involved in controlling AVP-induced [Ca2+]i 
responding patterns in corticotrophs. Extracts of representative calcium traces  






Repeated AVP induces repeatable [Ca2+]i responses in female 
BK-KO corticotrophs 
 
Figure 4.34 Repeated AVP induces repeatable [Ca2+]i responses in female BK-KO 
corticotrophs. (A) Representative calcium imaging traces of female BK-KO 
corticotrophs exposed to 2 nM AVP for three minutes and repeated three times at 25 
minutes intervals. 30 mM potassium chloride was applied at the end for one minute. 
(B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i changes in 
female BK-KO corticotrophs with repeated 2 nM AVP stimulation. Black line shows 
response to the first stimulus (starting at 15 min), grey line shows response to the 
second stimulus (starting at 40 min), and blue line shows response to the third stimulus 
(starting at 65 min). 
  





coincided nicely to each other indicated that [Ca2+]i responses to repeated 2 nM AVP 
stimulation were robust and repeatable in female BK-KO corticotrophs (Figure 4.34B). 
 
Two responding phenotypes and the mixture of the two were compared to identify any 
possible statistical difference. No significant differences were found among sustained 
elevation of [Ca2+]i, oscillatory [Ca
2+]i behaviour and the mixture (data not shown). 
Thus, the effects of repeated AVP on [Ca2+]i responses in female BK-KO corticotrophs 
were quantified on all calcium recordings together. Statistical analysis revealed that 
there were no significant differences between repeated AVP stimulation for AUC 
(10 min), AUC (peak) (Figure 4.35), peak, time to peak (Figure 4.36), response 
duration, peak duration (Figure 4.37) or time gap (Figure 4.38).  
 
These results suggest that [Ca2+]i responses evoked by repeated 2 nM AVP stimulation 
were stable and reproducible in female BK-KO corticotrophs.  
 
4.2.3.3 Female BK-KO corticotrophs have longer response duration and 
peak duration to repeated AVP stimulation compared to males  
Although both male and female BK-KO corticotrophs showed highly consistent and 
reproducible [Ca2+]i responses to repeated AVP stimulation, we examined whether 
there were differences between male and female BK-KO corticotrophs. Statistical  






Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
female BK-KO corticotrophs to repeated AVP 
 
Figure 4.35 Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in female 
BK-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (n = 12 from 5 
experiments, mixed effects model). All data are means ± SEM. 
  






Peak and time to peak of [Ca2+]i responses in female BK-KO 
corticotrophs to repeated AVP 
 
Figure 4.36 Peak and time to peak of [Ca2+]i responses in female BK-KO 
corticotrophs to repeated AVP. Quantification of effects of repeated exposure to 
2 nM AVP in (A) peak and (B) time to peak (n = 12 from 5 experiments, mixed effects 
model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
female BK-KO corticotrophs to repeated AVP 
 
Figure 4.37 Response duration and peak duration of [Ca2+]i responses in female 
BK-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) response duration and (B) peak duration (n = 12 from 5 
experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in female BK-KO corticotrophs 
to repeated AVP 
 
Figure 4.38 Time gap of [Ca2+]i responses in female BK-KO corticotrophs to 
repeated AVP. Quantification of effects of repeated exposure to 2 nM AVP in time gap 
(n = 12 from 5 experiments, mixed effects model). All data are means ± SEM. 
  





analysis of all parameters indicated that there were no significant differences between 
two [Ca2+]i response phenotypes as well as their mixture (data not shown). Therefore, 
all calcium imaging experiments were analysed together to determine whether there 
were sex differences in AVP-induced [Ca2+]i responses in BK-KO corticotrophs. 
Following repeated AVP stimulation, female and male BK-KO corticotrophs showed 
no statistically significant differences in AUC (10 min), AUC (peak) (Figure 4.39), 
peak, time to peak (Figure 4.40A&B) or time gap (Figure 4.41B). However, there were 
some significant differences, in particular with lower values in male BK-KO 
corticotrophs for response duration (p < 0.01) (Figure 4.40C) and peak duration 
(p < 0.05) (Figure 4.41A) compared to females in Stimulus 1. 
 
Overall, there were no major sex differences in AVP-induced [Ca2+]i responses in 
corticotrophs with a genetic deletion of BK channels. 
 
4.2.3.4 Genetic deletion of BK channels has no significant effect on 
AVP-induced [Ca2+]i responses in male corticotrophs 
Both male wild-type and BK-KO corticotrophs displayed highly reproducible [Ca2+]i 
responses to repeated AVP stimulation. To investigate whether genetic deletion of BK 
channels would affect AVP-induced [Ca2+]i responses in male corticotrophs, 
comparison and statistical analysis of each parameter were performed between male  






No significant sex difference in AVP-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses in BK-KO corticotrophs 
 
Figure 4.39 No significant sex difference in AVP-induced AUC (10 min) or AUC 
(peak) of [Ca2+]i responses in BK-KO corticotrophs. Quantification of effects of 
repeated exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (male n = 6 
from 3 experiments, female n = 12 from 5 experiments, mixed effects model). All data 
are means ± SEM. 
  






Female BK-KO corticotrophs have longer response duration 
but not peak or time to peak of [Ca2+]i responses to repeated 
AVP compared to males 
 
Figure 4.40 Female BK-KO corticotrophs have longer response duration but not 
peak or time to peak of [Ca2+]i responses to repeated AVP compared to males. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) peak, (B) time to 
peak and (C) response duration. ** p < 0.01 (male n = 6 from 3 experiments, female 
n = 12 from 5 experiments, mixed effects model). All data are means ± SEM. 
  






Female BK-KO corticotrophs have longer peak duration but 
not time gap of [Ca2+]i responses to repeated AVP compared to 
males 
 
Figure 4.41 Female BK-KO corticotrophs have longer peak duration but not time 
gap of [Ca2+]i responses to repeated AVP compared to males. Quantification of 
effects of repeated exposure to 2 nM AVP in (A) peak duration and (B) time gap. 
* p < 0.05 (male n = 6 from 3 experiments, female n = 12 from 5 experiments, mixed 
effects model). All data are means ± SEM. 
  





wild-type and BK-KO male corticotrophs.  
 
Statistical analysis revealed that there were no significant differences in AUC (10 min), 
AUC (peak) (Figure 4.42), peak, time to peak, response duration (Figure 4.43), peak 
duration or time to peak (Figure 4.44) between male wild-type and BK-KO 
corticotrophs. 
 
This suggests that genetic deletion of BK channels did not have a significant effect on 
[Ca2+]i responses to repeated AVP stimulation in male corticotrophs. 
 
4.2.3.5 AVP-induced response duration and peak duration of [Ca2+]i 
responses are significantly different between female wild-type and 
BK-KO corticotrophs  
As observed in male wild-type and BK-KO corticotrophs, there were no significant 
differences in AUC (10 min), AUC (peak) (Figure 4.45), peak, time to peak (Figure 
4.46A&B) or time gap (Figure 4.47B) either. However, female BK-KO corticotrophs 
displayed significantly (p < 0.01) longer response duration (Figure 4.46C) and peak 
duration (Figure 4.47A) at each stimulus compared to female wild-type corticotrophs. 
 
These results suggest that although female BK-KO corticotrophs could evoke robust  






No significant differences in AVP-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses between male wild-type and 
BK-KO corticotrophs  
 
Figure 4.42 No significant differences in AVP-induced AUC (10 min) and AUC 
(peak) of [Ca2+]i responses between male wild-type and BK-KO corticotrophs. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) AUC (10 min) and 
(B) AUC (peak) (wild-type n = 16 from 9 experiments, BK-KO n = 6 from 3 
experiments, mixed effects model). All data are means ± SEM. 
  






No significant differences in AVP-induced peak, time to peak 
or response duration of [Ca2+]i responses between male 
wild-type and BK-KO corticotrophs 
 
Figure 4.43 No significant differences in AVP-induced peak, time to peak or 
response duration of [Ca2+]i responses between male wild-type and BK-KO 
corticotrophs. Quantification of effects of repeated exposure to 2 nM AVP in (A) 
peak, (B) time to peak and (C) response duration (wild-type n = 16 from 9 
experiments, BK-KO n = 6 from 3 experiments, mixed effects model). All data are 
means ± SEM. 






No significant differences in AVP-induced peak duration or 
time gap of [Ca2+]i responses between male wild-type and 
BK-KO corticotrophs 
 
Figure 4.44 No significant differences in AVP-induced peak duration or time gap 
of [Ca2+]i responses between male wild-type and BK-KO corticotrophs. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) peak duration and 
(B) time gap (wild-type n = 16 from 9 experiments, BK-KO n = 6 from 3 experiments, 
mixed effects model). All data are means ± SEM. 
  






No significant differences in AVP-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses between female wild-type and 
BK-KO corticotrophs 
 
Figure 4.45 No significant differences in AVP-induced AUC (10 min) and AUC 
(peak) of [Ca2+]i responses between female wild-type and BK-KO corticotrophs. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) AUC (10 min) and 
(B) AUC (peak) (wild-type n = 24 from 8 experiments, BK-KO n = 12 from 5 
experiments, mixed effects model). All data are means ± SEM. 
  






Female BK-KO corticotrophs have longer response duration 
but not peak or time to peak of [Ca2+]i responses to repeated 
AVP compared to female wild-type corticotrophs 
 
Figure 4.46 Female BK-KO corticotrophs have longer response duration but not 
peak or time to peak of [Ca2+]i responses to repeated AVP compared to female 
wild-type corticotrophs. Quantification of effects of repeated exposure to 2 nM AVP 
in (A) peak (B) time to peak and (C) response duration. ** p < 0.01 (wild-type n = 24 
from 8 experiments, BK-KO n = 12 from 5 experiments, mixed effects model). All 
data are means ± SEM. 






Female BK-KO corticotrophs have longer peak duration but 
not time gap of [Ca2+]i responses to repeated AVP compared to 
female wild-type corticotrophs 
 
Figure 4.47 Female BK-KO corticotrophs have longer peak duration but not time 
gap of [Ca2+]i responses to repeated AVP compared to female wild-type 
corticotrophs. Quantification of effects of repeated exposure to 2 nM AVP in (A) peak 
duration and (B) time gap (wild-type n = 24 from 8 experiments, BK-KO n = 12 from 
5 experiments, mixed effects model). All data are means ± SEM. 
  





[Ca2+]i responses as female wild-type corticotrophs, genetic deletion of BK channels 
resulted in a significantly longer response duration and peak duration to repeated AVP 
stimulation in female corticotrophs. 
 
Overall, both male and female BK-KO corticotrophs had robust and consistent [Ca2+]i 
responses to repeated AVP stimulation as wild-type corticotrophs. Genetic deletion of 
BK channels had no significant effect on AVP-induced [Ca2+]i responses in male 
corticotrophs. However, response duration and peak duration were significantly 
increased in female BK-KO corticotrophs in all three stimuli. Stable AUC (10 min), 
AUC (peak) and peak suggest that AVP-induced [Ca2+]i responses are independent of 
BK channels and genetic deletion of BK channels may affect male and female 
corticotrophs differently. 
 
4.2.4 Do BK-KO corticotrophs display synergy between CRH 
and AVP at the level of intracellular free calcium? 
Previous study in Chapter Three indicated that there was no synergistic [Ca2+]i 
responses between CRH and AVP in male wild-type corticotrophs. Although no 
statistical synergy was observed in female wild-type corticotrophs at the population 
level, 26.7% (4 out of 15 cells) of cells displayed synergistic [Ca2+]i responses to CRH 
and AVP at the single cell level. Thus, we investigated whether there were synergistic 





[Ca2+]i responses between CRH and AVP in BK-KO corticotrophs. The experiments 
were only performed on female BK-KO corticotrophs as synergy was only observed 
in female wild-type corticotrophs. 
 
4.2.4.1 No synergistic [Ca2+]i response between CRH and AVP in female 
BK-KO corticotrophs at the population level 
Calcium imaging experiments were performed on female BK-KO corticotrophs 
following the repeated stimulation protocol used in female wild-type corticotrophs 
(see 3.2.5.2). To counteract the possible influence due to the sequence of the two single 
stimuli, the order of CRH and AVP was randomized (CRH, AVP, combination, n = 10 
or AVP, CRH, combination, n = 11 from 6 experiments). 
 
All female BK-KO corticotrophs displayed sustained elevation of [Ca2+]i to individual 
0.2 nM CRH stimulation despite of the order of two single stimuli, which was similar 
to [Ca2+]i responses to repeated CRH stimulation. When stimulated with 2 nM AVP 
alone, two phenotypes of [Ca2+]i responses were observed as before. 61.9% (13 out of 
21) of female BK-KO corticotrophs displayed sustained [Ca2+]i elevation, which was 
more than female wild-type corticotrophs (53.3%). The remaining 8 cells (38.1%) 
responded with oscillatory [Ca2+]i behaviour, which was slightly less than female 
wild-type corticotrophs (46.7%) showing oscillatory [Ca2+]i behaviour. Stimulation 





with the combination of 0.2 nM CRH and 2 nM AVP, female BK-KO corticotrophs 
exhibited sustained and significant [Ca2+]i increase, no matter what the exposure order 
and AVP-induced [Ca2+]i responding patterns were (Figure 4.48A & Figure 4.49A). 
Although AVP evoked two phenotypes of [Ca2+]i responses, extracts of representative 
calcium imaging traces suggested that [Ca2+]i changes were coincident when 
responding to two single stimuli and combined stimulus following either stimulation 
sequence (Figure 4.48B & Figure 4.49B). 
 
The synergistic [Ca2+]i responses and the effects of two single stimuli and combined 
stimulus on [Ca2+]i responses were evaluated with the same parameters used in 
wild-type corticotrophs. As the comparison between the AUC of the combined 
stimulus and the sum of the AUC of the two single stimuli was used to determine 
synergistic [Ca2+]i responses, AUC (10 min) and AUC (peak) were analysed between 
AVP-induced sustained elevation of [Ca2+]i (n = 13) and oscillatory [Ca
2+]i behaviour 
(n = 8) first. Statistical analysis revealed that female BK-KO corticotrophs showed no 
significant differences between the two [Ca2+]i response phenotypes in either AUC 
(10 min) or AUC (peak) (data not shown). Therefore, statistical analysis was 
performed on all female BK-KO corticotrophs together. The statistical calculation of 
AUC (10 min), AUC (peak) and peak was performed on log-transformed data and the 
others were performed on raw data. 






CRH, AVP and CRH/AVP induce [Ca2+]i responses in female 
BK-KO corticotrophs 
 
Figure 4.48 CRH, AVP and CRH/AVP induce [Ca2+]i responses in female BK-KO 
corticotrophs. (A) Representative calcium imaging traces of female BK-KO 
corticotrophs exposed to 0.2 nM CRH, 2 nM AVP and 0.2 nM CRH together with 2 nM 
AVP at 25 minutes intervals. 30 mM potassium chloride was applied at the end for one 
minute. (B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i 
changes in female BK-KO corticotrophs with stimuli. Black line shows response to 
0.2 nM CRH (starting at 15 min), grey line shows response to 2 nM AVP (starting at 
40 min), and blue line shows response to the combined stimulus (starting at 65 min). 
  






AVP, CRH and CRH/AVP induce [Ca2+]i responses in female 
BK-KO corticotrophs 
 
Figure 4.49 AVP, CRH and CRH/AVP induce [Ca2+]i responses in female BK-KO 
corticotrophs. (A) Representative calcium imaging traces of female BK-KO 
corticotrophs exposed to 2 nM AVP, 0.2 nM CRH and 0.2 nM CRH together with 2 nM 
AVP at 25 minutes intervals. 30 mM potassium chloride was applied at the end for one 
minute. (B) Superposition of extracts of the two traces shown in A, showing [Ca2+]i 
changes in female BK-KO corticotrophs with stimuli. Black line shows response to 
2 nM CRH (starting at 15 min), grey line shows response to 0.2 nM AVP (starting at 
40 min), and blue line shows response to the combined stimulus (starting at 65 min). 
  





There were no statistically significant differences among the [Ca2+]i responses induced 
by CRH, AVP and the combined stimulus in AUC (10 min) or AUC (peak). However, 
the combined stimulus was significantly (p < 0.001) smaller than the sum of the two 
single stimuli in both AUC (10 min) and AUC (peak). These data suggest that female 
BK-KO corticotrophs did not show synergy between CRH and AVP at the level of 
[Ca2+]i. Although the synergistic [Ca
2+]i responses were not observed at the population 
level, in 1 out of 21 cells (4.8%), AUC (10 min) as well as AUC (peak) of the combined 
stimulus was larger than the sum of the two single stimuli (Figure 4.50). Peak or time 
to peak were not significantly different between the two single stimuli and combined 
stimulus (Figure 4.51A&B). Stimulation with AVP resulted in a shorter response 
duration, which was significantly (p < 0.05) different from CRH stimulus but not 
combined stimulus (Figure 4.51C). There were no significant differences in peak 
duration or time gap among CRH-, AVP- and CRH/AVP-induced [Ca2+]i responses 
either (Figure 4.52). 
 
These results suggest that there were no synergistic [Ca2+]i responses between CRH 
and AVP at the population level in female BK-KO corticotrophs. However, a reduced 
proportion of female BK-KO corticotrophs (4.8%) showed synergistic [Ca2+]i 
responses at single cell level compared to wild-type female corticotrophs (26.7%). 
  






No synergistic [Ca2+]i responses to CRH/AVP in female BK-KO 
corticotrophs 
 
Figure 4.50 No synergistic [Ca2+]i responses to CRH/AVP in female BK-KO 
corticotrophs. Quantification of effects of exposure to 0.2 nM CRH, 2 nM AVP and 
the combination of the two in (A) AUC (10 min) and (B) AUC (peak). The comparison 
of the AUC of the combined stimulus and the sum of the two single stimuli was used 
as a measurement of synergy. *** p < 0.001 (n = 21 from 6 experiments, mixed effects 
model). All data are means ± SEM. 






CRH induces longer response duration but not peak or time to 
peak of [Ca2+]i responses in female BK-KO corticotrophs 
 
Figure 4.51 CRH induces longer response duration but not peak or time to peak 
of [Ca2+]i responses in female BK-KO corticotrophs. Quantification of effects of 
exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak, (B) 
time to peak and (C) response duration. * p < 0.05 (n = 21 from 6 experiments, mixed 
effects model). All data are means ± SEM. 
  






Peak duration and time gap of [Ca2+]i responses to CRH, AVP 
and CRH/AVP in female BK-KO corticotrophs 
 
Figure 4.52 Peak duration and time gap of [Ca2+]i responses to CRH, AVP and 
CRH/AVP in female BK-KO corticotrophs. Quantification of effects of exposure to 
0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak duration and (B) 
time gap (n = 21 from 6 experiments, mixed effects model). All data are means ± SEM. 
  






Summary of major findings in results 



















CRH ↓↓ ↓↓ ↓↓↓ ↔︎ ↔︎ ↔︎  ↔︎ 
AVP ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ 
CRH/AVP N/A 
F 
CRH ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ 
AVP ↔︎ ↔︎ ↔︎ ↔︎ ↑↑ ↑↑ ↔︎ 
CRH/AVP ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ ↔︎ 
↓ decrease; ↑ increase; ↔︎ no significant difference (compared to wild-type) 
↓ p < 0.05; ↓↓ p < 0.01; ↓↓↓ p < 0.001 
  






In this chapter, I investigated the role of BK channels in controlling spontaneous as 
well as CRH- and AVP-induced changes at the level of intracellular free calcium. 
Genetic deletion of BK channels differentially affects spontaneous [Ca2+]i signalling 
in male and female corticotrophs. Compared to wild-type corticotrophs, stimulation 
with repeated CRH resulted in a significantly reduced [Ca2+]i responses in male, but 
not female, BK-KO corticotrophs. In contrast, repeated AVP induced reproducible and 
consistent [Ca2+]i responses in BK-KO corticotrophs from both sexes that were not 
significantly different from the [Ca2+]i responses in wild-type corticotrophs. However, 
acute pharmacological inhibition of BK channels with paxilline had no significant 
effect on CRH-induced [Ca2+]i responses in either male or female wild-type 
corticotrophs.  Loss of BK channels did not significantly affect synergistic [Ca2+]i 
responses to CRH and AVP. 
 
4.3.1 CRH-induced [Ca2+]i responses are suppressed in male 
BK-KO corticotrophs but not affected by acute 
pharmacological inhibition of BK channels in wild-type 
corticotrophs 
The central finding in this Chapter is that [Ca2+]i responses to repeated CRH 
stimulation in corticotrophs from male, but not female, BK-KO mice were 





significantly attenuated compared to wild-type. However, surprisingly, CRH-induced 
[Ca2+]i responses were not significantly attenuated following acute pharmacological 
inhibition of BK channels in wild-type corticotrophs using the specific BK channel 
inhibitor paxilline. Importantly, previous studies have shown that both genetic deletion, 
as well as acute pharmacological inhibition with paxilline, of BK channels in male 
corticotrophs prevents CRH-induced transition to electrical bursting (Duncan et al., 
2015). Taken together, these data suggest two potential important features of 
CRH-induced [Ca2+]i responses: (i) CRH-induced electrical bursting observed on the 
millisecond to second timescale is not critical for controlling the longer (minutes) 
“global” [Ca2+]i responses analysed in this Thesis; (ii) genetic deletion of BK channels 
results in compensatory changes in the ion channel and/or signalling landscape of male 
corticotrophs resulting in suppression of CRH-induced [Ca2+]i responses. 
 
At face value, the attenuation of CRH-induced [Ca2+]i responses in male corticotrophs 
from BK-KO mice support the original hypothesis that lack of BK channels would 
decrease [Ca2+]i responses due to a loss of CRH-induced bursting. Indeed, as indicated 
before, CRH regulates corticotrophs through cAMP/PKA pathway that results in a 
Ca2+ influx via L-type Ca2+ channels and CRH-induced transition to bursting is 
dependent on BK channels (Lee & Tse, 1997; Duncan et al., 2015). In other pituitary 
cells, bursting has been suggested to have larger capacity to drive calcium influx than 





spiking (Van Goor et al., 2001b; Stojilkovic et al., 2005) and this is dependent on BK 
channels. Electrical bursts are observed on the millisecond to second timescale 
whereas the [Ca2+]i responses analysed here are on the second to minute timescale. 
However, as this effect was not observed in acute pharmacological inhibition of BK 
channels with paxilline, this suggest that there is not a direct link between electrical 
bursting and long-term changes in global [Ca2+]i signalling induced by CRH. 
 
It has been previously shown that CRH still significantly increases electrical spiking 
frequency in BK-KO, or paxilline treated, corticotrophs (Duncan et al., 2015). 
As increased spiking events can still drive Ca2+ into the cell, it is therefore proposed 
that blockade of BK channels with paxilline, or knockout of BK channels, prevents the 
transition to bursting but still enables significant elevation of global Ca2+ influx 
through single spiking following stimulation with CRH. This suggests that increased 
spiking frequency may also deliver the similar total amount of global Ca2+ as bursting 
behaviour with consequently similar level of global [Ca2+]i signalling. Indeed, a recent 
study has suggested that spiking can be as effective as bursting for hormone release 
when release sites are located close to the channel, although bursting is generally more 
effective at evoking secretion (Tagliavini et al., 2016). This study also revealed 
that bursting is not more effective than spiking if spiking frequency increases to a level 
where the active time of Ca2+ influx is comparable to bursting. As indicated in Chapter 





One, two distinct populations of BK channels have been implicated in the generation 
of bursting: BK-near channels, located close proximity to voltage-gated Ca2+ channels, 
are rapidly activated by the high Ca2+ concentration in the microdomains around the 
channels to facilitate bursting; BK-far channels, involve the termination of a burst that 
are located distantly from voltage-gated Ca2+ channels (Tsaneva-Atanasova et al., 
2007; Duncan et al., 2015). Since the activation of BK-near channels is necessary for 
the bursting, genetic deletion or pharmacological inhibition of BK channels may result 
in the loss of bursting behaviour but not affect the bulk [Ca2+]i concentration. . Another 
potential explanation for the lack of effect of paxilline is that BK-near and BK-far 
channels expressed in corticotrophs might be differentially sensitive to paxilline. For 
example, if paxilline blocks more BK-far channels than BK-near channels this would 
be predicted to result in longer bursting and [Ca2+]i responses in corticotrophs. 
Although there is some evidence that the molecular composition of BK channel can 
determine their sensitivity to different BK channel blockers, to date there is no 
evidence to suggest that BK channels are differentially responsive to paxilline. For 
example, BK channels assembled with β4 subunits are resistant to iberiotoxin but are 
inhibited similarly by paxilline (Meera et al., 2000). In addition, paxilline displayed 
the same IC50 for paxilline inhibition (~ 17nM) of different BK channel splice variants, 
including STREX and ZERO that are expressed in corticotrophs (Saleem et al., 2009). 
Thus, while we cannot exclude that BK far and BK near may be differentially sensitive 





to paxilline, there is no current evidence to suggest that BK channels are differentially 
regulated by paxilline and paxilline was used at saturating (1uM) concentrations in 
these assays. Furthermore, as the electrical activity is measured on the timescale of 
milliseconds to seconds which may not have impact on global [Ca2+]i signalling over 
minutes. To address this question, it would be important to measure [Ca2+]i responses 
and electrical activity in the same cells to address whether [Ca2+]i responses measured 
on millisecond timescale correlate with electrical bursting in corticotrophs. Moreover, 
understanding whether the pattern of [Ca2+]i responses on millisecond timescale rather 
than global [Ca2+]i changes are more important for hormone secretion in corticotrophs 
will be important. 
 
As CRH-induced [Ca2+]i responses were significantly attenuated in male BK-KO 
corticotrophs, this also suggests that potential compensatory mechanisms are 
occurring in corticotrophs as a result of the global loss of BK channels. Considering 
the differences between BK-KO and paxilline treated corticotrophs, it is suspected the 
reduced [Ca2+]i signalling in BK-KO corticotrophs has modified the landscape of ion 
channel expression and/or signalling pathways to compensate for the long-term lack 
of BK channels in mice. Increasing evidence have revealed compensatory mechanisms 
after deletion of BK channels. A previous study in murine bladder demonstrated that 
smooth muscle-specific deletion of the BK channel caused a more severe overactive 





urinary bladder syndrome compared with constitutive BK channel knockout, which 
suggests the existence of compensatory mechanisms (Sprossmann et al., 2009). 
Reduced L-type Ca2+ current density, enhanced expression of PKA, activation of 
β-adrenergic signalling pathways independently of BK channels were identified in 
constitutive BK channel knockout detrusor muscle. Another study also reported a 
compensatory mechanism in the regulation of airway tone. Mice with genetic deletion 
of BK channel displayed a reduced sensitivity following cholinergic stimulation, 
which is caused by an up-regulation of cGMP/PKG signalling pathway to 
counterbalance the enhanced Ca2+ influx via voltage-gated Ca2+ channels even they 
were not up-regulated (Sausbier et al., 2006). As [Ca2+]i signalling was reduced in male 
BK-KO corticotrophs when stimulated with CRH, but not AVP (Section 4.2.3), it is 
likely that compensation specifically modifies the CRH-induced signalling pathway. 
Whether this involves down-regulation of signalling events between CRH receptor 
activation and L-type Ca2+ channels or may involve up-regulation of Ca2+ 
sequestration and removal of Ca2+ remain unknown. However, compensation is 
unlikely to occur at the level of CRH receptors or cAMP/PKA signalling pathway, 
because addition of a fast activating BK current with dynamic clamp can induce 
CRH-dependent bursting in corticotrophs isolated from BK-KO mice or paxilline 
treated wild-type corticotrophs (Duncan et al., 2015, 2016). Compensation is also 
supported by the fact that spontaneous [Ca2+]i active time is reduced in male BK-KO, 





but not paxilline-treated, corticotrophs, and this may also contribute to the attenuated 
CRH-induced [Ca2+]i responses. 
 
To address the compensation theory, analysis of changes in mRNA, protein and 
function levels of L-type calcium channel and other ion channels in BK-KO 
corticotrophs will be required. Fluorescence-activated cell sorting (FACS) would 
provide a method for sorting and purifying corticotrophs from the mixture of pituitary 
anterior hormone secretion cells to address more global mRNA and protein analysis. 
In addition, addressing whether similar changes in CRH-induced [Ca2+]i responses 
were also observed in corticotrophs from mice in which BK channels have been 
conditionally deleted only in corticotrophs will allow us to address if this is a cell 
autonomous change. 
 
Importantly, these results also revealed differences between male and female 
corticotrophs with respect to both spontaneous and CRH-induced [Ca2+]i responses 
when BK channels were genetically deleted. Firstly, there was a reduction in 
spontaneous active time in male BK-KO corticotrophs (32.1 ± 6.1%) that approached 
statistical significance compared with controls (53.0 ± 3.1%). In contrast, female 
BK-KO corticotrophs (49.8 ± 3.6%) displayed a significant increase in spontaneous 
active time compared to wild-type corticotrophs (39.9 ± 3.0%). Moreover, in male, but 





not female corticotrophs, CRH-induced [Ca2+]i responses were attenuated in BK-KO 
corticotrophs compared to wild-type. This suggests that the functional role of BK 
channels and the ion channel/signalling pathways controlling spontaneous and 
CRH-induced [Ca2+]i signalling is different between male and female corticotrophs. 
Previous data have reported differences between male and female corticotroph 
excitability. For example, corticotrophs from female mice express intermediate 
conductance (IK) Ca2+-activated K+ channels and inhibition of IK channels with 
specific IK channel blocker promoted bursting behaviour in female corticotrophs and 
mice genetic deletion of IK channels showed hyperresponsivenss to restraint stress 
(Liang et al., 2011). However, unpublished data from the Shipston Lab (Dr Peter J. 
Duncan, personal communication) revealed a lack of effect of IK inhibition in male 
corticotrophs. Importantly, female wild-type corticotrophs displaying limited 
electrical bursting behaviour to CRH/AVP, with stimulation largely driven by increases 
in spike frequency even though BK channel mRNA, protein and single channel 
currents can be detected in corticotrophs from female mice. Intriguingly, loss of BK 
channels in corticotrophs from female mice also showed a lower percentage of cells 
that displayed synergy in [Ca2+]i responses to the combination of CRH and AVP, ~ 30% 
of female wild-type corticotrophs showed synergistic [Ca2+]i responses compared to 
only ~ 8% of female BK-KO corticotrophs. No significant synergistic [Ca2+]i responses 
were seen in male corticotrophs isolated from both wild-type and BK-KO mice. This 





sex difference further supports the existence of sexual dimorphism in the regulation of 
corticotroph [Ca2+]i responses and physiological function. 
 
The mechanism(s) underlying these differences remains to be explored although a 
potential mechanism may involve differential control by circulating sex steroids. For 
example, oestrogen and testosterone have both been reported to regulate the expression 
and/or properties of both BK channels as well as Ca2+ channels in the pituitary (Xie & 
McCobb, 1998; Fiordelisio et al., 2007). Cleary, further investigation of potential sex 
differences is warranted. 
 
4.3.2 AVP-induced [Ca2+]i responses are unaffected by genetic 
deletion of BK channels in both male and female corticotrophs 
Stimulation with repeated 2 nM AVP resulted in a significant elevation of [Ca2+]i in 
both male and female BK-KO corticotrophs. However, no significant differences were 
observed compared with corticotrophs isolated from both male and female wild-type 
mice, which suggests that BK channels play no major role in modulating AVP-evoked 
calcium signalling. This is consistent with the lack of a role for BK channels in 
regulating electrical activity. Stimulation with AVP results in an increase in single 
spiking frequency rather than a transition to bursting behaviour in male corticotrophs 
(Duncan et al., 2015). This AVP-induced electrical activity is independent of BK 





channel function, and thus is in agreement with the lack of effect predicted and 
observed in the absence of BK channels seen in 4.2.3. AVP regulates the activity of 
corticotrophs through IP3/PKC pathway which results in the release of calcium from 
intracellular IP3-sensitive calcium pool as well as influx via L-type calcium channels 
(Tse & Lee, 1998; Romanò et al., 2017). This involves a biphasic pattern of [Ca
2+]i 
signalling with a transient and plateau phase that controls the exocytosis during the 
AVP-evoked elevation of [Ca2+]i (Tse & Lee, 1998). This also suggests that the 
potential compensatory mechanisms observed in CRH-induced [Ca2+]i responses in 
BK-KO corticotrophs are not involved in AVP-induced signalling pathways, perhaps 
also suggesting Ca2+ influx is not a major component of AVP-induced [Ca2+]i responses 
in murine corticotrophs as also observed in rat corticotrophs (Romanò et al., 2017). 




Interestingly, it is worth noting that although two phenotypes of [Ca2+]i responses were 
observed in both wild-type and BK-KO corticotroph, ablation of BK channels results 
in the percentage of female corticotrophs displaying oscillatory [Ca2+]i behaviour 
decreasing from 50.0% (12/24 cells) to 8.3% (1/12 cells) compared to female 
wild-type corticotrophs, while oscillatory [Ca2+]i behaviour in male BK-KO 
corticotrophs increased from 25% (4/16 cells) to 50% (3/6 cells). In addition, wild-type 





corticotrophs always responded to repeated AVP stimulation with consistent 
deterministic patterns of [Ca2+]i responses: either sustained elevation of [Ca
2+]i or 
oscillatory [Ca2+]i behaviour in any single cell from 40 calcium imaging recordings. 
However, 16.7% (1/6 cells) of male and 8.3% (1/12 cells) of female BK-KO 
corticotrophs displayed a mixture of two phenotypes of [Ca2+]i response following 
repeated AVP stimulation. This oscillatory [Ca2+]i behaviour is likely to result 
primarily from IP3-sensitive calcium signalling and may suggest subtle roles of BK 
channels as has been reported for other calcium-activated potassium channels in 
pituitary cells (Shipston, 2018). 
 
CRH is a more potent hypothalamic secretagogue in stimulating ACTH secretion 
compared to AVP, including in murine corticotrophs. Stimulation with CRH or AVP 
results in distinct patterns of electrical activity, transition from spiking into bursting 
and increasing spiking frequency respectively, in wild-type corticotrophs. However, 
the accompanied sustained “global” [Ca2+]i responses measured over minutes is 
largely similar. This may also support the hypothesis that it is the pattern of [Ca2+]i 
responses, rather than the global [Ca2+]i responses that is important for secretion. 
Indeed, genetic deletion, or pharmacological inhibition, of BK channels, results in 
attenuation of CRH-evoked ACTH secretion in male corticotrophs (Brunton et al., 
2007; Duncan et al., 2015). To address this question, simultaneous measurement of 





electrical behaviour, [Ca2+]i responses and secretion in the same timescale are required. 
 
4.4 Chapter summary  
Genetic deletion of BK channels revealed a sexual dimorphism in spontaneous [Ca2+]i 
signalling with a significantly increased active time in female corticotrophs and a 
reduction of active time approached statistical significance in male corticotrophs 
compared to wild-type. Following CRH stimulation, male corticotrophs isolated from 
BK-KO mice showed a significant reduction in [Ca2+]i responses compared to 
wild-type. In contrast, CRH-induced [Ca2+]i responses were unaffected in 
corticotrophs from female BK-KO mice. However, acute pharmacological blockage 
of BK channels with paxilline had no significant impact on CRH-induced [Ca2+]i 
responses in either male or female corticotrophs. This paradoxical result may suggest 
the existence of compensatory mechanisms in corticotrophs following global deletion 
of BK channels. Importantly, this suggests that CRH-induced changes in bursting 
behaviour, which are dependent on BK channels in male corticotrophs, is not important 
for the global changes in [Ca2+]i responses measured over minutes. Rather, the patterns 
of [Ca2+]i responses in the millisecond to second timescale may be more important for 
controlling CRH-evoked secretion. AVP-evoked [Ca2+]i responses were largely 
unaffected by genetic deletion of BK channels in either male or female corticotrophs 
although the number of female BK-KO corticotrophs that displayed oscillatory [Ca2+]i 





behaviour was decreased compared to wild-type controls. 
 
The role of BK channels in the control of CRH-induced [Ca2+]i responses and the 
correlation between the patterns of [Ca2+]i signalling and secretion of ACTH warrant 
further study. 





















Calcium signalling in zDHHC23-KO 
corticotrophs 
  





Chapter 5: Calcium signalling in zDHHC23-
KO corticotrophs 
5.1 Introduction 
In this chapter, the aim was to investigate the role of the S-acyl transferase zDHHC23, 
that controls surface expression of BK channels, in the modulation of spontaneous and 
secretagogue-induced intracellular free calcium ([Ca2+]i) signalling in corticotrophs. I 
first examined the effects of the deletion of zDHHC23 on spontaneous [Ca2+]i 
signalling in corticotrophs. Calcium imaging experiments were then performed to 
investigate whether genetically deletion of zDHHC23 have an impact on corticotrophs 
following CRH or AVP stimulation as well as the synergy between CRH and AVP at 
the level of [Ca2+]i. All experiments were performed and analysed in male and female 
corticotrophs respectively. 
 
5.1.1 S-acylation is regulated by zDHHCs  
Cellular proteins are regulated by a wide variety of post-translational modifications 
(PTMs), such as lipid modifications and phosphorylation. In particular, protein 
S-acylation, the only fully reversible lipid PTM, provides a ubiquitous and dynamic 
mechanism to regulate the properties and functions of various proteins and 
physiological processes (Resh, 2006a; Chamberlain & Shipston, 2015). S-acylation of 





most proteins is enzymatically controlled by a large family of transmembrane 
zinc-finger containing protein acyl-transferases (zDHHC family, 23/24 zDHHCs 
genes in mammals). zDHHCs have a highly conserved Asp-His-His-Cys (DHHC) 
signature sequence across species from yeast to humans that is important for catalytic 
activity (Shipston, 2011; Chamberlain & Shipston, 2015). In addition, distinct zDHHC 
enzymes display substrate specificity (Greaves & Chamberlain, 2011) and specific 
subcellular localization and tissue distribution (Ohno et al., 2006). 
 
5.1.2 BK channels are modulated by S-acylation  
S-acylation has been implicated in the regulation of a diverse array of ion channels, 
such as the function of L-type Ca2+ channels (Chien et al., 1996), the voltage sensing 
of the voltage-gated Kv1.1 channels (Gubitosi-Klug et al., 2005) and the 
phosphorylation of BK channels (Tian et al., 2008). Importantly, recent studies suggest 
that S-acylation of BK channels plays an important role in controlling the properties 
and function including surface expression, trafficking and channel activity (Shipston, 
2014b; Chamberlain & Shipston, 2015). 
 
The BK channel pore-forming α-subunit is S-acylated at two distinct sites: cysteine 
residues within the intracellular loop between transmembrane domains S0 and S1 
(S0-S1 loop) and the alternatively spliced STREX insert in the intracellular linker 





between the two RCK domains in the C-terminus (Shipston, 2013). Of particular 
interest is the S-acylation of the S0-S1 loop of BK channels that has been suggested to 
be crucial in cell surface expression (Jeffries et al., 2010). S-acylation of S0-S1 loop 
allows the interaction between S0-S1 loop and the plasma membrane to regulate 
surface expression (Jeffries et al., 2010). It has been shown that distinct S-acylation 
sites of the same ion channel could be modulated by different subsets of zDHHCs, 
where the S-acylation of the S0-S1 loop is predominately controlled by zDHHC22 and 
zDHHC23 and overexpression of zDHHC23 increases the surface expression of the 
S0-S1 loop (Tian et al., 2010, 2012). In addition, the zDHHCs controlling the 
S-acylation of BK channels are also expressed at ER, Golgi and/or plasma membrane 
suggesting that the regulation of BK channel function may occur at various sites and 
multiple phases in the ion channel life cycle (Shipston, 2014a). 
 
In this chapter, calcium imaging experiments were performed to determine whether 
deletion of zDHHC23 had an effect on [Ca2+]i responses in corticotrophs. As 
zDHHC23 is highly expressed in murine corticotrophs and controls cell surface 
expression of BK channels, it was predicted that zDHHC23-mediated S-acylation 
plays an important role in controlling BK channel-dependent excitability and 
accompanied modulation of [Ca2+]i signalling in corticotrophs. Importantly, a previous 
study suggested that knockdown of zDHHC23 resulted in a significant reduction in 





surface expression of BK channel as well as S-acylation of the BK channel (Tian et 
al., 2012). As BK channels are essential in CRH-induced transition to bursting but not 
AVP-evoked spiking frequency increase, it was hypothesised that corticotrophs 
isolated from zDHHC23 knockout mice would show a reduction in [Ca2+]i responses 
to CRH but not AVP. 
 
5.2 Results  
5.2.1 Genetic deletion of zDHHC23 has no effect on 
spontaneous [Ca2+]i in corticotrophs 
Before investigating the role of zDHHC23-mediated S-acylation in secretagogue-
evoked corticotroph [Ca2+]i signalling, the spontaneous [Ca
2+]i signalling in 
zDHHC23-KO corticotrophs was examined. Calcium imaging was performed on 
corticotrophs isolated from zDHHC23-KO mice and the active time of spontaneous 
[Ca2+]i signalling over a five minute “baseline” period was analysed in males and 
females respectively. All data were analysed together, only data from zDHHC23-KO 
corticotrophs and the comparison between wild-type and zDHHC23-KO corticotrophs 
are presented in this chapter. The analysis of these data was done in conjunction with 
the analyses for Chapters Three and Four (see 2.6.3). Overall, the mean active time of 
spontaneous [Ca2+]i signalling across all zHHDC23-KO corticotrophs was 51.1 ± 2.8% 
(n = 87 from 47 experiments) with a negative skewed distribution. The active time was  






The active time of spontaneous [Ca2+]i signalling is not 
different between male and female zDHHC23-KO corticotrophs 
 
Figure 5.1 The active time of spontaneous [Ca2+]i signalling is not different 
between male and female zDHHC23-KO corticotrophs. (A) The mean active time 
of spontaneous [Ca2+]i signalling in all zDHHC23-KO corticotrophs. (B) The 
distribution of spontaneous [Ca2+]i active time in all zDHHC23-KO corticotrophs. The 
distribution of spontaneous [Ca2+]i active time in (C) female and (D) male 
zDHHC23-KO corticotrophs (female n = 56, male n = 31, mixed effects model). Red 
line indicates the fit of distribution density. All data are means ± SEM, N > 3 
independent experiments. 
  





not significantly different between male and female corticotrophs with 53.4 ± 4.1% in 
male corticotrophs (n = 31 from 21 experiments) and 49.8 ± 3.7% in female 
corticotrophs (n = 56 form 26 experiments) (Figure 5.1). Calcium imaging traces were 
normalized between 0 and 1 (the peak of the response to stimulus) to compare the 
relative change in maximum amplitude of spontaneous [Ca2+]i signalling between 
zDHHC23-KO corticotrophs. All patterns of spontaneous [Ca2+]i signalling were 
observed in zDHHC23-KO corticotrophs, including [Ca2+]i oscillation (33.3%), 
sustained [Ca2+]i elevation (52.9%) as well as low amplitude, complex patterns of 
[Ca2+]i behaviour (12.6%), and only 1 out of 87 cells was quiescent under basal 
conditions (Figure 5.3A). zDHHC23-KO corticotrophs had a spontaneous [Ca2+]i 
maximum amplitude of 69.7 ± 2.1% (n = 87 from 47 experiments) which was 
positively skewed (Figure 5.2A&B). The maximum amplitude of spontaneous [Ca2+]i 
signalling in female corticotrophs was 64.9 ± 2.7% (n = 56 from 26 experiments), 
which was not significantly different from male corticotrophs with a mean of 78.2 ± 
2.8% (n = 31 from 21 experiments) (Figure 5.2A). In addition, no low amplitude 
[Ca2+]i was seen in male corticotrophs and the distribution of maximum amplitude was 
heavily skewed to the right in both male and female zDHHC23-KO corticotrophs 
(Figure 5.2C&D). These results suggest that there were no significant sex differences 
in the maximum amplitude of spontaneous [Ca2+]i signalling. 
 






The maximum amplitude of spontaneous [Ca2+]i signalling is 
not different between male and female zDHHC23-KO 
corticotrophs 
 
Figure 5.2 The maximum amplitude of spontaneous [Ca2+]i signalling is not 
different between male and female zDHHC23-KO corticotrophs. (A) The mean 
maximum amplitude of spontaneous [Ca2+]i signalling in all zDHHC23-KO 
corticotrophs. (B) The distribution of spontaneous [Ca2+]i maximum amplitude in all 
zDHHC23-KO corticotrophs. The distributions of spontaneous [Ca2+]i maximum 
amplitude in (C) female and (D) male zDHHC23-KO corticotrophs (female n = 56, 
male n = 31, mixed effects model). Red line indicates the fit of distribution density. 
All data are means ± SEM, N > 3 independent experiments. 
  





Statistical calculation was performed to compare spontaneous [Ca2+]i signalling 
between wild-type and zDHHC23-KO corticotrophs in terms of active time and 
maximum amplitude. Overall, analysis of active time revealed a mean of 45.2 ± 2.2% 
in wild-type corticotrophs (n = 121 from 56 experiments) with no significant 
differences compared to corticotrophs from zDHHC23-KO mice (n = 87 from 47 
experiments) with the active time of 51.1 ± 2.8% (Figure 5.3B). The maximum 
amplitude in wild-type and zDHHC23-KO corticotrophs was not significantly 
different either, being 69.8 ± 1.7% and 69.7 ± 2.1% respectively (Figure 5.3C). 
Moreover, there were no significant differences between wild-type and zDHHC23-KO 
corticotrophs in active time or maximum amplitude of spontaneous [Ca2+]i signalling 
when analysing male or female corticotrophs separately.  
 
These results suggest that genetic deletion of zDHHC23 had no significant effect on 
spontaneous [Ca2+]i signalling in male or female corticotrophs. 
 
5.2.2 Progressive attenuation of [Ca2+]i responses to repeated 
CRH stimulation in zDHHC23-KO corticotrophs 
After determining that genetic deletion of zDHHC23 had no significant effect on 
spontaneous [Ca2+]i signalling of corticotrophs, the role of zDHHC23 in controlling 
[Ca2+]i responses induced by CRH was investigated in male corticotrophs first.   






Genetic deletion of zDHHC23 has no effect on spontaneous 
[Ca2+]i signalling in corticotrophs 
 
Figure 5.3 Genetic deletion of zDHHC23 has no effect on spontaneous [Ca2+]i 
signalling in corticotrophs. (A) All patterns of spontaneous [Ca2+]i signalling were 
seen in zDHHC23-KO corticotrophs. (B) The distribution and mean of spontaneous 
[Ca2+]i active time in male and female wild-type and zDHHC23-KO corticotrophs. (C) 
The distribution and mean of spontaneous [Ca2+]i maximum amplitude in male and 
female wild-type and zDHHC23-KO corticotrophs (wild-type n = 121, zDHHC23-KO 
n = 87, mixed effects model). Green line and red line indicate the fit of distribution 
density of wild-type and zDHHC23-KO corticotrophs respectively. All data are 
means ± SEM, N > 3 independent experiments. 





5.2.2.1 Repeated CRH stimulation results in progressively attenuated 
[Ca2+]i responses in male zDHHC23-KO corticotrophs 
Calcium imaging recordings were obtained from male zDHHC23-KO corticotrophs 
(n = 11 from 6 experiments) following the same repeated stimulation protocol used 
previously for wild-type corticotrophs (see 3.2.3.1). 
 
In response to a three minute exposure to 0.2 nM CRH stimulation, all zDHHC23-KO 
male corticotrophs responded rapidly with a significant and sustained [Ca2+]i elevation 
that returned to baseline after a few minutes (Figure 5.4A). Superposition of extracts 
of the calcium imaging traces shown indicated that [Ca2+]i changes were stable in some 
cells (Figure 5.4B, bottom), whereas the others displayed a progressive attenuation of 
[Ca2+]i responses following repeated CRH stimulation (Figure 5.4B, top). 
 
The effects of 0.2 nM CRH on [Ca2+]i in zDHHC23-KO corticotrophs were evaluated 
using the same parameters as for wild-type corticotrophs including AUC (10min), 
AUC (peak), peak, time to peak, response duration, peak duration and time gap. Log 
transformation was performed on AUC (10min), AUC (peak) and peak as before. 
Statistical analysis revealed that AUC (10 min) and AUC (peak) were significantly 
attenuated between Stimulus 1 and Stimulus 3 (p < 0.001). AUC (10 min) was also 
significantly decreased (p < 0.05) between Stimulus 2 and Stimulus 3 (Figure 5.5).  






Progressive attenuation of [Ca2+]i responses in male 
zDHHC23-KO corticotrophs to repeated CRH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
Figure 5.4 Progressive attenuation of [Ca2+]i responses in male zDHHC23-KO 
corticotrophs to repeated CRH. (A) Representative calcium imaging traces of male 
zDHHC23-KO corticotrophs exposed to 0.2 nM CRH for three minutes and repeated 
three times at 25 minutes intervals. 30 mM potassium chloride was applied at the end 
for one minute. (B) Superposition of extracts of the two traces shown in A, showing 
[Ca2+]i changes in male zDHHC23-KO corticotrophs with repeated 0.2 nM CRH 
stimulation. Black line shows response to the first stimulus (starting at 15 min), grey 
line shows response to the second stimulus (starting at 40 min), and blue line shows 
response to the third stimulus (starting at 65 min). 
  





Peak showed significantly reduction between Stimulus 1 and Stimulus 3 (p < 0.001), 
Stimulus 2 and Stimulus 3 (p < 0.001) (Figure 5.6A). However, there were no 
statistically significant differences in time to peak, (Figure 5.6B), response duration, 
peak duration (Figure 5.7) or time gap (Figure 5.8) following repeated CRH 
stimulation. 
 
The progressive attenuation in AUC (10 min), AUC (peak) and peak suggest that 
zDHHC23 is important for allowing sustained [Ca2+]i responses to repeated CRH 
stimulation in male zDHHC23-KO corticotrophs. 
 
5.2.2.2 Repeated CRH stimulation results in progressively attenuated 
[Ca2+]i responses in zDHHC23-KO female corticotrophs 
Calcium imaging experiments were performed on female corticotrophs isolated from 
zDHHC23-KO mice (n = 19 from 11 experiments) following the same protocol used 
in male zDHHC23-KO corticotrophs. 
 
Representative calcium imaging traces shown in Figure 5.9A revealed that stimulation 
with 0.2 nM CRH for three minutes resulted in a rapid and sustained increase of [Ca2+]i 
in female zDHHC23-KO corticotrophs. Importantly, there was a similar attenuation of 
[Ca2+]i responses upon repeated CRH stimulation as observed in male zDHHC23-KO 
  






Attenuation of AUC (10 min) and AUC (peak) of [Ca2+]i 
responses in male zDHHC23-KO corticotrophs to repeated 
CRH 
 
Figure 5.5 Attenuation of AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
male zDHHC23-KO corticotrophs to repeated CRH. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak). *** 
p < 0.001, * p < 0.05 (n = 11 from 6 experiments, mixed effects model). All data are 
means ± SEM. 






Attenuation of peak but not time to peak of [Ca2+]i responses 
in male zDHHC23-KO corticotrophs to repeated CRH 
 
Figure 5.6 Attenuation of peak but not time to peak of [Ca2+]i responses in male 
zDHHC23-KO corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) peak and (B) time to peak. *** p < 0.001 (n = 11 from 
6 experiments, mixed effects model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
male zDHHC23-KO corticotrophs to repeated CRH 
 
Figure 5.7 Response duration and peak duration of [Ca2+]i responses in male 
zDHHC23-KO corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) response duration and (B) peak duration (n = 11 from 
6 experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in male zDHHC23-KO 
corticotrophs to repeated CRH 
 
Figure 5.8 Time gap of [Ca2+]i responses in male zDHHC23-KO corticotrophs to 
repeated CRH. Quantification of effects of repeated exposure to 0.2 nM CRH in time 
gap (n = 11 from 6 experiments, mixed effects model). All data are means ± SEM. 
  





corticotrophs (Figure 5.9B).  
 
Repeated CRH stimulation significantly reduced AUC (10 min) and AUC (peak) of 
Stimulus 3 (p < 0.001) and Stimulus 2 (p < 0.05) compared to Stimulus 1(Figure 5.10). 
Peak was also displayed significantly attenuation between Stimulus 1 and Stimulus 3 
(p < 0.001), Stimulus 2 and Stimulus 3 (p < 0.01) as well as Stimulus 2 and Stimulus 
3 (p < 0.01) (Figure 5.11A). Time to peak (Figure 5.11B), response duration, peak 
duration (Figure 5.12) and time gap (Figure 5.13) showed no statistically significant 
differences following repeated 0.2 nM CRH stimulation.  
 
These data suggest that female zDHHC23-KO corticotrophs were also less able to 
sustain robust [Ca2+]i responses to repeated CRH stimulation. 
 
5.2.2.3 Genetic deletion of zDHHC23 differentially controls AUC (peak) 
and response duration of [Ca2+]i responses in male and female 
corticotrophs 
Although corticotrophs from both male and female zDHHC23-KO mice displayed 
progressive attenuation of [Ca2+]i responses to repeated CRH stimulation, we 
investigated whether there were differences between male and female zDHHC23-KO 
corticotrophs. 
 






Progressive attenuation of [Ca2+]i responses in female 
zDHHC23-KO corticotrophs to repeated CRH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 
Figure 5.9 Progressive attenuation of [Ca2+]i responses in female zDHHC23-KO 
corticotrophs to repeated CRH. (A) Representative calcium imaging traces of 
female zDHHC23-KO corticotrophs exposed to 0.2 nM CRH for three minutes and 
repeated three times at 25 minutes intervals. 30 mM potassium chloride was applied 
at the end for one minute. (B) Superposition of extracts of the two traces shown in A, 
showing [Ca2+]i changes in female zDHHC23-KO corticotrophs with repeated 0.2 nM 
CRH stimulation. Black line shows response to the first stimulus (starting at 15 min), 
grey line shows response to the second stimulus (starting at 40 min), and blue line 
shows response to the third stimulus (starting at 65 min). 
 
  






Attenuation of AUC (10 min) and AUC (peak) of [Ca2+]i 
responses in female zDHHC23-KO corticotrophs to repeated 
CRH 
 
Figure 5.10 Attenuation of AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
female zDHHC23-KO corticotrophs to repeated CRH. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) AUC (10 min) and (B) AUC (peak). *** 
p < 0.001, * p < 0.05 (n = 19 from 11 experiments, mixed effects model). All data are 
means ± SEM. 
  






Attenuation of peak but not time to peak of [Ca2+]i responses 
in female zDHHC23-KO corticotrophs to repeated CRH 
 
Figure 5.11 Attenuation of peak but not time to peak of [Ca2+]i responses in female 
zDHHC23-KO corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) peak and (B) time to peak. *** p < 0.001, ** p < 0.01 
(n = 19 from 11 experiments, mixed effects model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
female zDHHC23-KO corticotrophs to repeated CRH 
 
Figure 5.12 Response duration and peak duration of [Ca2+]i responses in female 
zDHHC23-KO corticotrophs to repeated CRH. Quantification of effects of repeated 
exposure to 0.2 nM CRH in (A) response duration and (B) peak duration (n = 19 from 
11 experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in female zDHHC23-KO 
corticotrophs to repeated CRH 
 
Figure 5.13 Time gap of [Ca2+]i responses in female zDHHC23-KO corticotrophs 
to repeated CRH. Quantification of effects of repeated exposure to 0.2 nM CRH in 
time gap (n = 19 from 11 experiments, mixed effects model). All data are 
means ± SEM. 
  





Statistical analysis revealed that AUC (peak) but not AUC (10 min) was significantly 
(p < 0.05) different between male and female zDHHC23-KO corticotrophs at each 
CRH stimulus (Figure 5.14). There were no significant differences in peak or time to 
peak although male corticotrophs tended to have higher variability (Figure 5.15A&B). 
However, female corticotrophs displayed significantly (p < 0.05) longer response 
duration in Stimulus 3 compared to males (Figure 5.15C). Peak duration and time gap 
were not significantly different following repeated CRH stimulation (Figure 5.16). 
 
In summary, progressive attenuation of [Ca2+]i responses to repeated CRH stimulation 
was observed in both male and female zDHHC23-KO corticotrophs with sex 
differences in AUC (peak) and response duration. 
 
5.2.2.4 No significant difference in [Ca2+]i responses to repeated CRH 
stimulation between male wild-type and zDHHC23-KO corticotrophs 
To investigate whether the attenuation of CRH-induced [Ca2+]i responses with each 
stimulus in male zDHHC23-KO corticotrophs were significantly different from the 
[Ca2+]i responses in male wild-type corticotrophs, comparison and statistical analysis 
of each parameter was performed. 
 
Although there was a significant reduction in AUC (10 min) and AUC (peak) with  






AUC (peak) but not AUC (10 min) of [Ca2+]i responses to 
repeated CRH are significantly different between female and 
male zDHHC23-KO corticotrophs 
 
Figure 5.14 AUC (peak) but not AUC (10 min) of [Ca2+]i responses to repeated 
CRH are significantly different between female and male zDHHC23-KO 
corticotrophs. Quantification of effects of repeated exposure to 0.2 nM CRH in (A) 
AUC (10 min) and (B) AUC (peak) (male n = 11 from 6 experiments, female n = 19 
from 11 experiments, mixed effects model). All data are means ± SEM. 
  






Female zDHHC23-KO corticotrophs have higher response 
duration but not peak or time to peak of [Ca2+]i responses to 
repeated CRH compared to males 
 
Figure 5.15 Female zDHHC23-KO corticotrophs have higher response duration 
but not peak or time to peak of [Ca2+]i responses to repeated CRH compared to 
males. Quantification of effects of repeated exposure to 0.2 nM CRH in (A) peak, (B) 
time to peak and (C) response duration. * p < 0.05 (male n = 11 from 6 experiments, 
female n = 19 from 11 experiments, mixed effects model). All data are means ± SEM. 
  






No significant sex difference in CRH-induced peak duration or 
time gap [Ca2+]i responses in zDHHC23-KO corticotrophs 
 
Figure 5.16 No significant sex difference in CRH-induced peak duration or time 
gap [Ca2+]i responses in zDHHC23-KO corticotrophs. Quantification of effects of 
repeated exposure to 0.2 nM CRH in (A) peak duration and (B) time gap (male n = 11 
from 6 experiments, female n = 19 from 11 experiments, mixed effects model). All 
data are means ± SEM. 
  





repeated exposure to CRH in male zDHHC23-KO, but not wild-type, corticotrophs, 
comparison of each stimulus to the comparable response in wild-type corticotrophs 
revealed no significant statistical differences (Figure 5.17). Peak was significantly 
attenuated in both wild-type and zDHHC23-KO male corticotrophs following repeated 
CRH stimulation, however, no significant differences were observed between them at 
each stimulus (Figure 5.18A). This may in part reflect the higher variability in male 
corticotrophs. In addition, there were no significant differences between male 
wild-type and zDHHC23-KO corticotrophs in time to peak, response duration (Figure 
5.18B&C), peak duration or time gap (Figure 5.19). 
 
Overall, these results suggest that genetic deletion of zDHHC23 had no effect on 
CRH-induced [Ca2+]i signalling in male corticotrophs compared to wild-type. 
 
5.2.2.5 No significant difference in [Ca2+]i responses to repeated CRH 
stimulation between female wild-type and zDHHC23-KO corticotrophs 
As observed in male zDHHC23-KO corticotrophs, female zDHHC23-KO 
corticotrophs also showed significant decline in AUC (peak), AUC (10 min) and peak 
with repeated exposure to CRH. However, as for male wild-type and zDHHC23-KO 
corticotrophs, there were no statistically significant differences in these parameters at 
each CRH stimulus between female wild-type and zDHHC23-KO corticotrophs either  






No significant differences in CRH-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses between male wild-type and 
zDHHC23-KO corticotrophs 
 
Figure 5.17 No significant differences in CRH-induced AUC (10 min) or AUC 
(peak) of [Ca2+]i responses between male wild-type and zDHHC23-KO 
corticotrophs. Quantification of effects of repeated exposure to 0.2 nM CRH in (A) 
AUC (10 min) and (B) AUC (peak). *** p < 0.001, * p < 0.05 (wild-type n = 12 from 
8 experiments, zDHHC23-KO n = 11 from 6 experiments, mixed effects model). All 
data are means ± SEM. 
  






No significant differences in CRH-induced peak, time to peak 
or response duration of [Ca2+]i responses between male 
wild-type and zDHHC23-KO corticotrophs 
 
Figure 5.18 No significant differences in CRH-induced peak, time to peak or 
responses duration of [Ca2+]i responses between male wild-type and 
zDHHC23-KO corticotrophs. Quantification of effects of repeated exposure to 
0.2 nM CRH in (A) peak, (B) time to peak and (C) response duration. *** p < 0.001, 
** p < 0.01 (wild-type n = 12 from 8 experiments, zDHHC23-KO n = 11 from 6 
experiments, mixed effects model). All data are means ± SEM. 






No significant differences in CRH-induced peak duration or 
time gap of [Ca2+]i responses between male wild-type and 
zDHHC23-KO corticotrophs 
 
Figure 5.19 No significant differences in CRH-induced peak duration or time gap 
of [Ca2+]i responses between male wild-type and zDHHC23-KO corticotrophs. 
Quantification of effects of repeated exposure to 0.2 nM CRH in (A) peak duration 
and (B) time gap (wild-type n = 12 from 8 experiments, zDHHC23-KO n = 11 from 6 
experiments, mixed effects model). All data are means ± SEM. 
  





(Figure 5.20 & Figure 5.21A). Female wild-type and zDHHC23-KO corticotrophs had 
no significant differences in time to peak, response duration (Figure 5.21B&C), peak 
duration or time gap (Figure 5.22) to repeated CRH stimulation either. 
 
This suggests that genetic deletion of zDHHC23 did not affect [Ca2+]i responses to 
repeated CRH stimulation in female corticotrophs. 
 
In summary, genetic deletion of zDHHC23 significantly reduced the ability to respond 
consistently to repeated CRH stimulation in both male and female corticotrophs. 
However, there were no significant sex differences in CRH-induced [Ca2+]i responses 
and there were no statistically significant differences between [Ca2+]i responses at each 
CRH stimulus when comparing wild-type and zDHHC23-KO corticotrophs. Thus, 
while zDHHC23 may play a subtle role in controlling the stability of [Ca2+]i responses 
to repeated CRH stimulation, zDHHC23 does not play a major role to control 
CRH-induced [Ca2+]i signalling in murine corticotrophs. 
 
5.2.3 Genetic deletion of zDHHC23 has no significant effect on 
AVP-induced [Ca2+]i responses in male and female 
corticotrophs 
The above data suggest that zDHHC23 is not a major mechanism to control 






No significant differences in CRH-induced AUC (10 min) and 
AUC (peak) of [Ca2+]i responses between female wild-type and 
zDHHC23-KO corticotrophs 
 
Figure 5.20 No significant differences in CRH-induced AUC (10 min) and AUC 
(peak) of [Ca2+]i responses between female wild-type and zDHHC23-KO 
corticotrophs. Quantification of effects of repeated exposure to 0.2 nM CRH in (A) 
AUC (10 min) and (B) AUC (peak). *** p < 0.001, ** p < 0.01, * p < 0.05 (wild-type 
n = 14 from 7 experiments, zDHHC23-KO n = 19 from 11 experiments, mixed effects 
model). All data are means ± SEM. 
  






No significant differences in CRH-induced peak, time to peak 
or response duration of [Ca2+]i responses between female 
wild-type and zDHHC23-KO corticotrophs 
 
Figure 5.21 No significant differences in CRH-induced peak, time to peak or 
response duration of [Ca2+]i responses between female wild-type and 
zDHHC23-KO corticotrophs. Quantification of effects of repeated exposure to 
0.2 nM CRH in (A) peak, (B) time to peak and (C) response duration. *** p < 0.001 
(wild-type n = 14 from 7 experiments, zDHHC23-KO n = 19 from 11 experiments, 
mixed effects model). All data are means ± SEM. 






No significant differences in CRH-induced peak duration or 
time gap of [Ca2+]i responses between female wild-type and 
zDHHC23-KO corticotrophs 
 
Figure 5.22 No significant differences in CRH-induced peak duration or time gap 
of [Ca2+]i responses between female wild-type and zDHHC23-KO corticotrophs. 
Quantification of effects of repeated exposure to 0.2 nM CRH in (A) peak duration 
and (B) time gap (wild-type n = 14 from 7 experiments, zDHHC23-KO n = 19 from 
11 experiments, mixed effects model). All data are means ± SEM. 
  





spontaneous or CRH-induced [Ca2+]i responses in murine corticotrophs. Experiments 
were also performed to investigate whether knockout of zDHHC23 controlled [Ca2+]i 
responses to repeated 2 nM AVP stimulation in corticotrophs.  
 
As observed in wild-type corticotrophs, zDHHC23-KO corticotrophs also displayed 
two phenotypes of [Ca2+]i responses. Following repeated 2 nM AVP stimulation, 
79.2% (19 out of 24) of cells always exhibited sustained elevation of [Ca2+]i; 8.3% of 
(2 out of 24) cells showed oscillatory  [Ca2+]i behaviour. In the remaining 3 cells 
(12.5%), both sustained increase of [Ca2+]i and oscillatory [Ca
2+]i behaviour were 
found in one cell upon repeated AVP stimulation. This was different from wild-type 
corticotrophs, with 60% of cells showing sustained [Ca2+]i elevation and the rest 
showing oscillatory [Ca2+]i behaviour. Importantly, the mixture of the two phenotypes 
of [Ca2+]i responses was not observed in the same corticotroph from wild-type mice. 
This suggests that genetic deletion of zDHHC23 may affect the pattern of [Ca2+]i 
responses to AVP in corticotrophs. Next, AVP-induced [Ca2+]i responses were 
examined in male and female zDHHC23-KO corticotrophs separately and quantified 
using the same parameters for wild-type corticotrophs.  
 
  





5.2.3.1 Repeated AVP evokes robust [Ca2+]i responses in male 
zDHHC23-KO corticotrophs 
Calcium imaging experiments were performed on male zDHHC23-KO corticotrophs 
(n = 10 from 8 experiments) following the same repeated stimulation protocol used for 
wild-type corticotrophs (see 3.2.4.1). 
 
When exposed to repeated 2 nM AVP, 8 out of 10 cells showed sustained elevation of 
[Ca2+]i (Figure 5.23A, top) and the other 2 cells displayed both sustained [Ca
2+]i 
increase and oscillatory [Ca2+]i behaviour (Figure 5.23A, bottom). No cell showed 
repetitive oscillatory [Ca2+]i responses to AVP. It’s interesting to note that two 
phenotypes of [Ca2+]i responses did not appear in one cell in male wild-type 
corticotrophs. The dynamics of [Ca2+]i responses to repeated AVP stimulation was 
similar to each other when corticotrophs showed sustained [Ca2+]i increase (Figure 
5.23B, top). Although some corticotrophs displayed two phenotypes of [Ca2+]i 
responses between repeated AVP stimulation, [Ca2+]i responses were still consistent in 
response duration (Figure 5.23B, bottom). 
 
All parameters were examined between the two response phenotypes to examine 
whether they had significant differences. Statistical analysis revealed that there were 
no significant differences between sustained increase of [Ca2+]i and the mixture of  






Repeated AVP induces repeatable [Ca2+]i responses in male 
zDHHC23-KO corticotrophs 
 
Figure 5.23 Repeated AVP induces repeatable [Ca2+]i responses in male 
zDHHC23-KO corticotrophs. (A) Representative calcium imaging traces of male 
zDHHC23-KO corticotrophs exposed to 2 nM AVP for three minutes and repeated 
three times at 25 minutes intervals. 30 mM potassium chloride was applied at the end 
for one minute. (B) Superposition of extracts of the two traces shown in A, showing 
[Ca2+]i changes in male zDHHC23-KO corticotrophs with repeated 2 nM AVP 
stimulation. Black line shows response to the first stimulus (starting at 15 min), grey 
line shows response to the second stimulus (starting at 40 min), and blue line shows 
response to the third stimulus (starting at 65 min). 
  





sustained and oscillatory [Ca2+]i behaviour (data not shown). Therefore, statistical 
analysis was performed on all male zDHHC23-KO corticotrophs together. There were 
no significant differences in AUC (10 min), AUC (peak) (Figure 5.24), peak, time to 
peak (Figure 5.25), responses duration, peak duration (Figure 5.26) or time gap (Figure 
5.27) in male zDHHC23-KO corticotrophs following repeated AVP stimulation. 
 
This suggests that repeated 2 nM AVP stimulation evokes robust and consistent [Ca2+]i 
responses in male zDHHC23-KO corticotrophs. 
 
5.2.3.2 Repeated AVP evokes robust [Ca2+]i responses in female 
zDHHC23-KO corticotrophs 
The calcium imaging experiments were performed on corticotrophs isolated from 
female zDHHC23-KO mice (n = 14 from 7 experiments) following the same protocol 
used in male zDHHC23-KO corticotrophs. 
 
When stimulated with 2 nM AVP, all female zDHHC23-KO corticotrophs showed two 
different phenotypes of [Ca2+]i responses as male zDHHC23-KO corticotrophs. 11 out 
of 14 cells displayed sustained elevation of [Ca2+]i and oscillatory [Ca
2+]i behaviour 
was observed in 2 cells (Figure 5.28A). Only 1 cell showed both sustained [Ca2+]i 
increase and oscillatory [Ca2+]i behaviour following repeated AVP stimulation.  






Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
male zDHHC23-KO corticotrophs to repeated AVP 
 
Figure 5.24 Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in male 
zDHHC23-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (n = 10 from 8 
experiments, mixed effects model). All data are means ± SEM. 
  






Peak and time to peak of [Ca2+]i responses in male 
zDHHC23-KO corticotrophs to repeated AVP 
  
Figure 5.25 Peak and time to peak of [Ca2+]i responses in male zDHHC23-KO 
corticotrophs to repeated AVP. Quantification of effects of repeated exposure to 
2 nM AVP in (A) peak and (B) time to peak (n = 10 from 8 experiments, mixed effects 
model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
male zDHHC23-KO corticotrophs to repeated AVP 
 
Figure 5.26 Response duration and peak duration of [Ca2+]i responses in male 
zDHHC23-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) response duration and (B) peak duration (n = 10 from 8 
experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in male zDHHC23-KO 
corticotrophs to repeated AVP 
 
Figure 5.27 Time gap of [Ca2+]i responses in male zDHHC23-KO corticotrophs to 
repeated AVP. Quantification of effects of repeated exposure to 2 nM AVP in time gap 
(n = 10 from 8 experiments, mixed effects model). All data are means ± SEM. 
  





However, this was different from female wild-type corticotrophs where each response 
phenotype accounted for 50% respectively and the mixture of the two phenotypes did 
not appear in one single cell. As the differences were observed in both male and female 
zDHHC23-KO corticotrophs compared to wild-type controls, this suggests that 
zDHHC23 may play a role in controlling the patterns of [Ca2+]i responses induced by 
AVP in corticotrophs. Extracts of calcium imaging traces were highly coincidental in 
both phenotypes indicated that [Ca2+]i responses to repeated 2 nM AVP stimulus were 
reproducible in female zDHHC23-KO corticotrophs (Figure 5.28B). 
 
The comparison and analysis of all parameters were performed between AVP-induced 
two phenotypes of [Ca2+]i responses to examine whether they were different. These 
parameters failed to show any significant difference between sustained elevation and 
oscillatory [Ca2+]i behaviour (data not shown), thus statistical analysis was performed 
on all female zDHHC23-KO corticotrophs together. As observed in male 
zDHHC23-KO corticotrophs, AUC (10 min), AUC (peak) (Figure 5.29), peak, time to 
peak (Figure 5.30), response duration, peak duration (Figure 5.31) and time gap 
(Figure 5.32) showed no significant differences following repeated AVP stimulation. 
 
These results suggest that repeated 2 nM AVP stimulation induced highly repeatable 
and stable [Ca2+]i responses in female zDHHC23-KO corticotrophs. 






Repeated AVP induces repeatable [Ca2+]i responses in female 
zDHHC23-KO corticotrophs 
 
Figure 5.28 Repeated AVP induces repeatable [Ca2+]i responses in female 
zDHHC23-KO corticotrophs. (A) Representative calcium imaging traces of female 
zDHHC23-KO corticotrophs exposed to 2 nM AVP for three minutes and repeated 
three times at 25 minutes intervals. 30 mM potassium chloride was applied at the end 
for one minute. (B) Superposition of extracts of the two traces shown in A, showing 
[Ca2+]i changes in female zDHHC23-KO corticotrophs with repeated three times 2 nM 
AVP stimulation. Black line shows response to the first stimulus (starting at 15 min), 
grey line shows response to the second stimulus (starting at 40 min), and blue line 
shows response to the third stimulus (starting at 65 min). 
  






Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in 
female zDHHC23-KO corticotrophs to repeated AVP 
 
Figure 5.29 Stable AUC (10 min) and AUC (peak) of [Ca2+]i responses in female 
zDHHC23-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) (n = 14 from 7 
experiments, mixed effects model). All data are means ± SEM. 
  






Peak and time to peak of [Ca2+]i responses in female 
zDHHC23-KO corticotrophs to repeated AVP 
 
Figure 5.30 Peak and time to peak of [Ca2+]i responses in female zDHHC23-KO 
corticotrophs to repeated AVP. Quantification of effects of repeated exposure to 
2 nM AVP in (A) peak and (B) time to peak (n = 14 from 7 experiments, mixed effects 
model). All data are means ± SEM. 
  






Response duration and peak duration of [Ca2+]i responses in 
female zDHHC23-KO corticotrophs to repeated AVP 
 
Figure 5.31 Response duration and peak duration of [Ca2+]i responses in female 
zDHHC23-KO corticotrophs to repeated AVP. Quantification of effects of repeated 
exposure to 2 nM AVP in (A) response duration and (B) peak duration (n = 14 from 7 
experiments, mixed effects model). All data are means ± SEM. 
  






Time gap of [Ca2+]i responses in female zDHHC23-KO 
corticotrophs to repeated AVP 
 
Figure 5.32 Time gap of [Ca2+]i responses in female zDHHC23-KO corticotrophs 
to repeated AVP. Quantification of effects of repeated exposure to 2 nM AVP in time 
gap (n = 14 from 7 experiments, mixed effects model). All data are means ± SEM. 
  





5.2.3.3 AVP-induced [Ca2+]i responses are not significantly different 
between male and female zDHHC23-KO corticotrophs 
Both male and female zDHHC23-KO corticotrophs had robust and consistent [Ca2+]i 
responses to repeated AVP stimulation, we investigated whether there were differences 
between male and female zDHHC23-KO corticotrophs. Previous results indicated that 
there were no significant differences between AVP-evoked two phenotypes of [Ca2+]i 
responses in both male and female zDHHC23-KO corticotrophs. Thus, the comparison 
and statistical analysis of AVP-induced [Ca2+]i responses were performed on all 
calcium imaging experiments to examine whether there were sex differences in 
zDHHC23-KO corticotrophs. 
 
Statistically analysis revealed that there were no significant differences in AUC 
(10min), AUC (peak) (Figure 5.33), peak, time to peak, response duration (Figure 
5.34), peak duration or time gap (Figure 5.35) at each AVP stimulus between male and 
female zDHHC23-KO corticotrophs, although male zDHHC23-KO corticotrophs 
tended to have higher [Ca2+]i responses in AUC (peak), AUC (10 min) and peak. 
 
In conclusion, [Ca2+]i responses to repeated 2 nM AVP stimulation were highly 
consistent and reproducible in both male and female zDHHC23-KO corticotrophs. 
Genetic deletion of zDHHC23 had no significant sex differences in AVP-induced  






No significant sex difference in AVP-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses in zDHHC23-KO corticotrophs 
 
Figure 5.33 No significant sex difference in AVP-induced AUC (10 min) or AUC 
(peak) of [Ca2+]i responses in zDHHC23-KO corticotrophs. Quantification of 
effects of repeated exposure to 2 nM AVP in (A) AUC (10 min) and (B) AUC (peak) 
(male n = 10 from 8 experiments, female n = 14 from 7 experiments, mixed effects 
model). All data are means ± SEM. 
  






No significant sex difference in AVP-induced peak, time to 
peak or response duration of [Ca2+]i responses in 
zDHHC23-KO corticotrophs 
 
Figure 5.34 No significant sex difference in AVP-induced peak, time to peak or 
response duration of [Ca2+]i responses in zDHHC23-KO corticotrophs. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) peak, (B) time to 
peak and (C) response duration (male n = 10 from 8 experiments, female n = 14 from 
7 experiments, mixed effects model). All data are means ± SEM. 
  






No significant sex difference in AVP-induced peak duration or 
time gap of [Ca2+]i responses in zDHHC23-KO corticotrophs 
 
Figure 5.35 No significant sex difference in AVP-induced peak duration or time 
gap of [Ca2+]i responses in zDHHC23-KO corticotrophs. Quantification of effects 
of repeated exposure to 2 nM AVP in (A) peak duration and (B) time gap (male n = 10 
from 8 experiments, female n = 14 from 7 experiments, mixed effects model). All data 
are means ± SEM. 
  







5.2.3.4 Genetic deletion of zDHHC23 has no significant effect on 
AVP-induced [Ca2+]i responses in male corticotrophs 
Male wild-type and zDHHC23-KO corticotrophs showed consistent [Ca2+]i responses 
to repeated AVP stimulation. Each parameter was then compared between male 
wild-type and zDHHC23-KO corticotrophs to examine whether genetic deletion of 
zDHHC23 had effect on AVP-induced [Ca2+]i responses. 
 
Following repeated AVP stimulation, male zDHHC23-KO corticotrophs showed no 
statistically significant differences in AUC (10 min), AUC (peak) (Figure 5.36), peak, 
time to peak, response duration (Figure 5.37), peak duration or time gap (Figure 5.38) 
at each stimulus compared to male wild-type corticotrophs. 
 
These results suggest that genetic deletion of zDHHC23 had no significant effect on 
[Ca2+]i responses evoked by repeated 2 nM AVP stimulation in male corticotrophs. 
 
5.2.3.5 Genetic deletion of zDHHC23 has no significant effect on 
AVP-induced [Ca2+]i responses in female corticotrophs 
Next, the same statistical analysis was performed between female wild-type and 
zDHHC23-KO corticotrophs. Genetic deletion of zDHHC23 showed no statistically 






No significant differences in AVP-induced AUC (10 min) or 
AUC (peak) [Ca2+]i responses between male wild-type and 
zDHHC23-KO corticotrophs 
 
Figure 5.36 No significant differences in AVP-induced AUC (10 min) or AUC 
(peak) [Ca2+]i responses between male wild-type and zDHHC23-KO 
corticotrophs. Quantification of effects of repeated exposure to 2 nM AVP in (A) AUC 
(10 min) and (B) AUC (peak) (wild-type n = 16 from 9 experiments, zDHHC23-KO 
n = 10 from 8 experiments, mixed effects model). All data are means ± SEM. 
  






No significant differences in AVP-induced peak, time to peak 
or response duration [Ca2+]i responses between male 
wild-type and zDHHC23-KO corticotrophs 
 
Figure 5.37 No significant differences in AVP-induced peak, time to peak or 
response duration [Ca2+]i responses between male wild-type and zDHHC23-KO 
corticotrophs. Quantification of effects of repeated exposure to 2 nM AVP in (A) 
peak, (B) time to peak and (C) response duration (wild-type n = 16 from 9 experiments, 
zDHHC23-KO n = 10 from 8 experiments, mixed effects model). All data are 
means ± SEM. 






No significant differences in AVP-induced peak duration or 
time gap [Ca2+]i responses between male wild-type and 
zDHHC23-KO corticotrophs 
 
Figure 5.38 No significant differences in AVP-induced peak duration or time gap 
[Ca2+]i responses between male wild-type and zDHHC23-KO corticotrophs. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) peak duration and 
(B) time gap (wild-type n = 16 from 9 experiments, zDHHC23-KO n = 10 from 8 
experiments, mixed effects model). All data are means ± SEM. 
  





significant differences in AUC (10 min), AUC (peak) (Figure 5.39), peak, time to peak, 
responses duration (Figure 5.40), peak duration or time gap (Figure 5.41) compared to 
female wild-type corticotrophs.  
 
This suggest that female zDHHC23-KO corticotrophs, as female wild-type 
corticotrophs, could also evoke robust and consistent [Ca2+]i responses to repeated 
AVP stimulation. 
 
In summary, repeated AVP stimulation evoked robust and reproducible [Ca2+]i 
responses in both male and female zDHHC23-KO corticotrophs, which was similar to 
wild-type corticotrophs. Some differences were observed between male and female 
zDHHC23-KO corticotrophs in AVP-induced [Ca2+]i responses, however, they were 
not considered statistically significant different. Thus, zDHHC23 does not play a role 
in controlling AVP-induced [Ca2+]i signalling in murine corticotrophs. 
 
5.2.4 Do zDHHC23-KO corticotrophs show synergy between 
CRH and AVP at the level of intracellular free calcium? 
Previous study in Chapter Three suggested that there were no significant synergistic 
[Ca2+]i responses between CRH and AVP in wild-type corticotrophs at the population 
level, but a proportion of (26.7%) female, but not male, wild-type corticotrophs  






No significant differences in AVP-induced AUC (10 min) or 
AUC (peak) of [Ca2+]i responses between female wild-type and 
zDHHC23-KO corticotrophs  
 
Figure 5.39 No significant differences in AVP-induced AUC (10 min) or AUC 
(peak) of [Ca2+]i responses between female wild-type and zDHHC23-KO 
corticotrophs. Quantification of effects of repeated exposure to 2 nM AVP in (A) AUC 
(10 min) and (B) AUC (peak) (wild-type n = 24 from 8 experiments, zDHHC23-KO 
n = 14 from 7 experiments, mixed effects model). All data are means ± SEM. 
  






No significant differences in AVP-induced peak, time to peak 
or response duration of [Ca2+]i responses between female 
wild-type and zDHHC23-KO corticotrophs 
 
Figure 5.40 No significant differences in AVP-induced peak, time to peak or 
response duration [Ca2+]i responses between female wild-type and zDHHC23-KO 
corticotrophs. Quantification of effects of repeated exposure to 2 nM AVP in (A) 
peak, (B) time to peak and (C) response duration (wild-type n = 24 from 8 experiments, 
zDHHC23-KO n = 14 from 7 experiments, mixed effects model). All data are 
means ± SEM. 
  






No significant differences in AVP-induced peak duration or 
time gap of [Ca2+]i responses between female wild-type and 
zDHHC23-KO corticotrophs 
 
Figure 5.41 No significant differences in AVP induced peak duration or time gap 
of [Ca2+]i responses between female wild-type and zDHHC23-KO corticotrophs. 
Quantification of effects of repeated exposure to 2 nM AVP in (A) peak duration and 
(B) time gap (wild-type n = 24 from 8 experiments, zDHHC23-KO n = 14 from 7 
experiments, mixed effects model). All data are means ± SEM. 
  





showed synergy at the single cell level. Thus, following experiments were performed 
to determine whether deletion of zDHHC23 had an effect on synergistic [Ca2+]i 
responses to CRH and AVP in corticotrophs. 
 
5.2.4.1 No synergistic [Ca2+]i response between CRH and AVP in male 
zDHHC23-KO corticotrophs at the population level 
Calcium imaging recordings were obtained from male corticotrophs isolated from 
zDHHC23-KO mice following the repeated stimulation protocol used in male 
wild-type corticotrophs (see 3.2.5.1). The order of two single stimuli was randomized 
to minimize the possible effect due to the order of exposure to CRH and AVP (CRH, 
AVP, combination, n = 5 or AVP, CRH, combination, n = 5 from 8 experiments). 
 
When stimulated with 0.2 nM CRH, male zDHHC23-KO corticotrophs always had 
sustained elevation of [Ca2+]i irrespective of the stimulus order. Two phenotypes of 
[Ca2+]i responses observed before were also found when exposed to 2 nM AVP. 
However, only 1 out of 10 cells showed the oscillatory [Ca2+]i behaviour and the other 
9 cells had sustained [Ca2+]i responses regardless of the sequence of stimulus. The 
sustained elevation and oscillatory of [Ca2+]i responses were 54.5% and 45.5% 
respectively when investigating the synergistic [Ca2+]i responses in male wild-type 
corticotrophs. However, AVP-induced oscillatory calcium behaviour tended to be rare 





in male zDHHC23-KO corticotrophs suggesting that deletion of zDHHC23 may have 
effect on [Ca2+]i responding patterns in corticotrophs when stimulation with AVP. 
Stimulation with 0.2 nM CRH and 2 nM AVP together resulted in significant and 
sustained increase of [Ca2+]i (Figure 5.42A & Figure 5.43A). The extracts of calcium 
imaging traces of typical experiments for male zDHHC23-KO corticotrophs were 
shown in Figure 5.42B and Figure 5.43B. The [Ca2+]i responses to two single stimuli 
and combined stimulus were coincident in spite of the stimulus order and the 
phenotypes of [Ca2+]i responses elicited by AVP. 
 
The AUC of the combined stimulus was compared to the sum of the AUC of the two 
single stimuli to examine whether there were synergistic [Ca2+]i responses in male 
zDHHC23-KO corticotrophs. Comparison and analysis of each parameter between 
AVP-induced sustained elevation of [Ca2+]i (n = 9) and oscillatory [Ca
2+]i behaviour 
(n = 1) revealed that there were no significant differences between the two phenotypes 
of [Ca2+]i responses. Therefore, statistical analysis was performed on all male 
zDHHC23-KO corticotrophs together. The statistical calculation of AUC (10 min), 
AUC (peak) and peak was performed on log-transformed data and the others were 
performed on raw data. 
  






CRH, AVP and CRH/AVP induce [Ca2+]i responses in male 
zDHHC23-KO corticotrophs 
 
Figure 5.42 CRH, AVP and CRH/AVP induce [Ca2+]i responses in male 
zDHHC23-KO corticotrophs. (A) Representative calcium imaging traces of male 
zDHHC23-KO corticotrophs exposed to 0.2 nM CRH, 2 nM AVP and 0.2 nM CRH 
together with 2 nM AVP at 25 minutes intervals. 30 mM potassium chloride was 
applied at the end for one minute. (B) Superposition of extracts of the two traces shown 
in A, showing [Ca2+]i changes in male zDHHC23-KO corticotrophs with stimuli. 
Black line shows response to 0.2 nM CRH (starting at 15 min), grey line shows 
response to 2 nM AVP (starting at 40 min), and blue line shows response to the 
combined stimulus (starting at 65 min). 
  






AVP, CRH and CRH/AVP induce [Ca2+]i responses in male 
zDHHC23-KO corticotrophs 
 
Figure 5.43 AVP, CRH and CRH/AVP induce [Ca2+]i responses in male 
zHDHC23-KO corticotrophs. (A) Representative calcium imaging traces of male 
zDHHC23-KO corticotrophs exposed to 2 nM AVP, 0.2 nM CRH, 0.2 nM CRH 
together with 2 nM AVP at 25 minutes intervals. 30 mM potassium chloride was 
applied at the end for one minute. (B) Superposition of extracts of the two traces shown 
in A, showing [Ca2+]i changes in male zDHHC23-KO corticotrophs with stimuli. 
Black line shows response to 2 nM AVP (starting at 15 min), grey line shows response 
to 0.2 nM CRH (starting at 40 min), and blue line shows response to the combined 
stimulus (starting at 65 min). 
  





[Ca2+]i responses evoked by the combined stimulus were significantly (p < 0.05) larger 
than AVP-induced [Ca2+]i responses in AUC (peak) but not AUC (10 min). However, 
the combined stimulus was significantly (p < 0.001) smaller than the sum of the two 
single stimuli in both AUC (10 min) and AUC (peak) (Figure 5.44). This suggests that 
male zDHHC23-KO corticotrophs did not show synergistic [Ca2+]i responses to CRH 
and AVP. Peak, time to peak, response duration (Figure 5.45), peak duration and time 
gap (Figure 5.46) showed no statistically significant differences between CRH-, 
AVP- and CRH/AVP-induced [Ca2+]i responses. 
 
These results suggest that there was no synergy between CRH and AVP in male 
zDHHC23-KO corticotrophs at the level of [Ca2+]i. 
 
5.2.4.2 No synergistic [Ca2+]i response between CRH and AVP in female 
zDHHC23-KO corticotrophs at the population level 
Calcium imaging experiments were performed on female zDHHC23-KO corticotrophs 
following the same protocol used in male zDHHC23-KO corticotrophs. The order of 
0.2 nM CRH and 2 nM AVP was randomized to counteract the possible effect caused 
by exposure sequence (CRH, AVP, combination, n = 6 or AVP, CRH, combination, 
n = 7 from 5 experiments).  
 






No synergistic [Ca2+]i response to CRH/AVP in male 
zDHHC23-KO corticotrophs 
 
Figure 5.44 No synergistic [Ca2+]i responses to CRH/AVP in male zDHHC23-KO 
corticotrophs. Quantification of effects of exposure to 0.2 nM CRH, 2 nM AVP and 
the combination of the two in (A) AUC (10 min) and (B) AUC (peak). The comparison 
of the AUC of the combined stimulus and the sum of the two single stimuli was used 
as a measurement of synergy. *** p < 0.001, * p < 0.05 (n = 10 from 8 experiments, 
mixed effects model). All data are means ± SEM. 
  






Peak, time to peak and response duration of [Ca2+]i responses 
to CRH, AVP and CRH/AVP in male zDHHC23-KO corticotrophs 
 
Figure 5.45 Peak, time to peak and response duration of [Ca2+]i responses to CRH, 
AVP and CRH/AVP in male zDHHC23-KO corticotrophs. Quantification of effects 
of exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak, 
(B) time to peak and (C) response duration (n = 10 from 8 experiments, mixed effects 
model). All data are means ± SEM. 
  






Peak duration and time gap of [Ca2+]i responses to CRH, AVP 
and CRH/AVP in male zDHHC23-KO corticotrophs 
 
Figure 5.46 Peak duration and time gap of [Ca2+]i responses to CRH, AVP and 
CRH/AVP in male zDHHC23-KO corticotrophs. Quantification of effects of 
exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak 
duration and (B) time gap (n = 10 from 8 experiments, mixed effects model). All data 
are means ± SEM. 
  





When stimulated with 0.2 nM CRH, 2 nM AVP and the combined stimulus in order, 
all 6 cells responded to CRH with sustained [Ca2+]i increase; 2 out of 6 cells displayed 
sustained elevation of [Ca2+]i to AVP and the other 4 cells showed oscillatory [Ca
2+]i 
behaviour; the combination of CRH and AVP resulted in significant increase of [Ca2+]i 
in all cells (Figure 5.47A). When exposed to 2 nM AVP, 0.2 nM CRH and the combined 
stimulus sequentially, all 7 cells showed sustained increase of [Ca2+]i when responding 
to CRH and the combined stimulus; AVP induced high frequency of oscillatory [Ca2+]i 
responses in 1 cell while the other 6 cells showed sustained [Ca2+]i elevation to AVP 
(Figure 5.48A). Compared to female wild-type corticotrophs, AVP-induced oscillatory 
[Ca2+]i behaviour was less likely to appear in female zDHHC23-KO corticotrophs 
suggesting that zDHHC23 probably play a role in controlling AVP-evoked [Ca2+]i 
response patterns in corticotrophs. Overlapping calcium traces seen in two different 
stimulation sequences indicated that [Ca2+]i responses to two single stimuli and 
combined stimulus were coincident regardless of AVP-induced phenotypes of [Ca2+]i 
responses (Figure 5.47B & Figure 5.48B). 
 
The synergistic [Ca2+]i responses and the effects of two single stimuli and combined 
stimulus on [Ca2+]i responses were evaluated with the same parameters used in male 
zDHHC23-KO corticotrophs. Sustained increase of [Ca2+]i (n = 8) and oscillatory 
[Ca2+]i behaviour (n = 5) showed no statistically significant differences in either AUC 






CRH, AVP and CRH/AVP induce [Ca2+]i responses in female 
zDHHC23-KO corticotrophs 
 
Figure 5.47 CRH, AVP and CRH/AVP induce [Ca2+]i responses in female 
zDHHC23-KO corticotrophs. (A) Representative calcium imaging traces of female 
zDHHC23-KO corticotrophs exposed to 0.2 nM CRH, 2 nM AVP and 0.2 nM CRH 
together with 2 nM AVP at 25 minutes intervals. 30 mM potassium chloride was 
applied at the end for one minute. (B) Superposition of extracts of the two traces shown 
in A, showing [Ca2+]i changes in female zDHHC23-KO corticotrophs with stimuli. 
Black line shows response to 0.2 nM CRH (starting at 15 min), grey line shows 
response to 2 nM AVP (starting at 40 min), and blue line shows response to the 
combined stimulus (starting at 65 min). 
  






AVP, CRH and CRH/AVP induce [Ca2+]i responses in female 
zDHHC23-KO corticotrophs 
 
Figure 5.48 AVP, CRH and CRH/AVP induce [Ca2+]i responses in female 
zHDHC23-KO corticotrophs. (A) Representative calcium imaging traces of female 
zDHHC23-KO corticotrophs exposed to 2 nM AVP, 0.2 nM CRH and 0.2 nM CRH 
together with 2 nM AVP at 25 minutes intervals. 30 mM potassium chloride was 
applied at the end for one minute. (B) Superposition of extracts of the two traces shown 
in A, showing [Ca2+]i changes in female zDHHC23-KO corticotrophs with stimuli. 
Black line shows response to 2 nM AVP (starting at 15 min), grey line shows response 
to 0.2 nM CRH (starting at 40 min), and blue line shows response to the combined 
stimulus (starting at 65 min). 
  





(10 min) or AUC (peak) (data not shown). Therefore, statistical analysis was 
performed on all female zDHHC23-KO corticotrophs together.  
 
There were no significant differences in [Ca2+]i responses induced by CRH, AVP and 
combined stimulus in AUC (10 min), but AUC (peak) displayed significant differences 
between CRH and AVP (p < 0.05), AVP and combined stimulus (p < 0.05). Importantly, 
combined stimulus was significantly (p < 0.001) smaller than the sum of the two single 
stimuli in both AUC (10 min) and AUC (peak). This suggests that there was no synergy 
between CRH and AVP at the level of [Ca2+]i when considering the population. 
However, in 1 out of 13 cells (7.7%) the AUC (10 min) and AUC (peak) of combined 
stimulus were larger than the sum of the two single stimuli (Figure 5.49). CRH-, 
AVP- and CRH/AVP-induced [Ca2+]i responses were not significantly different in peak, 
time to peak, response duration (Figure 5.50), peak duration or time gap (Figure 5.51). 
 
These results suggest that there was no synergistic [Ca2+]i response between CRH and 
AVP in female zDHHC23-KO corticotrophs when considering the population. 
However, a small portion of female zDHHC23-KO corticotrophs (7.7%) showed 
synergistic [Ca2+]i response at the single cell level.  
  






No synergistic [Ca2+]i responses to CRH/AVP in female 
zDHHC23-KO corticotrophs 
 
Figure 5.49 No synergistic [Ca2+]i responses to CRH/AVP in female 
zDHHC23-KO corticotrophs. Quantification of effects of exposure to 0.2 nM CRH, 
2 nM AVP and the combination of the two in (A) AUC (10 min) and (B) AUC (peak). 
The comparison of the AUC of the combined stimulus and the sum of the two single 
stimuli was used as a measurement of synergy. *** p < 0.001, * p < 0.05 (n = 13 from 
5 experiments, mixed effects model). All data are means ± SEM. 
  






Peak, time to peak and response duration of [Ca2+]i responses 
to CRH, AVP and CRH/AVP in female zDHHC23-KO 
corticotrophs 
 
Figure 5.50 Peak, time to peak and response duration of [Ca2+]i responses to CRH, 
AVP and CRH/AVP in female zDHHC23-KO corticotrophs. Quantification of 
effects of exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) 
peak, (B) time to peak and (C) response duration (n = 13 from 5 experiments, mixed 
effects model). All data are means ± SEM. 
  






Peak duration and time gap of [Ca2+]i responses to CRH, AVP 
and CRH/AVP in female zDHHC23-KO corticotrophs 
 
Figure 5.51 Peak duration and time gap of [Ca2+]i responses to CRH, AVP and 
CRH/AVP in female zDHHC23-KO corticotrophs. Quantification of effects of 
exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in (A) peak 
duration and (B) time gap (n = 13 from 5 experiments, mixed effects model). All data 
are means ± SEM. 
  





5.2.4.3 CRH/AVP-induced [Ca2+]i responses are not significantly 
different between male and female zDHHC23-KO corticotrophs 
Although there were no synergistic [Ca2+]i responses to CRH/AVP in either male or 
female zDHHC23-KO corticotrophs at the level of population, we examined whether 
there were differences between male and female zDHHC23-KO corticotrophs. 
 
Statistical analysis revealed that there were no significant differences between male 
and female zDHHC23-KO corticotrophs in AUC (10 min) or AUC (peak), although 
male zDHHC23-KO corticotrophs tended to have larger [Ca2+]i responses to two single 
stimuli and combined stimulus compared to females (Figure 5.52). In addition, CRH-
, AVP-, CRH/AVP-induced [Ca2+]i responses showed no significant differences 
between male and female zDHHC23-KO corticotrophs in peak, time to peak, response 
duration, response duration (Figure 5.53) or time gap (Figure 5.54) either. 
 
In summary, there were no statistically significant differences between male and 
female zDHHC23-KO corticotrophs in [Ca2+]i responses induced by CRH, AVP and 
the combination of the two. 
  






No significant sex difference in AUC (10 min) or AUC (peak) of 
[Ca2+]i responses to CRH, AVP and CRH/AVP in zDHHC23-KO 
corticotrophs 
 
Figure 5.52 No significant sex difference in AUC (10 min) or AUC (peak) of [Ca2+]i 
responses to CRH, AVP and CRH/AVP in zDHHC23-KO corticotrophs. 
Quantification of effects of exposure to 0.2 nM CRH, 2 nM AVP and the combination 
of the two in (A) AUC (10 min) and (B) AUC (peak) (male n = 10 from 8 experiments, 
female n = 13 from 5 experiments, mixed effects model). All data are means ± SEM. 
  






No significant sex difference in peak, time to peak, response 
duration or peak duration of [Ca2+]i responses to CRH, AVP and 
CRH/AVP in zDHHC23-KO corticotrophs 
 
Figure 5.53 No significant sex difference in peak, time to peak, response duration 
or peak duration of [Ca2+]i responses to CRH, AVP and CRH/AVP in 
zDHHC23-KO corticotrophs. Quantification of effects of exposure to 0.2 nM CRH, 
2 nM AVP and the combination of the two in (A) peak, (B) time to peak, (C) response 
duration and (D) peak duration (male n = 10 from 8 experiments, female n = 13 from 
5 experiments, mixed effects model). All data are means ± SEM. 
  






No significant sex difference in time gap of [Ca2+]i responses 
to CRH, AVP and CRH/AVP in zDHHC23-KO corticotrophs 
 
Figure 5.54 No significant sex difference in time gap of [Ca2+]i responses to CRH, 
AVP and CRH/AVP in zDHHC23-KO corticotrophs. Quantification of effects of 
exposure to 0.2 nM CRH, 2 nM AVP and the combination of the two in time gap (male 
n = 10 from 8 experiments, female n = 13 from 5 experiments, mixed effects model). 
All data are means ± SEM. 
  






In this chapter, calcium imaging experiments were performed on zDHHC23-KO 
corticotrophs to investigate the role of zDHHC23 in controlling calcium signalling in 
murine corticotrophs. Global genetic deletion of zDHHC23 resulted in progressively 
attenuated [Ca2+]i responses to repeated CRH stimulation in both male and female 
corticotrophs. However, there were no significant differences when compared to 
[Ca2+]i responses induced by CRH in wild-type corticotrophs. Overall, loss of 
zDHHC23 had no significant effect on spontaneous or AVP-induced [Ca2+]i responses 
in murine corticotrophs. Interestingly, in a small proportion of zDHHC23-KO 
corticotrophs, the [Ca2+]i responses to repeated AVP stimulation in the same cell 
showed a mixture of sustained and oscillatory [Ca2+]i responses. This was never 
observed in wild-type corticotrophs that always showed deterministic responses to 
AVP. This suggests zDHHC23 may play a role in controlling the pattern of AVP-
induced [Ca2+]i signalling rather than effects on global or peak of [Ca
2+]i responses. 
Loss of zDHHC23 did not significantly affect synergistic [Ca2+]i responses to CRH 
and AVP. Thus, while zDHHC23 may play a role in the ability of corticotrophs to 
sustain repeated [Ca2+]i responses to CRH and control the pattern of AVP-induced 
[Ca2+]i signalling, overall zDHHC23 plays a relatively minor role in controlling [Ca
2+]i 
responses to either CRH or AVP in murine corticotrophs. 
 





5.3.1 Progressive attenuation of CRH-induced [Ca2+]i 
responses in zDHHC23-KO corticotrophs 
Genetic deletion of zDHHC23 did not affect spontaneous [Ca2+]i active time or 
maximum amplitude compared to wild-type corticotrophs. This suggests a limited role 
of zDHHC23 in controlling [Ca2+]i signalling under basal conditions. 
 
Compared to the robust and consistent [Ca2+]i responses in wild-type corticotrophs, 
repeated CRH stimulation resulted in a progressive attenuation of [Ca2+]i responses in 
both male and female zDHHC23-KO corticotrophs. However, [Ca2+]i responses were 
not significantly different from [Ca2+]i responses to CRH in wild-type corticotrophs. 
Genetic deletion of zDHHC23 is predicted to reduce cell surface expression of BK 
channels in corticotrophs as it controls BK channel trafficking. Previous studies 
in HEK293 cells reported that S-acylation of the S0-S1 loop of BK channels was 
mainly controlled by zDHHC23, which was involved in controlling BK channel 
surface trafficking (Tian et al., 2012). Loss of S0-S1 loop S-acylation reduces BK 
channel cell surface expression by ~ 50% and thus represents a partial loss of function. 
Thus, the progressive attenuation of CRH-, but not AVP-induced [Ca2+]i responses in 
zDHHC23-KO corticotrophs may represent a partial loss of BK channel function. 
However, it remains unclear whether BK channel surface expression is reduced in 
murine corticotrophs lacking zDHHC23. This represents a significant technical 





challenge as zDHHC23 and BK channels are expressed in other anterior pituitary cells 
such as somatotrophs and gonadotrophs (Van Goor et al., 2001a). Thus, purification 
of corticotrophs will be required to allow proteomic analysis of BK channel 
S-acylation in zDHHC23-KO corticotrophs and BK channel cell surface expression is 
hampered by a lack of antibodies to external epitopes of BK channels. Clearly, voltage 
clamp recordings are required to determine whether loss of zDHHC23 results in 
reduced BK channel currents in corticotrophs. 
 
Ablation of BK channels resulted in a significant reduction in [Ca2+]i responses in male 
corticotrophs whereas genetic deletion of zDHHC23 only induce minor differences 
that are not statistically significant different. These results may suggest that zDHHC23 
is not an important determinant in the regulation of CRH-induced [Ca2+]i responses or 
regulate corticotroph calcium signalling through a BK-independent pathway. In 
addition, the gradually declining calcium signals may also suggest the role of 
zDHHC23 in maintaining appropriate responses to repeated stressors on a longer 
timescale.  
 
However, as CRH-induced [Ca2+]i responses were progressively reduced in both male 
and female corticotrophs from zDHHC23-KO mice, whereas genetic ablation of BK 
channels only attenuated CRH-induced [Ca2+]i responses in male corticotrophs, this 





suggest that the small effects of zDHHC23 may result from controlling of S-acylation 
of other components of the CRH-signalling pathway. To date relatively few targets for 
zDHHC23 have been identified, although the STRING database (Szklarczyk et al., 
2017) suggests zDHHC23 may interact with other proteins such as zinc finger protein 
Zfp69, Zfp84 and S-acyl transferase zDHHC22 (String-db.org, 2019). zDHHC22 has 
also been shown to control S-acylation of BK channels and regulate the localization 
of BK channels at the plasma membrane (Tian et al., 2012). In addition, G-protein 
coupling receptors (GPCRs), including CRH receptors,  adenylate cyclases (ACs) 
(Naumenko & Ponimaskin, 2018) and L-type Ca2+ channels (Chien et al., 1996) have 
been shown or predicted to be S-acylated. Taken together, genetic deletion of 
zDHHC23 may modify multiple pathways in corticotrophs although importantly these 
would appear to be important for CRH-, but not AVP-induced [Ca2+]i responses. To 
address whether zDHHC23 controls CRHR1 signalling pathway, PRESTO-Tango 
(parallel receptorome expression and screening via transcriptional output, with 
transcriptional activation following arrestin translocation) assay may provide a viable  
approach (Kroeze et al., 2015). 
 
5.3.2 Does zDHHC23 control the pattern of AVP-evoked [Ca2+]i 
responses in corticotrophs? 
Genetic deletion of zDHHC23 did not result in significant differences in [Ca2+]i 





responses to repeated AVP stimulation compared to wild-type controls. However, loss 
of zDHHC23 did result in a reduction in the percentage of corticotrophs that displayed 
oscillatory [Ca2+]i behaviour decreasing from 50.0% (12/24 cells) to 14.3% (2/14 cells) 
in female corticotrophs, while oscillatory [Ca2+]i behaviour was not observed in male 
zDHHC23-KO corticotrophs compared to 25.0% (4/16 cells) of male wild-type 
corticotrophs showing oscillatory [Ca2+]i behaviour. Moreover, repeated stimulation 
with AVP in wild-type corticotrophs always evoked consistent deterministic patterns 
of [Ca2+]i responses: either sustained elevation of [Ca
2+]i or oscillatory [Ca
2+]i 
behaviour was only observed in any single cell from 40 calcium imaging recordings. 
However, 20.0% (2/10 cells) of male and 7.1% (1/14 cells) of female zDHHC23-KO 
corticotrophs displayed a mixture of two phenotypes of [Ca2+]i response following 
repeated AVP stimulation. Previous studies in gonadotrophs revealed that 
gonadotropin-releasing hormone (GnRH) induced an oscillatory release of Ca2+ 
through IP3-sensitive intracellular calcium stores, which activates SK channels causing 
the hyperpolarization of gonadotrophs (Tse & Hille, 1992; Tse et al., 1993). Thus, a 
plausible explanation for the decreased oscillatory Ca2+ release in zDHHC23-KO 
corticotrophs, together with the mixture of [Ca2+]i response patterns, may indicate that 
zDHHC23 plays a role in the coupling between IP3-mediated Ca
2+ release and 
membrane ion channels that is important for the control of Ca2+ oscillations. 
 





5.4 Chapter summary  
Genetic deletion of the S-acyl transferase zDHHC23 had no significant effect on 
spontaneous [Ca2+]i signalling. Repeated CRH stimulation resulted in a progressive 
attenuation of [Ca2+]i responses in both male and female zDHHC23-KO corticotrophs, 
although this was not significantly different from wild-type controls. This suggests 
that zDHHC23 may have a minor role in supporting [Ca2+]i responses to repeated CRH 
stimulation but is unlikely to be due to control of BK channels per se as this was 
observed in both male and female corticotrophs. Following repeated AVP stimulation, 
corticotrophs isolated from zDHHC23-KO mice induced consistent and reproducible 
[Ca2+]i responses. However, AVP-induced oscillatory [Ca
2+]i behaviour was reduced 
in both male and female zDHHC23-KO corticotrophs compared to wild-type 
corticotrophs and a small proportion of cells responded with both sustained and 
oscillatory [Ca2+]i responses — something never observed in wild-type corticotrophs. 
In addition, female zDHHC23-KO corticotrophs showed a reduced proportion of cells 
that showed synergistic [Ca2+]i responses compared to wild-type. Taken together, this 
suggests that zDHHC23 may be important for controlling the pattern of AVP-induced 
[Ca2+]i signalling perhaps by controlling coupling between IP3-mediated Ca
2+ release 
and membrane ion channels.















General discussion and future work 
  





Chapter 6: General discussion and future 
work 
6.1 Hypothesis and aims 
The central hypothesis of this Thesis was that CRH-, but not AVP-induced intracellular 
free calcium ([Ca2+]i) responses are dependent on functional BK channels in murine 
corticotrophs. To address this hypothesis, the primary aims of this thesis were to: (i) 
exploit a new POMC-GCaMP6s reporter using lentivirus-mediated transduction to 
allow specific labelling of live murine corticotrophs in vitro; (ii) characterise the 
spontaneous and secretagogue-induced [Ca2+]i responses in wild-type corticotrophs; 
(iii) investigate the role of BK channels in regulating [Ca2+]i signalling in 
corticotrophs; (iv) identify the regulation of corticotroph [Ca2+]i signalling by S-acyl 
transferase zDHHC23.  
 
6.2 Discussion and future work 
6.2.1 CRH-induced [Ca2+]i responses are suppressed in male 
BK-KO corticotrophs 
The GCaMP6s calcium reporter was specifically expressed in murine corticotrophs by 
using lentiviral-mediated transduction under the control of a minimal rat Pomc 
promoter. This allowed robust real-time identification of live murine corticotrophs in 





vitro for calcium imaging experiments to examine spontaneous and secretagogue-
induced [Ca2+]i responses. In most previous studies, CRH and/or AVP-induced [Ca
2+]i 
responses were examined in response to a single supraphysiological concentration of 
secretagogue in corticotrophs. However, in vivo corticotrophs must respond to 
repeated changes in CRH and AVP at physiologically relevant concentrations. To 
address this, a repeated stimulation protocol was established in this study to allow 
robust and repeatable [Ca2+]i responses to pulses of secretagogue at physiological 
concentrations with frequency of pulses similar to those reported in vivo.  
 
Repeated CRH stimulation resulted in significant and rapid sustained elevation of 
global [Ca2+]i in wild-type corticotrophs with no significant differences between male 
and female wild-type corticotrophs. [Ca2+]i responses to repeated CRH stimulation in 
corticotrophs from male, but not female, BK-KO mice were significantly attenuated 
compared to wild-type. Surprisingly, CRH-induced [Ca2+]i responses were not 
significantly attenuated following acute pharmacological inhibition of BK channels in 
both male and female wild-type corticotrophs with the specific BK channel inhibitor 
paxilline. Previous studies have revealed that both genetic deletion and 
pharmacological inhibition of BK channels with paxilline prevents CRH-induced 
transition to bursting in male corticotrophs (Duncan et al., 2015). Taken together, these 
results suggest two potential mechanisms: (i) CRH-induced transition to bursting 





observed on the millisecond to second timescale, which are dependent on BK channels, 
is not important for the global [Ca2+]i responses measured over minutes in male 
corticotrophs (Figure 6.1); (ii) potential compensatory changes are occurring in male 
corticotrophs following global deletion of BK channels in ion channel landscape 
and/or CRH-induced signalling pathway. 
 
At face value, genetic deletion of BK channels resulted in the attenuation of 
CRH-induced [Ca2+]i responses in male corticotrophs suggest that loss of BK channels 
would decrease [Ca2+]i responses due to a loss of CRH-induced transition to bursting. 
However, surprisingly, acute pharmacological blockade of BK channels with paxilline 
did not show the same effect. This suggests that CRH-induced electrical bursting 
measured on the millisecond to second timescale probably has no direct link to global 
[Ca2+]i signalling measured over minutes. Genetic deletion or pharmacological 
inhibition of BK channels may result in the loss of bursting but have no impact on 
global [Ca2+]i signalling. Moreover, CRH has been shown to increases electrical 
spiking frequency in BK-KO, or paxilline treated, corticotrophs (Duncan et al., 2015). 
As CRH regulates corticotrophs through cAMP/PKA pathway that drives Ca2+ influx 
via L-type Ca2+ channels (Lee & Tse, 1997; Duncan et al., 2015), it is likely that 
inhibition of BK channels with paxilline, or knockout of BK channels, prevents the 
transition to CRH-induced bursting but still enables significant accumulation of global 






Schematic diagram of different timescale between global 
[Ca2+]i signalling and electrical activity in corticotrophs  
 
Figure 6.1 Schematic diagram of different timescale between global [Ca2+]i 
signalling and electrical activity in corticotrophs. (A) Global [Ca2+]i response is 
measured over minutes. (B) Electrical activity (spiking and bursting) is measured on 
the millisecond to second timescale. Grey shading indicates membrane potential 
between −50 mv to +10 mv. Electrical activity images are adapted from Duncan et al., 
2016. 





Ca2+ influx through single spiking. A recent study has also shown that electrical 
spiking can be as effective as bursting at evoking hormone secretion when release sites 
are located close to the channel or spiking frequency increases to a level to deliver the 
similar total amount of global Ca2+ as bursting (Tagliavini et al., 2016). To address 
these questions, it would be important to examine the correlation between [Ca2+]i 
responses measured on millisecond timescale and electrical bursting behaviour in 
corticotrophs. Furthermore, it is important to understand what is more important for 
hormone secretion in corticotrophs: the global [Ca2+]i signalling over minutes, the 
pattern of [Ca2+]i responses on millisecond timescale or the pattern of electrical activity 
(bursting). In addition, a calcium indicator expressed at the plasma membrane or 
vesicles will allow us to measure calcium changes at the level of plasma membrane or 
vesicle, which will help to address the role of calcium in evoking hormone secretion. 
 
As CRH-induced [Ca2+]i responses were significantly attenuated in male, but not 
female, BK-KO corticotrophs, and paxilline-treated corticotrophs showed different 
[Ca2+]i responses compared to BK-KO corticotrophs, the other potential mechanism is 
that compensation is occurring in corticotrophs. The ion channel landscape and/or 
signalling pathways have been modified to compensate for the long-term lack of BK 
channels in mice. Importantly, these compensatory changes specifically modify CRH, 
but not AVP-induced calcium signalling pathway and affect male and female 





corticotrophs differentially. Differences were observed between male and female 
BK-KO corticotrophs in both spontaneous and CRH-induced [Ca2+]i responses. 
Unpublished data from the Shipston Lab (Dr Peter J. Duncan, personal communication) 
revealed that female wild-type corticotrophs showed limited electrical bursting 
behaviour upon stimulation, with largely showing spiking frequency increases, which 
is different from male wild-type corticotrophs. This suggests that the functional role 
of BK channels and the ion channels/signalling pathways controlling spontaneous and 
CRH-induced [Ca2+]i responses are different between male and female corticotrophs. 
The compensatory changes may regulate CRH-induced calcium signalling pathways 
differentially between male and female corticotrophs. In addition, genetic deletion of 
BK channels resulted in a reduction in spontaneous [Ca2+]i active time in male 
corticotrophs whereas female BK-KO corticotrophs showed an increase compared to 
wild-type. The maximum amplitude of spontaneous [Ca2+]i signalling was unaffected 
by genetic deletion of BK channels. However, acute pharmacological inhibition of BK 
channels had no effect on either active time or maximum amplitude of spontaneous 
[Ca2+]i signalling, which may also reflect compensation. If the compensation really 
occurs in corticotrophs, how does the compensation modify the signalling pathway? 
Whether this down-regulates CRH receptor activation, the amount of L-type Ca2+ 
channels or up-regulates the sequestration of Ca2+ remain unknown. Analysis of 
changes in mRNA, protein and function levels of L-type Ca2+ channel and other ion 





channels in BK-KO corticotrophs will be required to address the compensation theory. 
As mice with global genetic deletion of BK channels were used in this study, the same 
calcium imaging experiments could be performed on corticotrophs from mice in which 
BK channels have been conditionally deleted only in corticotrophs to examine whether 
CRH induces similar [Ca2+]i responses.  
 
Genetic deletion of zDHHC23 had no effect on spontaneous [Ca2+]i signalling in any 
corticotrophs. This suggests that BK channels per se, rather than zDHHC23 that 
controls S-acylation of BK channels, is partly responsible for controlling [Ca2+]i 
signalling under basal conditions. Loss of zDHHC23 resulted in a progressive 
attenuation of [Ca2+]i responses to repeated CRH stimulation in both male and female 
corticotrophs. However, CRH-induced [Ca2+]i responses were not significantly 
different from wild-type. This suggests the limited role of zDHHC23 in the regulation 
of CRH-induced [Ca2+]i responses or zDHHC23 regulates corticotroph [Ca
2+]i 
signalling through a BK-independent pathway. Voltage clamp recordings could be 
performed in zDHHC23-KO corticotrophs to determine whether loss of zDHHC23 
leads to reduced BK channel currents in corticotrophs. 
  





6.2.2 Genetic deletion of BK channels or zDHHC23 have no 
effect on AVP-induced [Ca2+]i responses in corticotrophs 
Following repeated AVP stimulation, two phenotypes of [Ca2+]i response, sustained 
elevation of [Ca2+]i and oscillatory [Ca
2+]i behaviour, were observed in wild-type 
corticotrophs. These distinct [Ca2+]i response patterns were deterministic in wild-type 
corticotrophs and no sex differences were observed. Corticotrophs from both male and 
female BK-KO mice showed significant elevation of [Ca2+]i following AVP 
stimulation and two phenotypes of [Ca2+]i response were observed as well. However, 
there were no significant differences between wild-type and BK-KO corticotrophs in 
both sexes. This suggests that BK channels are not vital in controlling AVP-induced 
[Ca2+]i responses in corticotrophs. This is in accord with the role of BK channels in 
regulating electrical activity. Genetic deletion of BK channels results in an increase in 
spiking frequency rather than a transition to bursting in male corticotrophs following 
AVP stimulation (Duncan et al., 2015). AVP-induced electrical activity is independent 
of BK channels, which agrees with the lack of effect on [Ca2+]i responses in BK-KO 
corticotrophs. As AVP regulates corticotrophs through IP3/PKC pathway which results 
in the release of calcium from intracellular IP3-sensitive calcium pool as well as influx 
via L-type Ca2+ channels (Tse & Lee, 1998; Romanò et al., 2017), this suggests that 
the potential compensatory changes observed in CRH-induced [Ca2+]i responses in 
BK-KO corticotrophs are not involved in AVP-induced calcium signalling pathways. 





It may also suggest that Ca2+ influx via L-type Ca2+ channels is not a major component 
in regulating AVP-induced [Ca2+]i responses in murine corticotrophs. Loss of 
zDHHC23 had no significant effect on [Ca2+]i responses to repeated AVP stimulation 
in either male or female corticotrophs compared to wild-type. Interestingly, genetic 
deletion of BK channels and zDHHC23 resulted in a reduction in the percentage of 
female corticotrophs displaying oscillatory [Ca2+]i behaviour compared to female 
wild-type corticotrophs. Furthermore, both male and female corticotrophs from 
BK-KO and zDHHC23-KO mice displayed a mixture of two phenotypes of [Ca2+]i 
responses following repeated AVP stimulation, which is different from wild-type 
corticotrophs always showing consistent deterministic patterns of [Ca2+]i responses. 
Oscillatory [Ca2+]i behaviour is likely to result primarily from IP3-sensitive calcium 
signalling. These data suggest that BK channels and zDHHC23 play no major role in 
controlling AVP-induced [Ca2+]i responses in corticotrophs, however, they may partly 
regulate the coupling between IP3-mediated Ca
2+ release and membrane ion channels 
that is important for the control of Ca2+ oscillations. 
 
6.2.3 Lack of synergistic [Ca2+]i responses to CRH and AVP 
CRH and AVP have been shown to act synergistically to increase the secretion of 
ACTH in corticotrophs. This synergy has been considered to occur at multiple levels 
signalling in corticotrophs. However, whether the synergy also occurs at the level of 





intracellular free calcium is largely unexplored. This study suggests that there was no 
synergistic [Ca2+]i response in any male corticotrophs isolated from wild-type, BK-KO 
or zDHHC23-KO mice. Although female corticotrophs did not display synergistic 
[Ca2+]i responses to CRH and AVP at the population level, ~ 30% of wild-type, ~ 5% 
of BK-KO and ~ 8% of zDHHC23-KO female corticotrophs showed synergistic 
[Ca2+]i responses at the single cell level. It is unclear whether this proportion of female, 
but not male, corticotrophs that shows synergistic [Ca2+]i responses reflects stochastic 
variability in corticotroph signalling pathways or represents distinct subpopulation of 
corticotrophs. In addition, the high degree of variability in spontaneous [Ca2+]i 
signalling that can be roughly categorized into three subtypes may also reflect 
stochastic variability in corticotroph behaviour or implies potential distinct 
subpopulation of corticotrophs. To address this, corticotroph [Ca2+]i signalling could 
be analysed in pituitary slices instead of pituitary cultures to determine whether there 
is a correlation between [Ca2+]i responses and the location of corticotrophs within the 
pituitary gland. It is possible that synergistic [Ca2+]i responses to CRH and AVP were 
not observed in this study because 0.2 nM CRH alone and 2 nM AVP alone have 
already induced maximal [Ca2+]i responses. Although this was not been formally tested 
in these studies, these concentrations of CRH alone and AVP alone did not maximally 
stimulate ACTH secretion in primary isolated rodent corticotrophs in vitro and when 
administered together synergistic stimulation of ACTH release was measured (Vale et 





al., 1981; Gibbs & Vale, 1982; unpublished data from the Shipston Lab). To verify that 
the concentrations for both CHR and AVP were not maximal, a dose-response curve 
determining [Ca2+]i responses to a wide range of both CRH alone and AVP alone 
concentrations is required for future studies. In addition, as the synergy between CRH 
and AVP does not occur at the level of [Ca2+]i may suggest that synergistic secretion 
of ACTH is regulated through other signalling pathways rather than the intracellular 
free calcium.  
 
[Ca2+]i signalling has not been systematically analysed in mouse corticotrophs between 
males and females in previous studies, although sexual dimorphism has been shown 
to occur at multiple levels of HPA axis function. Sex differences observed in this study 
may suggest potential sexual dimorphism also occurs at the level of corticotroph 
calcium signalling. Thus, it is necessary to investigate the regulation of corticotroph 
calcium signalling in male and female corticotrophs respectively in further studies. 
The stage of the oestrous cycle of the female mice used in this study was not 
determined. As indicated in Chapter One, sex steroids can regulate the expression and 
function of ion channels expressed in the pituitary and the activity of the HPA stress 
axis varies during different stages of oestrous cycles (Fiordelisio et al., 2007; 
Panagiotakopoulos & Neigh, 2014). In future studies, monitoring the oestrous cycles 
of the female animals used will be valuable to examine whether apparent differences 





between male and female corticotrophs may, in part, be dependent on the stage of the 
oestrous cycle. 
 
In the intact mouse anterior pituitary, 5-10% of the cells are corticotrophs; that is, 
representing approximately 4,000-5,000 cells. In the majority of the calcium imaging 
experiments done in this study, a minimum of 10 cells were randomly analysed under 
each condition, which thus represents less than 0.5% of the total population of 
corticotrophs in the anterior pituitary gland. However, in each group, the results were 
relatively consistent that might suggesting that they might be representative of the 
whole population. Further studies using larger numbers of cells to investigate the 
potential heterogeneity of corticotroph properties and regulation are required as well 
as in ex vivo experiments using the intact pituitaries to address whether location in the 
gland is also an important factor. 
 
6.3 Conclusion 
In conclusion, development of the POMC-GCaMP6s lentivirus allowed the specific 
identification of murine anterior pituitary corticotrophs in vitro and the examination of 
spontaneous and CRH- and/or AVP-induced [Ca2+]i responses in corticotrophs. CRH 
induced sustained elevations of [Ca2+]i whereas AVP evoked two phenotypes of [Ca
2+]i 
response: sustained [Ca2+]i elevation and oscillatory [Ca
2+]i response. Genetic deletion 





of BK channels significantly reduced CRH-, but not AVP-induced [Ca2+]i responses in 
male, but not female, corticotrophs. However, acute pharmacological blockade of BK 
channels did not show the same effect in wild-type corticotrophs. This suggests 
potential compensatory mechanisms may occur in corticotrophs as a result of deletion 
of BK channels. Moreover, CRH-induced transition to bursting, which are dependent 
on BK channels, may be not important for the global changes in [Ca2+]i responses 
measured over minutes. zDHHC23 plays a limited role in controlling [Ca2+]i signalling 
in corticotrophs. There is no synergy between CRH and AVP in corticotrophs at the 
intracellular free calcium level. 
 
Anterior pituitary corticotrophs, the central components of the HPA axis, are important 
for regulating the neuroendocrine responses to stress. Corticotrophs receive inputs 
from hypothalamic secretagogues with the negative feedback of glucocorticoids from 
the adrenal gland at the level of both the pituitary and the hypothalamus to keep the 
balance of HPA axis. The secretion of ACTH is regulated through an increase in 
electrical excitability in corticotrophs, which is associated with an increase in the level 
of intracellular free calcium. Therefore, it is important to characterise the role of 
specific ion channels and their signalling pathways in regulating electrical activity and 
[Ca2+]i responses of corticotrophs. Further studies of the correlation between electrical 
excitability and [Ca2+]i signalling in corticotrophs would suggest potential 





mechanisms for ACTH secretion and HPA axis regulation. Glucocorticoid has been 
shown to suppress bursting activity following CRH/AVP stimulation in corticotrophs 
(Duncan et al., 2016), thus it is important to further investigate the regulation of 
corticotroph [Ca2+]i signalling by glucocorticoids which would provide new insight of 
negative feedback in controlling HPA axis function at the level of [Ca2+]i signalling. 
The approach developed in this Thesis will allow us to explore the mechanisms of 
[Ca2+]i signalling and its regulation that will lead to a greater understanding of the 
physiological role of corticotrophs and the control of the stress axis, which potentially 
leads to novel therapeutic targets and drugs for stress-related disorders. 
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files <- dir(pattern = "csv$") 
files <- files[grep("treatments", files, invert = T)] 
 
shinyUI( 
  fluidPage 
      ( 
      titlePanel("Calcium Imaging Analysis"), 
      sidebarLayout 
        ( 
        sidebarPanel 
            ( 
            selectInput("experiment", "Experiment", choices = c("Select an 
experiment", files)),  
            selectInput("visualization", label = "Plot type", choices = c("All traces" = 
"traces", 
                                      "Single trace" = "single”)), 
            fluidRow( 
              column(width = 3,numericInput("timeFrom", "Min time", min = 0, max 
= 1000,              step = 0.5, value = 0,width = 100)), 
              column(width = 3, numericInput("timeTo", "Max time", min = 0, max = 
1000,                step = 0.5, value = 120, width = 100)), 
              column(width = 3, numericInput("yFrom", "Min y", step = 0.5, value = 
0, width              = 100)), 
              column(width = 3, numericInput("yTo", "Max y", step = 0.5, value = 
1000, width              = 100)), 
              column(width = 5, checkboxInput("autoscaleY", "autoscale y", value = 
TRUE)), 
              column(width = 5, checkboxInput("normalise", "normalise y", value = 
FALSE)) 
               ), 
          downloadButton('downloadPlot', 'Download Plot (PDF)'), 
          conditionalPanel( 
             "(input.visualization == 'single' || input.visualization == 'peaks') && 
input.experiment != 'Select an experiment'", 
             sliderInput("traceNum", label = "Trace #", min = 1, max = 10, step = 1, 
value = 1, round = TRUE, ticks = FALSE), 
             checkboxInput("bgSub", label = "Background subtracted", value = 
TRUE), 




             checkboxInput("showActThr", label = "Show activity threshold", value 
= FALSE), 
             sliderInput("centile", label = "Centile", min = 1, max = 100, step = 1, 
value = 10), 
             sliderInput("span", label = "Span", value = 0.2, min = 0.01, max = 2, step 
= 0.01), 
             sliderInput("activityThresh", label = "Activity threshold", value = 0.15, 
min = 0.01, max = 1, step = 0.01) 
            ),  
            conditionalPanel( 
               "input.visualization == 'single' && input.experiment != 'Select an 
experiment'", 
                checkboxInput("showTreatments", "Show treatments", value = 
TRUE), 
                checkboxInput("showStats", "Show statistics", value = TRUE) 
              ), 
            conditionalPanel( 
                "input.showStats == 1 && input.visualization == 'single'  
                  && input.experiment != 'Select an experiment'", 
                verbatimTextOutput("plotStats") 
                ) 
            ),  
          mainPanel 
              ( 
              plotOutput("mainPlot", height = "500px", click = "plotClick", hover = 
hoverOpts("plot_hover", delay = 100, delayType = "throttle")), 
              conditionalPanel( 
                  "input.visualization == 'single'  
                  && input.experiment != 'Select an experiment'", 
                  verbatimTextOutput("plotCoords")), 
              conditionalPanel( 
                  "input.visualization != 'peaks'  
                  && input.experiment != 'Select an experiment'", 
                  tableOutput("treatmentTable")) 
                           ) 
      ) 
    ) 
  ) 
 
  





II. The Sever script 
library(shiny) 
 
fmt <- function(num, dig = 2) 
  { 
  format(num, nsmall = dig, digits = dig, scientific = FALSE) 
  } 
 
shinyServer(function(input, output, clientData, session) 
  { 
  read.data <- reactive( 
    { 
    if (input$experiment != "Select an experiment") 
      { 
      tmp <- read.csv(input$experiment) 
      calcium$traces <- as.matrix(tmp[, !(colnames(tmp) %in% c("Background", 
"Time"))]) 
      if (is.null(tmp$Background)) 
        calcium$bg <- 1:nrow(calcium$traces) 
      else 
        calcium$bg <- tmp$Background 
      if (is.null(tmp$Time)) 
        calcium$time <- rep(0, nrow(calcium$traces)) 
      else 
        calcium$time <- tmp$Time 
      treatments.file <- paste(substr(input$experiment, 1, nchar(input$experiment) - 
4), "- treatments.csv") 
      if (file.exists(treatments.file)) 
        calcium$treatments <- read.csv(treatments.file) 
      else 
        calcium$treatments <- NULL 
       
      calcium$baseline <- NULL 
      calcium$baselinesd <- NULL 
       
      updateSliderInput(session, "traceNum", max = ncol(calcium$traces)) 
      updateNumericInput(session, "timeTo", value = max(calcium$time)/60) 
       
      calcium$peaks.start <- NULL 
      calcium$peaks.end <- NULL 
      calcium$peaks <- NULL 
      } 
    }) 
 
  calcium <- reactiveValues() 




    click1 = NULL,   
    range = NULL    
    ) 
 
  observeEvent(input$plotClick,  
              { 
              if (is.null(clicksValues$click1)) 
                  { 
                  clicksValues$click1 <- max(1, input$plotClick$x) * 60 
                  clicksValues$range <- NULL 
                  } 
              else  
                  { 
                  clicksValues$range <- range(clicksValues$click1, max(1, 
input$plotClick$x) * 60) 
                  clicksValues$click1 <- NULL 
                  } 
              }) 
   
  output$plotStats <- renderPrint( 
    { 
    trace <- calcium$traces[,input$traceNum] 
    basecv <- trace[1:calcium$treatments$From[1]] -  
              calcium$bg[1:calcium$treatments$From[1]] 
    basecv <- (basecv - min(basecv)) / diff(range(basecv)) 
    basecv <- sd(basecv) / mean(basecv) 
 
    if (is.null(clicksValues$range))  
      { 
      cat("Select a region of the plot (two clicks) to get stats.") 
      } 
    else 
      { 
      rg <- clicksValues$range 
       
      region <- trace[rg[1]:rg[2]] - calcium$bg[rg[1]:rg[2]] 
      region.scaled <- (region - min(trace-calcium$bg)) / diff(range(trace-
calcium$bg)) 
       
      output <- paste0("Length: ", fmt(diff(rg) / 60), " (", fmt(rg[1] / 60),  
                          " to ", fmt(rg[2] / 60) ,")", 
                       "\nMean value: ", fmt(mean(region)), 
                       "\nMax value: ", fmt(max(region)),  
                          " at ", fmt((which.max(region) + rg[1]) / 60), 
                       "\nCV: ", fmt(sd(region)/mean(region)), 
                       "\nAUC: ", fmt(sum(region) - 
sum(calcium$baseline[rg[1]:rg[2]])), 
                       "\n%Time active: ", fmt(sum(region.scaled > 






                                                 length(region.scaled) * 100) 
                       ) 
      cat(output) 
      } 
    }) 
   
  output$treatmentTable <- renderTable( 
    { 
    if (input$experiment == "Select an experiment") 
      { 
      NULL 
      } 
    else if (!is.null(calcium$treatments)) 
      { 
      data.frame("Treatment" = calcium$treatments$Treatment, 
                 "From" = calcium$treatments$From / 60, 
                 "Duration" = calcium$treatments$Duration / 60) 
      } 
    else 
      { 
      NULL 
      }  
    }) 
   
  output$plotCoords <- renderPrint( 
    if (!is.null(input$plot_hover) & input$visualization == "single") 
      paste("X:", format(input$plot_hover$x, digits = 2, nsmall = 1),  
            "- Y:", format(input$plot_hover$y, digits = 2, nsmall = 1)) 
    else 
      cat(" ") 
    ) 
   
  output$peakStats <- renderPrint( 
    cat(paste("Number of peaks: ", length(calcium$peaks))) 
    ) 
   
  plotTraceFn <- function() 
      { 
      read.data() 
       
      if (input$experiment == "Select an experiment") 
      { 
        plot(0, 0, "n", axes = F, xlab = "", ylab = "") 
      } 
      else 
      { 




        { 
        
          if (input$visualization == "traces") 
          { 
            plot(0, 0, "n", ylim = c(1, ncol(calcium$traces) + 1), bty = "n",  
                 xlab = "Time (min)", ylab = "", yaxt = "n",  
                 xlim = c(input$timeFrom, input$timeTo) 
            i <- 1 
            apply(calcium$traces, 2, function(t) 
            { 
              t <- t - calcium$bg 
              t <- (t - min(t)) / diff(range(t)) 
              lines(calcium$time / 60, t + i) 
              i <<- i + 1 
            }) 
             
            if (!is.null(calcium$treatments)) 
            { 
              tr <- calcium$treatments 
              rect(tr$From/60, 0, tr$From/60 + tr$Duration/60, ncol(calcium$traces) 
* 2,  
                   border = 0, col = rgb(0, 0, 0, 0.2)) 
            } 
          } 
     
          else if (input$visualization == "single") 
          { 
            if (input$bgSub) 
            { 
              trace <- calcium$traces[,input$traceNum] - calcium$bg 
            } 
            else 
            { 
              trace <- calcium$traces[,input$traceNum]  
            }  
            times <- calcium$time / 60  
            if (input$normalise) 
            { 
              plot(times, (trace-min(trace)) / (max(trace)-min(trace)), t = "l", las = 1, 
xlim = c(input$timeFrom, input$timeTo), ylim = c(0, 1), xlab = "Time (min)", ylab = 
"", bty = "n", yaxt = "n") 
              axis(2, at = seq(0, 1, 0.2), las = 1) 
            } 
            else if (input$autoscaleY) 
              plot(times, trace, t = "l", las = 1, xlim = c(input$timeFrom, 
input$timeTo), xlab = "Time (min)", ylab = "", bty = "n") 
            else 
              plot(times, trace, t = "l", las = 1, xlim = c(input$timeFrom, 





input$timeTo), xlab = "Time (min)", ylab = "", bty = "n", ylim = c(input$yFrom, 
input$yTo)) 
             
            if (!is.null(calcium$treatments) & input$showTreatments) 
            { 
              tr <- calcium$treatments 
              rect(tr$From/60, -100, tr$From/60 + tr$Duration/60, max(trace) * 2,  
                   border = 0, col = rgb(0, 0, 0, 0.2)) 
            } 
             
            if (input$showBase) 
            { 
              q <- quantile(trace, input$centile/100) 
              baseline <- trace 
              baseline[baseline >= q] <- q 
              ls <- loess(baseline ~ times, span = input$span) 
              calcium$baseline <- predict(ls) 
              lines(times, calcium$baseline, col = "darkgreen", lwd = 2) 
            } 
             
            if (input$showActThr) 
            { 
              if (input$normalise) 
                abline(h = input$activityThresh, lty = "dashed", col = "orange") 
              else 
                abline(h = min(trace) + input$activityThresh * diff(range(trace)), 
                       lty = "dashed", col = "orange") 
            } 
             
            if (input$showStats) 
            { 
              rn <- clicksValues$range 
               
              if (!is.null(clicksValues$click1)) 
              { 
                abline(v = clicksValues$click1/60, lwd = 2, col = "darkorange") 
              } 
               
              if (!is.null(rn)) 
              { 
                rect(rn[1]/60, -100, rn[2]/60, max(trace) * 2,  
                     col = rgb(.9, .4, 0, .1), border = "darkorange") 
                 
                region <- trace[rn[1]:rn[2]] 
                 
                if (!is.null(calcium$baseline)) 
                  polygon(c(times[rn[1]:rn[2]], times[rn[2]:rn[1]]), 





                          border = NA) 
              } 
            }           
          } 
          
          else if (input$visualization == "peaks") 
          { 
            if (input$bgSub) 
            { 
              trace <- calcium$traces[,input$traceNum] - calcium$bg 
            } 
            else 
            { 
              trace <- calcium$traces[,input$traceNum]  
            } 
            times <- calcium$time / 60 
            if (input$autoscaleY) 
              plot(times, trace, t = "l", las = 1, xlim = c(input$timeFrom, 
input$timeTo), xlab = "Time (min)", ylab = "", bty = "n") 
            else 
              plot(times, trace, t = "l", las = 1, xlim = c(input$timeFrom, 
input$timeTo), xlab = "Time (min)", ylab = "", bty = "n", ylim = c(input$yFrom, 
input$yTo)) 
             
            q <- quantile(trace, input$centile/100) 
            baseline <- trace 
            baseline[baseline >= q] <- q 
            ls <- loess(baseline ~ times, span = input$span) 
            calcium$baseline <- predict(ls) 
             
            if (input$showBase) 
            { 
              lines(times, calcium$baseline, col = "darkgreen", lwd = 2) 
            } 
             
            calcium$baselinesd <- sd(trace[trace <= quantile(trace, 
input$centile/100)]) 
             
            threshold <- baseline + input$minheight * calcium$baselinesd 
             
            calcium$peaks <- NULL 
            calcium$peaks.start <- NULL 
            calcium$peaks.end <- NULL 
             
            t <- 2 
            last.end <- 1 
             





            while (t < length(trace)) 
            { 
              if (trace[t] > threshold[t]) 
              { 
                start <- which((trace[last.end:t] - baseline[last.end:t]) <= 0) 
                if (length(start) > 0) 
                  start <- max(start) + last.end 
                else 
                { 
                  t <- t + 1 
                  next 
                } 
                end <- which((trace[-1:-t] - baseline[-1:-t]) <= 0) 
                if (length(end) > 0) 
                  end <- min(end) + t 
                else 
                { 
                  t <- t + 1 
                  next 
                } 
                 
                last.end <- end 
                 
                peak <- which.max(trace[start:last.end]) + start - 1 
                 
                if ((end - start) >= input$peakwidth[1] & 
                    (end - start) <= input$peakwidth[2]) 
                { 
                  calcium$peaks.start <- c(calcium$peaks.start, start) 
                  calcium$peaks.end <- c(calcium$peaks.end, end) 
                  calcium$peaks <- c(calcium$peaks, peak) 
                   
                  t <- tail(calcium$peaks.end, 1) + 1 
                } 
              } 
               
              t <- t + 1 
            } 
             
            if (input$showPeaks) 
            { 
              points(times[calcium$peaks], trace[calcium$peaks], col = "purple", pch 
= 20, cex = 2) 
              points(times[calcium$peaks.start], trace[calcium$peaks.start], col = 
"blue", pch = 20, cex = 1) 
              points(times[calcium$peaks.end], trace[calcium$peaks.end], col = 
"orange", pch = 20, cex = 1) 




          } 
        } 
      } 
    } 
 
  output$mainPlot <- renderPlot( 
    { 
    plotTraceFn() 
    }) 
   
  output$downloadPlot <- downloadHandler( 
    contentType = "application/pdf", 
    filename = "plot.pdf", 
    content = function(file)  
      { 
      pdf(file, width = 10, height = 8) 
      plotTraceFn() 
      dev.off() 
      } 
    ) 
   
  }) 
 
 
